Adtalem Global Education (ATGE) 10-Q 5 May 20 2020 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Mar. 31, 2020	Apr. 28, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2020
Document Transition Report	false
Entity File Number	1-13988
Entity Registrant Name	Adtalem Global Education Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	36-3150143
Entity Address, Address Line One	500 West Monroe Street
Entity Address, City or Town	Chicago
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60661
City Area Code	866
Local Phone Number	374-2678
Title of 12(b) Security	Common stock,
Trading Symbol	ATGE
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		51,802,441
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000730464
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019
Current assets:
Cash and cash equivalents	$ 167,771	$ 204,202	$ 230,700
Investments in marketable securities	7,754	8,680	8,341
Restricted cash	807	1,022	391
Accounts receivable, net	98,732	83,560	89,578
Prepaid expenses and other current assets	126,785	29,313	44,524
Current assets held for sale	142,417	177,923	166,557
Total current assets	544,266	504,700	540,091
Noncurrent assets:
Property and equipment, net	286,346	283,433	279,387
Operating lease assets	188,629	0	0
Deferred income taxes	15,066	18,314	19,199
Intangible assets, net	290,092	297,989	237,013
Goodwill	686,235	687,256	627,685
Other assets, net	84,825	52,113	54,386
Other assets held for sale	348,561	398,891	390,942
Total noncurrent assets	1,899,754	1,737,996	1,608,612
Total assets	2,444,020	2,242,696	2,148,703
Current liabilities:
Accounts payable	33,932	53,385	39,092
Accrued payroll and benefits	40,373	46,664	39,439
Accrued liabilities	60,458	76,529	74,614
Deferred revenue	120,047	95,944	108,370
Current operating lease liabilities	51,926	0	0
Current portion of long-term debt	3,000	3,000	3,000
Current liabilities held for sale	34,950	36,109	44,690
Total current liabilities	344,686	311,631	309,205
Noncurrent liabilities:
Long-term debt	446,610	398,094	288,589
Long-term operating lease liabilities	179,195	0	0
Deferred income taxes	28,147	29,426	33,278
Other liabilities	91,011	86,326	88,190
Noncurrent liabilities held for sale	56,850	16,146	16,372
Total noncurrent liabilities	801,813	529,992	426,429
Total liabilities	1,146,499	841,623	735,634
Commitments and contingencies (Note 19)
Redeemable noncontrolling interest	2,962	9,543	8,482
Shareholders' equity:
Common stock, $0.01 par value per share, 200,000 shares authorized; 51,802, 55,303, and 56,954 shares outstanding as of March 31, 2020, June 30, 2019, and March 31, 2019, respectively	806	801	801
Additional paid-in capital	499,703	486,061	483,043
Retained earnings	2,183,620	2,012,902	1,964,169
Accumulated other comprehensive loss	(276,379)	(137,290)	(148,706)
Treasury stock, at Cost, 28,790, 24,830, and 23,149 shares as of March 31, 2020, June 30, 2019, and March 31, 2019, respectively	(1,113,191)	(970,944)	(894,720)
Total shareholders' equity	1,294,559	1,391,530	1,404,587
Total liabilities and shareholders' equity	$ 2,444,020	$ 2,242,696	$ 2,148,703

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Thousands	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019
Statement of Financial Position [Abstract]
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01
Common Stock, Shares Authorized	200,000	200,000	200,000
Common Stock, Shares Outstanding	51,802	55,303	56,954
Treasury Stock, Shares	28,790	24,830	23,149

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenue	$ 271,487	$ 258,703	$ 792,272	$ 749,603
Operating cost and expense:
Cost of educational services	118,712	120,192	374,004	349,803
Student services and administrative expense	96,434	90,746	292,169	269,161
Restructuring expense	1,854	2,186	10,339	45,194
Gain on sale of assets	0	0	(4,779)	0
Settlement gain			0	(15,571)
Total operating cost and expense	217,000	213,124	671,733	648,587
Operating income from continuing operations	54,487	45,579	120,539	101,016
Other income (expense):
Interest and dividend income	782	1,062	2,675	3,204
Interest expense	(5,191)	(4,786)	(15,585)	(14,710)
Investment (loss) gain	(1,548)	715	(1,106)	(407)
Gain on derivative	111,838		83,832	0
Net other income (expense)	105,881	(3,009)	69,816	(11,913)
Income from continuing operations before income taxes	160,368	42,570	190,355	89,103
Provision for income taxes	(6,937)	(7,843)	(18,213)	(17,370)
Income from continuing operations	153,431	34,727	172,142	71,733
Discontinued operations:
(Loss) income from discontinued operations before income taxes	(5,947)	3,222	(5,536)	1,271
Loss on disposal of discontinued operations before income taxes		(265)	0	(32,979)
Benefit from income taxes	3,228	182	3,778	5,762
(Loss) income from discontinued operations	(2,719)	3,139	(1,758)	(25,946)
Net income	150,712	37,866	170,384	45,787
Net loss attributable to redeemable noncontrolling interest from continuing operations	120	113	334	265
Net income attributable to redeemable noncontrolling interest from discontinued operations		(74)	0	(382)
Net income attributable to Adtalem Global Education	150,832	37,905	170,718	45,670
Amounts attributable to Adtalem Global Education:
Net income from continuing operations	153,551	34,840	172,476	71,998
Net (loss) income from discontinued operations	(2,719)	3,065	(1,758)	(26,328)
Net income attributable to Adtalem Global Education	$ 150,832	$ 37,905	$ 170,718	$ 45,670
Basic:
Continuing operations	$ 2.90	$ 0.60	$ 3.19	$ 1.22
Discontinued operations	(0.05)	0.05	(0.03)	(0.44)
Net	2.85	0.65	3.15	0.77
Diluted:
Continuing operations	2.88	0.59	3.16	1.20
Discontinued operations	(0.05)	0.05	(0.03)	(0.44)
Net	$ 2.83	$ 0.64	$ 3.13	$ 0.76
Weighted-average shares outstanding:
Basic shares	52,955	58,061	54,117	59,199
Diluted shares	53,319	58,802	54,576	60,004

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Condensed Financial Information of Parent Company Only Disclosure [Abstract]
Net income	$ 150,712	$ 37,866	$ 170,384	$ 45,787
Other comprehensive income (loss), net of tax
Loss on foreign currency translation adjustments	(117,669)	(5,238)	(139,539)	(6,193)
Unrealized (loss) gain on marketable securities, net of tax	(44)	50	(2)	36
Unrealized gain on interest rate swap, net of tax	452		452	0
Comprehensive income	33,451	32,678	31,295	39,630
Comprehensive loss attributable to redeemable noncontrolling interest	271	138	586	51
Comprehensive income attributable to Adtalem Global Education	$ 33,722	$ 32,816	$ 31,881	$ 39,681

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating activities:
Net income	$ 170,384	$ 45,787
Loss from discontinued operations	1,758	25,946
Income from continuing operations	172,142	71,733
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	11,328	10,369
Amortization and adjustments to operating lease assets	32,369	0
Depreciation	25,773	24,726
Amortization	8,860	5,990
Provision for bad debts	12,955	5,150
Deferred income taxes	1,824	23,717
Loss on disposals, accelerated depreciation, and adjustments to property and equipment	147	41,082
Realized and unrealized loss on investments	1,106	407
Realized gain on sale of assets	(4,779)	0
Insurance settlement gain	0	(15,571)
Unrealized gain on derivative	(83,832)	0
Changes in assets and liabilities:
Accounts receivable	(19,922)	(24,511)
Prepaid expenses and other current assets	(17,123)	(11,948)
Accounts payable	(18,495)	(4,433)
Accrued payroll and benefits	(6,291)	(12,755)
Accrued liabilities	(4,810)	6,156
Deferred revenue	24,103	9,423
Operating lease liabilities	(41,628)	0
Other assets and liabilities	(2,041)	(22,355)
Net cash provided by operating activities-continuing operations	91,686	107,180
Net cash provided by operating activities-discontinued operations	13,845	21,355
Net cash provided by operating activities	105,531	128,535
Investing activities:
Capital expenditures	(31,934)	(45,269)
Insurance proceeds received for damage to buildings and equipment	0	35,706
Proceeds from sales of marketable securities	1,572	1,625
Purchases of marketable securities	(1,755)	(6,070)
Proceeds from sale of assets	6,421	0
Cash received on purchase price adjustment	92	0
Loan to DeVry University	0	(10,000)
Net cash used in investing activities-continuing operations	(25,604)	(24,008)
Net cash used in investing activities-discontinued operations	(3,803)	(7,417)
Cash and restricted cash transferred in divestitures of discontinued operations	0	(48,876)
Net cash used in investing activities	(29,407)	(80,301)
Financing activities:
Proceeds from exercise of stock options	2,276	16,825
Employee taxes paid on withholding shares	(5,315)	(6,527)
Proceeds from stock issued under Colleague Stock Purchase Plan	0	421
Repurchases of common stock for treasury	(136,889)	(176,903)
Borrowings under credit facility	225,000	0
Repayments under credit facility	(177,250)	(2,250)
Proceeds from down payment on seller loan	5,200	0
Payment for purchase of redeemable noncontrolling interest of subsidiary	(6,247)	0
Net cash used in financing activities-continuing operations	(93,225)	(168,434)
Net cash used in financing activities-discontinued operations	(2,920)	(2,154)
Net cash used in financing activities	(96,145)	(170,588)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(27,907)	(449)
Net decrease in cash, cash equivalents and restricted cash	(47,928)	(122,803)
Cash, cash equivalents and restricted cash at beginning of period	300,467	444,405
Cash, cash equivalents and restricted cash at end of period	252,539	321,602
Less: cash, cash equivalents and restricted cash of discontinued operations at end of period	83,961	90,511
Cash, cash equivalents and restricted cash at end of period	$ 168,578	$ 231,091

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Loss [Member]	Treasury Stock [Member]	Total
Balance at the beginning of period - Net of Tax at Jun. 30, 2018	$ 793	$ 454,653	$ 1,917,373	$ (142,168)	$ (711,365)	$ 1,519,286
Cumulative effect adjustment upon the adoption			381	(381)
Net income attributable to Adtalem Global Education			45,670			45,670
Other comprehensive income (loss), net of tax				(6,157)		(6,157)
Change in redeemable noncontrolling interest put option			745			745
Stock-based compensation		11,227				11,227
Net activity from stock-based compensation awards	8	17,075			(6,785)	10,298
Proceeds from stock issued under Colleague Stock Purchase Plan		88			333	421
Repurchase of common shares for treasury					(176,903)	(176,903)
Balance at the end of period - Net of Tax at Mar. 31, 2019	801	483,043	1,964,169	(148,706)	(894,720)	1,404,587
Balance at the beginning of period - Net of Tax at Jun. 30, 2018	793	454,653	1,917,373	(142,168)	(711,365)	1,519,286
Repurchase of common shares for treasury						(254,769)
Balance at the end of period - Net of Tax at Mar. 31, 2020	806	499,703	2,183,620	(276,379)	(1,113,191)	1,294,559
Balance at the beginning of period - Net of Tax at Dec. 31, 2018	801	479,946	1,926,134	(143,518)	(833,716)	1,429,647
Net income attributable to Adtalem Global Education			37,905			37,905
Other comprehensive income (loss), net of tax				(5,188)		(5,188)
Change in redeemable noncontrolling interest put option			130			130
Stock-based compensation		3,039				3,039
Net activity from stock-based compensation awards		40			(126)	(86)
Proceeds from stock issued under Colleague Stock Purchase Plan		18			92	110
Repurchase of common shares for treasury					(60,970)	(60,970)
Balance at the end of period - Net of Tax at Mar. 31, 2019	801	483,043	1,964,169	(148,706)	(894,720)	1,404,587
Balance at the beginning of period - Net of Tax at Jun. 30, 2019	801	486,061	2,012,902	(137,290)	(970,944)	1,391,530
Net income attributable to Adtalem Global Education			170,718			170,718
Other comprehensive income (loss), net of tax				(139,089)		(139,089)
Stock-based compensation		11,405				11,405
Net activity from stock-based compensation awards	5	2,237			(5,358)	(3,116)
Repurchase of common shares for treasury					(136,889)	(136,889)
Balance at the end of period - Net of Tax at Mar. 31, 2020	806	499,703	2,183,620	(276,379)	(1,113,191)	1,294,559
Balance at the beginning of period - Net of Tax at Dec. 31, 2019	806	496,674	2,032,788	(159,118)	(1,076,238)	1,294,912
Net income attributable to Adtalem Global Education			150,832			150,832
Other comprehensive income (loss), net of tax				(117,261)		(117,261)
Stock-based compensation		2,811				2,811
Net activity from stock-based compensation awards		218			(83)	135
Repurchase of common shares for treasury					(36,870)	(36,870)
Balance at the end of period - Net of Tax at Mar. 31, 2020	$ 806	$ 499,703	$ 2,183,620	$ (276,379)	$ (1,113,191)	$ 1,294,559

Nature of Operations

Nature of Operations	9 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations	1. Nature of Operations In this Quarterly Report on Form 10-Q, Adtalem Global Education Inc., together with its subsidiaries, is collectively referred to as “Adtalem,” “we,” “our,” “us,” or similar references. Adtalem is a leading workforce solutions provider. We present two reportable segments as follows: Medical and Healthcare Financial Services “Home Office and Other” includes activity not allocated to a reportable segment. See Note 20 “Segment Information” for additional information. Adtalem Education of Brazil (“Adtalem Brazil”), Carrington College (“Carrington”), and DeVry University are presented as discontinued operations and assets held for sale in all periods presented as applicable. See Note 4 “Discontinued Operations and Assets Held for Sale” for additional information.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation A full listing of our significant accounting policies is described in Note 4 “Summary of Significant Accounting Policies” of our Annual Report on Form 10-K for the fiscal year ended June 30, 2019 (“2019 Form 10-K”). We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial statements and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (which are normal and recurring in nature) considered necessary for a fair presentation have been included. These consolidated financial statements and accompanying notes should be read in conjunction with our annual consolidated financial statements and the notes thereto included in our 2019 Form 10-K. We use the same accounting policies in preparing quarterly and annual financial statements. Unless otherwise noted, amounts presented within the Notes to Consolidated Financial Statements refer to our continuing operations. The World Health Organization declared the novel coronavirus (“COVID-19” or “virus”) to be a public health emergency on January 30, 2020. The virus has had tragic consequences across the globe, and its full impact is not yet known as of the May 5, 2020 filing date of this Form 10-Q. While the virus did not have significant impacts to the third quarter of fiscal year 2020 results of operations, depending on the length and severity of social distancing and other measures established to combat the virus, there could be significant impacts on future results of operations. Due to the effects of COVID-19 on operations and the seasonal nature of our business, quarterly revenue, expenses, earnings, and cash flows are not necessarily indicative of the results that may be achieved for the full fiscal year. Certain prior period amounts have been reclassified for consistency with the current period presentation. Recent Accounting Standards Recently adopted accounting standards In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02: “Leases (Topic 842).” This guidance was issued to increase transparency and comparability among organizations by recognizing right-of-use assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. We adopted this guidance, along with the related clarifications and improvements, effective July 1, 2019 using the modified retrospective approach without adjusting prior comparative periods. The adoption of this standard significantly impacts our Consolidated Balance Sheets, but did not impact our Consolidated Statements of Income. We elected the practical expedients package which allows us to forego reassessing (i) whether any expired or existing contracts are or contain leases; (ii) the lease classification for any expired or expiring leases; and (iii) initial direct costs for any existing leases. We did not elect the hindsight practical expedient, which permits the use of hindsight when determining the lease term and impairment of operating lease assets. See Note 11 “Leases” for the disclosures related to this new accounting standard. The impact on the Consolidated Balance Sheet upon adoption of Accounting Standards Codification (“ASC”) 842 is as follows (in thousands, except par value): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, ​ Adjustments due to ​ July 1, ​ 2019 adoption of ASC 842 2019 Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ Current assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ Cash and cash equivalents ​ $ 299,445 ​ $ — ​ $ 299,445 Investments in marketable securities ​ 8,680 ​ — ​ 8,680 Restricted cash ​ 1,022 ​ — ​ 1,022 Accounts receivable, net ​ 157,829 ​ — ​ 157,829 Prepaid expenses and other current assets ​ 37,724 ​ (3,483) ​ 34,241 Total current assets ​ 504,700 ​ (3,483) ​ 501,217 Noncurrent assets: ​ ​ ​ ​ ​ ​ Property and equipment, net ​ ​ 364,683 ​ ​ — ​ ​ 364,683 Operating lease assets ​ — ​ 282,978 ​ 282,978 Deferred income taxes ​ 18,314 ​ — ​ 18,314 Intangible assets, net ​ 418,097 ​ — ​ 418,097 Goodwill ​ 874,451 ​ — ​ 874,451 Other assets, net ​ 62,451 ​ — ​ 62,451 Total noncurrent assets ​ 1,737,996 ​ 282,978 ​ 2,020,974 Total assets ​ $ 2,242,696 ​ $ 279,495 ​ $ 2,522,191 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities and shareholders' equity: ​ ​ ​ Current liabilities: ​ ​ ​ Accounts payable ​ $ 57,627 ​ $ — ​ $ 57,627 Accrued salaries, wages, and benefits ​ 64,492 ​ — ​ 64,492 Accrued liabilities ​ 86,722 ​ (16,946) ​ 69,776 Deferred revenue ​ 99,790 ​ — ​ 99,790 Current operating lease liabilities ​ — ​ 66,707 ​ 66,707 Current portion of long-term debt ​ 3,000 ​ — ​ 3,000 Total current liabilities ​ 311,631 ​ 49,761 ​ 361,392 Noncurrent liabilities: ​ ​ ​ ​ ​ ​ Long-term debt ​ 398,094 ​ — ​ 398,094 Long-term operating lease liabilities ​ — ​ 269,387 ​ 269,387 Deferred income taxes ​ 29,426 ​ — ​ 29,426 Other liabilities ​ 102,472 ​ (39,653) ​ 62,819 Total noncurrent liabilities ​ 529,992 ​ 229,734 ​ 759,726 Total liabilities ​ 841,623 ​ 279,495 ​ 1,121,118 Redeemable noncontrolling interest ​ 9,543 ​ — ​ 9,543 Shareholders' equity: ​ ​ ​ ​ ​ ​ Common stock, $0.01 par value ​ 801 ​ — ​ 801 Additional paid-in capital ​ 486,061 ​ — ​ 486,061 Retained earnings ​ 2,012,902 ​ — ​ 2,012,902 Accumulated other comprehensive loss ​ (137,290) ​ — ​ (137,290) Treasury stock, at cost ​ (970,944) ​ — ​ (970,944) Total shareholders' equity ​ 1,391,530 ​ — ​ 1,391,530 Total liabilities and shareholders' equity ​ $ 2,242,696 ​ $ 279,495 ​ $ 2,522,191 ​ Upon the adoption of ASC 842, the following balances were removed from the Consolidated Balance Sheet as of July 1, 2019: (i) $3.5 million of prepaid rent balances within prepaid expenses and other current assets; (ii) $6.8 million of current deferred rent liability balances within accrued liabilities; (iii) $10.1 million of current restructure liability balances within accrued liabilities; (iv) $24.8 million of noncurrent deferred rent liability balances within other liabilities; and (v) $14.9 million of noncurrent restructure liability balances within other liabilities. In March 2020, FASB issued ASU No. 2020-04: “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance was issued to provide for temporary optional expedients and exceptions to the current guidance on certain contract modifications and hedge relationships to ease the burdens related to the expected market transition from the London Inter-bank Offered Rate (“LIBOR”) or other reference rates to alternative reference rates. The guidance is effective as of March 12, 2020 through December 31, 2022. We adopted this guidance in the third quarter of fiscal year 2020 and is not expected to have a significant effect on Adtalem’s Consolidated Financial Statements. Recently issued accounting standards not yet adopted In June 2016, FASB issued ASU No. 2016-13: “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” The guidance was issued to provide financial statement users with more decision-useful information about the expected losses on financial instruments by replacing the incurred loss impairment methodology with a methodology that reflects expected credit losses by requiring a broader range of reasonable and supportable information to inform credit loss estimates. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Management is evaluating the impact the guidance will have on Adtalem’s Consolidated Financial Statements and believes the guidance will be applied to our allowance for bad debts on trade receivables and institutional loans and will not have a significant impact on Adtalem’s Consolidated Financial Statements. Reclassifications Beginning in the first quarter of fiscal year 2020, Adtalem Brazil operations were classified as discontinued operations. See Note 4 “Discontinued Operations and Assets Held for Sale” for additional information. Prior period amounts have been revised to conform to the current classification. Certain expenses in prior periods previously allocated to Adtalem Brazil within our former Business and Law segment have been reclassified to the Home Office and Other segment based on discontinued operation reporting guidance regarding allocation of corporate overhead. For fiscal year 2020, home office costs to support the remaining businesses are being allocated to the Medical and Healthcare and Financial Services segments. See Note 20 “Segment Information” for additional information.

Acquisitions

Acquisitions	9 Months Ended
	Mar. 31, 2020
Acquisitions [Abstract]
Acquisitions	3. Acquisitions OnCourse Learning On May 31, 2019, Adtalem completed the acquisition of 100% of the equity interests of OCL for $118.3 million, net of cash of $1.2 million. Adtalem paid $118.4 million for this purchase during the fourth quarter of fiscal year 2019, and funded the purchase with available domestic cash balances and $100 million in borrowings under Adtalem’s revolving credit facility. Adtalem received $0.1 million related to a net working capital adjustment during the second quarter of fiscal year 2020. OCL is a leading provider of compliance training, licensure preparation, continuing education, and professional development in the banking and mortgage industries across the U.S. The acquisition furthers Adtalem’s growth strategy into financial services. The operations of OCL are included in Adtalem’s Financial Services segment. The results of OCL’s operations have been included in the Consolidated Financial Statements of Adtalem since the date of acquisition. The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed at the date of acquisition (in thousands): ​ ​ ​ ​ ​ May 31, ​ ​ 2019 Current assets ​ $ 5,260 Property and equipment ​ 1,197 Intangible assets ​ 63,100 Goodwill ​ 59,427 Total assets acquired ​ 128,984 Liabilities assumed ​ 9,445 Net assets acquired ​ $ 119,539 ​ Goodwill, which represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired, was all assigned to the Financial Services reporting unit and reportable segment. Factors that contributed to a purchase price resulting in the recognition of goodwill include OCL’s strategic fit into Adtalem’s expanding presence in financial services, the reputation of the OCL brand as a leader in the industry, and potential future growth opportunity. Of the $63.1 million of acquired intangible assets, $18.4 million was assigned to trade names, which has been determined not to be subject to amortization. The remaining acquired intangible assets were determined to be subject to amortization with an average useful life of approximately nine years. The values and estimated useful lives by asset type at the date of acquisition are as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ May 31, 2019 ​ ​ Value ​ Estimated ​ Assigned Useful Life Customer relationships ​ $ 26,400 ​ 11 years Curriculum ​ 11,600 6 years Course delivery technology ​ 6,700 5 years There is no proforma presentation of operating results for this acquisition due to the insignificant effect on consolidated operations.

Discontinued Operations and Ass

Discontinued Operations and Assets Held for Sale	9 Months Ended
	Mar. 31, 2020
Discontinued Operations and Assets Held for Sale
Discontinued Operations and Assets Held for Sale	4. Discontinued Operations and Assets Held for Sale On December 4, 2018, Adtalem completed the sale of Carrington to San Joaquin Valley College, Inc. (“SJVC”) for de minimis consideration. As the sale represented a strategic shift that has a major effect on Adtalem’s operations and financial results, Carrington is presented in Adtalem’s financial reporting as a discontinued operation. Adtalem has retained certain leases associated with the Carrington operations. Adtalem remains the primary lessee on these leases and subleases to Carrington. Adtalem records the proceeds from these subleases as an offset to operating costs. Adtalem also assigned certain leases to Carrington but remains contingently liable under these leases. Adtalem recorded a pre-tax loss of $11.1 million on the sale of Carrington and transferred $9.9 million of cash and restricted cash balances to Carrington in the second quarter of fiscal year 2019, subject to post-closing adjustments to be completed in fiscal year 2020. On December 11, 2018, Adtalem completed the sale of DeVry University to Cogswell Education, LLC (“Cogswell”) for de minimis consideration. As the sale represented a strategic shift that has a major effect on Adtalem’s operations and financial results, DeVry University is presented in Adtalem’s financial reporting as a discontinued operation. The purchase agreement includes an earn-out entitling Adtalem to payments of up to $20 million over a ten-year period payable based on DeVry University’s free cash flow. In connection with the closing of the sale, Adtalem loaned to DeVry University $10.0 million under the terms of the promissory note, dated as of December 11, 2018 (the “Note”). The Note bears interest at a rate of 4% per annum, payable annually in arrears, and has a maturity date of January 1, 2022. DeVry University may make prepayments on the Note. This loan is recorded as other assets, net on the Consolidated Balance Sheets. Adtalem has retained certain leases associated with DeVry University operations. Adtalem remains the primary lessee on these leases and subleases to DeVry University. In addition, Adtalem owns the buildings for certain DeVry University operating and administrative office locations and leases space to DeVry University under one-year operating leases, renewable annually at DeVry University’s option with the exception of one lease which expires December 2023. Adtalem records the proceeds from these leases and subleases as an offset to operating costs. Adtalem also assigned certain leases to DeVry University but remains contingently liable under these leases. Adtalem recorded a pre-tax loss of $21.7 million on the sale of DeVry University and transferred $39.0 million of cash and restricted cash balances to DeVry University in the second quarter of fiscal year 2019. On April 24, 2020, Adtalem completed the sale of Adtalem Brazil to Estácio Participações S.A. (“Estácio”) and Sociedade de Ensino Superior Estaćio de Sá Ltda, a wholly owned subsidiary of Estácio (“Purchaser”). As the sale represented a strategic shift that has a major effect on Adtalem’s operations and financial results, Adtalem Brazil is presented in Adtalem’s financial reporting as a discontinued operation. Pursuant to the terms and subject to the conditions set forth in the purchase agreement, Adtalem sold the issued and outstanding shares of Adtalem Brasil Holding S.A. (a/k/a Adtalem Brazil) to the Purchaser for R$1,920 million, subject to certain post-closing adjustments pursuant to the purchase agreement. Net proceeds received on April 24, 2020, after settlement of debt, transaction fees, taxes and hedge proceeds (described below) were $424.0 million, in addition to $73.0 million of cash previously unavailable, which is now available for general corporate use. In connection with the sale of Adtalem Brazil, Adtalem entered into a deal-contingent foreign currency hedge arrangement to economically hedge the Brazilian Real denominated sales price through mitigation of the currency exchange rate risk. The hedge agreement had a total notional amount of R$2,154 million (approximately $415 million as of March 31, 2020). The derivative associated with the hedge agreement did not qualify for hedge accounting treatment under ASC 815, and as a result, all changes in fair value were recorded within the income statement. Adtalem recorded a pre-tax unrealized gain on the hedge agreement derivative based on the foreign exchange forward spot rate as of March 31, 2020 of $111.8 million and $83.8 million for the three and nine months ended March 31, 2020, respectively, (see Note 18 “Fair Value Measurements” for additional information) with an $83.8 million asset included within prepaid expenses and other current assets on the March 31, 2020 Consolidated Balance Sheet. This deal-contingent foreign currency hedge was settled in conjunction with the close of the sale of Adtalem Brazil with cash proceeds of $110.7 million during the fourth quarter of fiscal year 2020. The following is a summary of balance sheet information of assets and liabilities reported as held for sale, which includes only Adtalem Brazil balances as Carrington and DeVry University were sold as of each period presented below (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, ​ June 30, ​ March 31, ​ 2020 2019 2019 Assets: ​ ​ ​ Current assets: ​ ​ ​ Cash and cash equivalents ​ $ 83,961 ​ $ 95,243 ​ $ 90,511 Accounts receivable, net ​ 52,507 ​ 74,269 ​ 65,794 Prepaid expenses and other current assets ​ 5,949 ​ 8,411 ​ 10,252 Total current assets held for sale ​ 142,417 ​ 177,923 ​ 166,557 Noncurrent assets: ​ ​ ​ ​ Property and equipment, net ​ ​ 57,610 ​ ​ 81,250 ​ ​ 80,234 Operating lease assets ​ 54,092 ​ — ​ — Intangible assets, net ​ 88,403 ​ 120,108 ​ 118,134 Goodwill ​ 138,914 ​ 187,195 ​ 183,575 Other assets, net ​ 9,542 ​ 10,338 ​ 8,999 Total noncurrent assets held for sale ​ 348,561 ​ 398,891 ​ 390,942 Total assets held for sale ​ $ 490,978 ​ $ 576,814 ​ $ 557,499 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ ​ ​ Current liabilities: ​ ​ ​ ​ Accounts payable ​ $ 2,378 ​ $ 4,242 ​ $ 3,230 Accrued payroll and benefits ​ 10,671 ​ 17,828 ​ 15,462 Accrued liabilities ​ 4,891 ​ 10,193 ​ 12,008 Deferred revenue ​ 8,688 ​ 3,846 ​ 13,990 Current operating lease liabilities ​ 8,322 ​ — ​ — Total current liabilities held for sale ​ 34,950 ​ 36,109 ​ 44,690 Noncurrent liabilities: ​ ​ ​ ​ ​ Long-term operating lease liabilities ​ 46,747 ​ — ​ — Other liabilities ​ 10,103 ​ 16,146 ​ 16,372 Total noncurrent liabilities held for sale ​ 56,850 ​ 16,146 ​ 16,372 Total liabilities held for sale ​ $ 91,800 ​ $ 52,255 ​ $ 61,062 ​ The following is a summary of income statement information of operations reported as discontinued operations, which includes Adtalem Brazil operations and includes Carrington’s and DeVry University’s operations through the date of each respective sale (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ ​ March 31, ​ March 31, ​ ​ 2020 2019 2020 2019 ​ Revenue ​ $ 41,355 ​ $ 49,906 ​ $ 142,160 ​ $ 355,506 ​ Operating cost and expense: ​ ​ ​ ​ ​ ​ Cost of educational services ​ 28,940 ​ 36,147 ​ 98,605 ​ 222,837 ​ Student services and administrative expense ​ 17,781 ​ 11,252 ​ 47,860 ​ 130,615 ​ Restructuring expense (gain) ​ 199 ​ (257) ​ 625 ​ (570) ​ Asset impairment charge - building and equipment ​ — ​ — ​ — ​ 1,953 ​ Total operating cost and expense ​ 46,920 ​ 47,142 ​ 147,090 ​ 354,835 ​ Operating (loss) income from discontinued operations ​ (5,565) ​ 2,764 ​ (4,930) ​ 671 ​ Other income (expense): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest and dividend income ​ ​ 425 ​ ​ 941 ​ ​ 2,164 ​ ​ 2,917 ​ Interest expense ​ ​ (807) ​ ​ (483) ​ ​ (2,770) ​ ​ (2,317) ​ Net other (expense) income ​ (382) ​ 458 ​ (606) ​ 600 ​ (Loss) income from discontinued operations before income taxes ​ ​ (5,947) ​ ​ 3,222 ​ ​ (5,536) ​ ​ 1,271 ​ Loss on disposal of discontinued operations before income taxes ​ ​ — ​ ​ (265) ​ ​ — ​ ​ (32,979) ​ Benefit from income taxes ​ 3,228 ​ 182 ​ 3,778 ​ 5,762 ​ (Loss) income from discontinued operations ​ ​ (2,719) ​ ​ 3,139 ​ ​ (1,758) ​ ​ (25,946) ​ Net income attributable to redeemable noncontrolling interest ​ ​ — ​ ​ (74) ​ ​ — ​ ​ (382) ​ Net (loss) income from discontinued operations attributable to Adtalem ​ $ (2,719) ​ $ 3,065 ​ $ (1,758) ​ $ (26,328) ​ ​

Revenue

Revenue	9 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenue	5. Revenue Revenue is recognized when control of the promised goods or services is transferred to our customers (students and members), in an amount that reflects the consideration we expect to be entitled in exchange for those goods or services. The following tables disaggregate revenue by source (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended March 31, 2020 ​ Medical and Financial Home Office ​ Consolidated Higher education $ 222,019 $ — $ — $ 222,019 Test preparation/certifications ​ ​ — ​ ​ 26,236 ​ ​ — ​ ​ 26,236 Conferences/seminars ​ ​ — ​ ​ 11,925 ​ ​ — ​ ​ 11,925 Memberships/subscriptions ​ ​ — ​ ​ 5,590 ​ ​ — ​ ​ 5,590 Other ​ ​ 5,325 ​ ​ 392 ​ ​ — ​ ​ 5,717 Total $ 227,344 $ 44,143 $ — $ 271,487 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Nine Months Ended March 31, 2020 ​ Medical and Financial Home Office ​ Consolidated Higher education $ 637,625 $ — $ — $ 637,625 Test preparation/certifications ​ ​ — ​ ​ 78,145 ​ ​ — ​ ​ 78,145 Conferences/seminars ​ ​ — ​ ​ 42,738 ​ ​ — ​ ​ 42,738 Memberships/subscriptions ​ ​ — ​ ​ 15,512 ​ ​ — ​ ​ 15,512 Other ​ ​ 17,386 ​ ​ 866 ​ ​ — ​ ​ 18,252 Total $ 655,011 $ 137,261 $ — $ 792,272 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended March 31, 2019 ​ Medical and Financial Home Office ​ Consolidated Higher education $ 217,423 $ — $ — $ 217,423 Test preparation/certifications ​ ​ — ​ ​ 27,562 ​ ​ (807) ​ ​ 26,755 Conferences/seminars ​ ​ — ​ ​ 3,860 ​ ​ — ​ ​ 3,860 Memberships/subscriptions ​ ​ — ​ ​ 4,299 ​ ​ — ​ ​ 4,299 Other ​ ​ 6,152 ​ ​ 214 ​ ​ — ​ ​ 6,366 Total $ 223,575 $ 35,935 $ (807) $ 258,703 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Nine Months Ended March 31, 2019 ​ ​ Medical and Financial Home Office ​ Consolidated Higher education ​ $ 630,083 $ — $ — $ 630,083 Test preparation/certifications ​ ​ — ​ ​ 83,576 ​ ​ (2,422) ​ ​ 81,154 Conferences/seminars ​ ​ — ​ ​ 17,405 ​ ​ — ​ ​ 17,405 Memberships/subscriptions ​ ​ — ​ ​ 12,135 ​ ​ — ​ ​ 12,135 Other ​ ​ 8,219 ​ ​ 607 ​ ​ — ​ ​ 8,826 Total $ 638,302 $ 113,723 $ (2,422) $ 749,603 ​ Certain prior period amounts in the above tables have been reclassified for consistency with the current period presentation. In addition, see Note 20 “Segment Information” for a disaggregation of revenue by geographical region. Performance Obligations and Revenue Recognition Higher education Test preparation/certifications Conferences/seminars Memberships/subscriptions Other Customer contracts generally have separately stated prices for each performance obligation contained in the contract. Therefore, each performance obligation generally has its own standalone selling price. For higher education students, arrangements for payment are agreed to prior to registration of the student’s first academic term. The majority of U.S. students obtain Title IV or other financial aid resulting in institutions receiving a significant amount of the transaction price at the beginning of the academic term. Students utilizing private funding or funding through Adtalem’s institutional loan programs (see Note 9 “Financing Receivables” for additional information) generally pay after the academic term is complete. For non-higher education customers, payment is typically due and collected at the time a customer places an order. Transaction Price Revenue, or transaction price, is measured as the amount of consideration expected to be received in exchange for transferring goods or services. For higher education, students may receive discounts, scholarships, or refunds, which gives rise to variable consideration. The amounts of discounts or scholarships are applied to individual student accounts when such amounts are awarded. Therefore, the transaction price is reduced directly by these discounts or scholarships from the amount of the standard tuition rate charged. Upon withdrawal, a student may be eligible to receive a refund or partial refund, the amount of which is dependent on the timing of the withdrawal during the academic term. If a student withdraws prior to completing an academic term, federal and state regulations and accreditation criteria permit Adtalem to retain only a set percentage of the total tuition received from such student, which varies with, but generally equals or exceeds, the percentage of the academic term completed by such student. Payment amounts received by Adtalem in excess of such set percentages of tuition are refunded to the student or the appropriate funding source. For contracts with similar characteristics and historical data on refunds, the expected value method is applied in determining the variable consideration related to refunds. Estimates of Adtalem’s expected refunds are determined at the outset of each academic term, based upon actual refunds in previous academic terms. Reserves related to refunds are presented as refund liabilities within accrued liabilities on the Consolidated Balance Sheets. All refunds are netted against revenue during the applicable academic term. Management reassesses collectability throughout the period revenue is recognized by the Adtalem institutions, on a student-by-student basis. This reassessment is based upon new information and changes in facts and circumstances relevant to a student’s ability to pay. Management also reassesses collectability when a student withdraws from the institution and has unpaid tuition charges. Such unpaid charges do not meet the threshold of reasonably collectible and are recognized as revenue on a cash basis. For test preparation and other Financial Services products, the transaction price is equal to the amount charged to the customer, which is the standard rate, less any discounts, and an estimate for returns or refunds. We believe it is probable that no significant reversal will occur in the amount of cumulative revenue recognized when the uncertainty associated with the variable consideration is subsequently resolved. Therefore, the estimate of variable consideration is not constrained. Contract Balances For our higher education institutions, students are billed at the beginning of each academic term and payment is due at that time. Adtalem’s performance obligation is to provide educational services in the form of instruction during the academic term. As instruction is provided, deferred revenue is reduced. A significant portion of student payments are from Title IV financial aid and other programs and are generally received during the first month of the respective academic term. For students utilizing Adtalem’s institutional loan programs (see Note 9 “Financing Receivables”), payments are generally received after the academic term, and the corresponding performance obligation, is complete. When payments are received, accounts receivable is reduced. For our Financial Services businesses, customers are billed and payment is due at the time of order placement. In most cases, performance obligations are delivered subsequent to payments received. Delivering our performance obligations reduces deferred revenue, and accounts receivable is reduced upon payments received. Becker offers flexible payment plans with terms of up to 12-months as a financing option for the Becker CPA Exam Review Course (see Note 9 “Financing Receivables”). In this case, payment is received after satisfying the performance obligation. Revenue of $91.0 million was recognized during the first nine months of fiscal year 2020 that was included in the deferred revenue balance at the beginning of fiscal year 2020. Revenue recognized from performance obligations that were satisfied or partially satisfied in prior periods was not material. The difference between the opening and closing balances of deferred revenue includes decreases from revenue recognized during the period, increases from charges related to the start of academic terms beginning during the period, and increases from payments received related to academic terms commencing after the end of the reporting period. Allowance for bad debts on short-term and long-term receivables as of March 31, 2020, June 30, 2019, and March 31, 2019 were $24.2 million, $14.5 million, and $11.0 million, respectively. The increase in the reserve is driven by higher bad debt expense, mainly at the medical and veterinary schools. Practical Expedients As our performance obligations have an original expected duration of one year or less, we have applied the practical expedient (as provided in ASC 606-10-50-14) to not disclose the information in ASC 606-10-50-13, which requires disclosure of the amount of the transaction price allocated to our performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period and when the entity expects to recognize this amount as revenue. All consideration from contracts with customers is included in the transaction price.

Restructuring Charges

Restructuring Charges	9 Months Ended
	Mar. 31, 2020
Restructuring and Related Activities [Abstract]
Restructuring Charges	6. Restructuring Charges During the third quarter and first nine months of fiscal year 2020, Adtalem recorded restructuring charges primarily related to the sale of Becker’s courses for healthcare students and Adtalem’s home office real estate consolidations and workforce reductions. During the third quarter and first nine months of fiscal year 2019, Adtalem recorded restructuring charges primarily related to the impairment of the property and equipment at the Dominica campus of RUSM and severance related to workforce reductions in Dominica. In January 2019, RUSM relocated its campus operations to Barbados with no plans to return to Dominica. The property and equipment in Dominica have been fully impaired as management determined the market value less the costs to sell the facilities or move the equipment was zero. In addition, during the third quarter and first nine months of fiscal year 2019, Adtalem recorded restructuring charges related to Adtalem’s home office real estate consolidations. When estimating costs of exiting lease space, estimates are made which could differ materially from actual results and result in additional restructuring charges or reversals in future periods. Termination benefit charges, resulting from reducing Adtalem’s workforce by 34 and 203 positions in the first nine months of fiscal year 2020 and 2019, respectively, represented severance pay and benefits for these employees. Adtalem’s home office is classified as “Home Office and Other” in Note 20 “Segment Information.” Pre-tax restructuring charges by segment were as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended March 31, 2020 ​ Nine Months Ended March 31, 2020 ​ Real Estate Termination ​ ​ Real Estate Termination ​ ​ ​ ​ and Other ​ Benefits ​ Total ​ and Other ​ Benefits ​ Total Medical and Healthcare ​ $ 810 ​ $ — ​ $ 810 ​ $ 1,129 ​ $ 225 ​ $ 1,354 Financial Services ​ — ​ — ​ — ​ 2,862 ​ 254 ​ 3,116 Home Office and Other ​ 255 ​ 789 ​ 1,044 ​ 4,779 ​ 1,090 ​ 5,869 Total ​ $ 1,065 ​ $ 789 ​ $ 1,854 ​ $ 8,770 ​ $ 1,569 ​ $ 10,339 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended March 31, 2019 ​ Nine Months Ended March 31, 2019 ​ Real Estate Termination ​ ​ Real Estate Termination ​ ​ ​ ​ and Other ​ Benefits ​ Total ​ and Other ​ Benefits ​ Total Medical and Healthcare ​ $ (110) ​ $ (23) ​ $ (133) ​ $ 40,033 ​ $ 1,294 ​ $ 41,327 Home Office and Other ​ 2,271 ​ 48 ​ 2,319 ​ 3,748 ​ 119 ​ 3,867 Total ​ $ 2,161 ​ $ 25 ​ $ 2,186 ​ $ 43,781 ​ $ 1,413 ​ $ 45,194 ​ The following table summarizes the separation and restructuring plan activity for the fiscal years 2020 and 2019, for which cash payments are required (in thousands): ​ ​ ​ ​ Liability balance as of June 30, 2018 $ 38,927 Increase in liability (separation and other charges) ​ 8,870 Reduction in liability (payments and adjustments) ​ (22,714) Liability balance as of June 30, 2019 ​ 25,083 ASC 842 (leases) adjustment (1) ​ ​ (25,030) Liability balance as of July 1, 2019 ​ 53 Increase in liability (separation and other charges) ​ 3,551 Reduction in liability (payments and adjustments) ​ (3,331) Liability balance as of March 31, 2020 ​ $ 273 (1) The liability balance of $0.3 million is recorded as accrued liabilities on the Consolidated Balance Sheet as of March 31, 2020. This liability balance represents exit cost accruals and costs for employees who have either not yet separated from Adtalem or for whom full severance has not yet been paid. All of these remaining costs are expected to be paid within the next 12 months. Additional restructuring charges are expected to be recorded during the remainder of fiscal year 2020 as Adtalem completes its current restructuring plans by June 30, 2020. Adjustments to leases that have been placed in restructure will result in charges extending past fiscal year 2020 and will be presented as future restructuring expense. Management may institute future restructuring plans.

Income Taxes

Income Taxes	9 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	7. Income Taxes Our effective income tax rates from continuing operations were 4.3% and 9.6% for the three and nine months ended March 31, 2020, respectively, and 18.4% and 19.5% for the three and nine months ended March 31, 2019, respectively. The effective tax rates in fiscal years 2020 and 2019 reflect the U.S. federal tax rate of 21% adjusted for foreign rate differences, benefits associated with local tax incentives, changes in valuation allowances and liabilities for uncertain tax positions, and tax benefits on stock-based compensation awards. Additionally, in the three and nine months ended March 31, 2020, we did not record a tax provision on the pre-tax unrealized gain of $111.8 million and $83.8 million, respectively, from a derivative contract related to the deal-contingent hedge agreement on the Adtalem Brazil sale completed on April 24, 2020 (see Note 4 “Discontinued Operations and Assets Held for Sale” for additional information). Three of Adtalem’s operating units benefit from local tax incentives: AUC, which operates in St. Maarten, RUSM, which operates in Barbados, and RUSVM, which operates in St. Kitts. AUC’s effective tax rate reflects benefits derived from investment incentives. RUSM and RUSVM each have agreements with their respective domestic governments that exempt them from local income taxation. RUSM has an exemption in Barbados until 2039. RUSVM has an exemption in St. Kitts until 2037. On March 27, 2020 the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, temporarily increases the amount of interest expense the company is allowed to deduct on its U.S. federal tax returns for fiscal years 2019 and 2020, modifies the Tax Credit and Jobs Act of 2017 to allow immediate expensing of qualified improvement property for U.S. federal income tax purposes retroactive to fiscal year 2018, and allows net operating losses incurred in fiscal years 2018, 2019, and 2020 to be carried back five-years and offset up to 100% of U.S. federal taxable income for tax years beginning before fiscal year 2021. Management is currently evaluating the impact of the CARES Act, but at present time does not expect that the provisions of the CARES Act would result in a material tax or cash benefit. Consistent with our 2019 Form 10-K disclosure, Adtalem continues to estimate its unrecognized tax benefits will decrease by $25 million to $27 million by June 30, 2020 due to the settlement of various audits and the lapsing of statutes of limitations.

Earnings per Share

Earnings per Share	9 Months Ended
	Mar. 31, 2020
Earnings per Share
Earnings per Share	8. Earnings per Share The following table sets forth the computations of basic and diluted earnings per share and stock awards not included in the computation of diluted earnings per share when their effect is anti-dilutive (in thousands, except per share data): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ March 31, ​ March 31, ​ 2020 2019 2020 2019 Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income (loss) attributable to Adtalem: ​ ​ ​ ​ ​ ​ ​ ​ Continuing operations ​ $ 153,551 ​ $ 34,840 ​ $ 172,476 ​ $ 71,998 Discontinued operations ​ ​ (2,719) ​ ​ 3,065 ​ ​ (1,758) ​ ​ (26,328) Net ​ $ 150,832 ​ $ 37,905 ​ $ 170,718 ​ $ 45,670 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-average shares outstanding ​ 52,498 ​ 57,583 ​ 53,647 ​ 58,656 Unvested participating RSUs ​ 457 ​ 478 ​ 470 ​ 543 Weighted-average basic shares outstanding ​ 52,955 ​ 58,061 ​ 54,117 ​ 59,199 Effect of dilutive stock awards ​ 364 ​ 741 ​ 459 ​ 805 Weighted-average diluted shares outstanding ​ 53,319 ​ 58,802 ​ 54,576 ​ 60,004 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Earnings (loss) per share attributable to Adtalem: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Continuing operations ​ $ 2.90 ​ $ 0.60 ​ $ 3.19 ​ $ 1.22 Discontinued operations ​ $ (0.05) ​ $ 0.05 ​ $ (0.03) ​ $ (0.44) Net ​ $ 2.85 ​ $ 0.65 ​ $ 3.15 ​ $ 0.77 Diluted: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Continuing operations ​ $ 2.88 ​ $ 0.59 ​ $ 3.16 ​ $ 1.20 Discontinued operations ​ $ (0.05) ​ $ 0.05 ​ $ (0.03) ​ $ (0.44) Net ​ $ 2.83 ​ $ 0.64 ​ $ 3.13 ​ $ 0.76 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-average anti-dilutive stock awards ​ ​ 992 ​ ​ 194 ​ ​ 942 ​ ​ 223 ​

Financing Receivables

Financing Receivables	9 Months Ended
	Mar. 31, 2020
Receivables [Abstract]
Financing Receivables	9. Financing Receivables Adtalem’s financing receivables consist of trade receivables related to institutional loan programs available to students at Chamberlain, AUC, RUSM, and RUSVM. These loan programs are designed to assist students who are unable to completely cover educational costs consisting of tuition, books, and fees, and are available only after all other student financial assistance has been applied toward those purposes. In addition, AUC, RUSM, and RUSVM loans may be used for students’ living expenses. Repayment plans for institutional loan program balances are developed to address the financial circumstances of the particular student. Interest charges at rates from 3.0% to 12.0% per annum accrue each month on the unpaid balance. Most students are required to begin repaying their loans while they are still in school with a minimum payment level designed to demonstrate their capability to repay, which reduces the possibility of over borrowing, and minimizes interest being accrued on the loan balance. Payments may increase upon completing or departing school. After a student leaves school, the student typically will have a monthly installment repayment plan. In addition, Becker offered an 18-month loan program for its Becker CPA Exam Review Course which is considered a financing receivable. Becker is no longer offering loans under this program. Instead, Becker is offering financing through flexible payment plans with terms of up to 12-months which is not considered a financing receivable. Allowances for uncollectible loans are determined by analyzing the current aging of institutional loans and historical loss rates of loans at each institution. Management performs this analysis monthly and quarterly throughout the year. In evaluating the collectability of all our receivable balances, we set our bad debt reserves incorporating the most recent and updated circumstances, facts, and analytics. Changes in assumed collection rates will result in changes in the necessary reserves. Loans are considered nonperforming if they are over 90 days past due. Since all of Adtalem’s institutional loans are generated through the extension of credit to fund educational costs, all such receivables are considered part of the same loan portfolio. The following table details the institutional loan balances along with the related allowances for credit losses (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Nine Months Ended ​ Year Ended ​ Nine Months Ended ​ ​ March 31, 2020 ​ June 30, 2019 ​ March 31, 2019 Gross institutional loans ​ ​ $ 50,296 ​ ​ $ 47,937 ​ ​ $ 47,259 Allowance for credit losses: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Balance as of July 1 $ (6,289) ​ ​ ​ $ (10,003) ​ ​ ​ $ (10,003) ​ ​ ​ Charge-offs and adjustments ​ ​ 664 ​ ​ ​ ​ ​ 10,777 ​ ​ ​ ​ ​ 9,965 ​ ​ ​ Recoveries ​ ​ (40) ​ ​ ​ ​ ​ (83) ​ ​ ​ ​ ​ (73) ​ ​ ​ Additional provision ​ ​ (9,026) ​ ​ ​ ​ ​ (6,980) ​ ​ ​ ​ ​ (4,571) ​ ​ ​ Balance as of end of period ​ ​ ​ ​ ​ (14,691) ​ ​ ​ ​ ​ (6,289) ​ ​ ​ ​ ​ (4,682) Net institutional loans ​ ​ ​ $ 35,605 ​ ​ ​ $ 41,648 ​ ​ ​ $ 42,577 ​ Of the net balances above, $16.9 million, $16.6 million, and $15.7 million were classified as accounts receivable, net on the Consolidated Balance Sheets as of March 31, 2020, June 30, 2019, and March 31, 2019, respectively, and $18.7 million, $25.1 million, and $26.9 million, representing amounts due beyond one year, were classified as other assets, net on the Consolidated Balance Sheets as of March 31, 2020, June 30, 2019, and March 31, 2019, respectively. The following table details the credit risk profiles of the institutional loan balances based on an aging of past due institutional loans (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Over ​ ​ ​ ​ ​ ​ ​ Total ​ ​ 1-29 Days ​ 30-59 Days ​ 60-89 Days ​ 90 Days ​ Total ​ ​ ​ Institutional ​ ​ Past Due ​ Past Due ​ Past Due ​ Past Due ​ Past Due ​ Current ​ Loans Institutional loans: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2020 ​ $ 3,484 ​ $ 1,145 ​ $ 1,673 ​ $ 13,382 ​ $ 19,684 ​ $ 30,612 ​ $ 50,296 June 30, 2019 ​ $ 3,578 ​ $ 2,458 ​ $ 687 ​ $ 9,888 ​ $ 16,611 ​ $ 31,326 ​ $ 47,937 March 31, 2019 ​ $ 4,092 ​ $ 4,412 ​ $ 4,125 ​ $ 4,543 ​ $ 17,172 ​ $ 30,087 ​ $ 47,259 ​ In connection with the completion of the sale of DeVry University, Adtalem loaned $10.0 million to DeVry University under the terms of the Note. The Note bears interest at a rate of 4% per annum, payable annually in arrears, and has a maturity date of January 1, 2022. The value of the DeVry University loan receivable included in other assets, net on the Consolidated Balance Sheet as of March 31, 2020, June 30, 2019, and March 31, 2019 is estimated by discounting the future cash flows using an average of current rates for similar arrangements, which is estimated at 4% per annum. Management has evaluated the collectability of this note and has determined no reserve is necessary. On July 31, 2019, Adtalem sold its Chicago, Illinois, campus facility to DePaul College Prep Foundation (“DePaul College Prep”). In connection with the sale, Adtalem holds a mortgage from DePaul College Prep for $46.8 million. The mortgage is due on July 31, 2024 as a balloon payment and bears interest at a rate of 4% per annum, payable monthly. The value of the DePaul College Prep loan receivable included in other assets, net on the Consolidated Balance Sheet as of March 31, 2020 is $41.1 million, which is estimated by discounting the future cash flows using an average of current rates for similar arrangements, which is estimated at 7% per annum. Management has evaluated the collectability of this note and has determined no reserve is necessary.

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Mar. 31, 2020
Property and Equipment, Net
Property and Equipment, Net	10. Property and Equipment, Net Property and equipment, net consists of the following (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, ​ June 30, ​ March 31, ​ 2020 2019 2019 Land $ 41,480 ​ $ 41,938 $ 41,182 Building ​ ​ 319,006 ​ ​ 322,657 ​ ​ 314,927 Equipment ​ ​ 244,369 ​ ​ 228,533 ​ ​ 227,692 Construction in progress ​ ​ 13,899 ​ ​ 13,545 ​ ​ 14,540 Property and equipment, gross ​ ​ 618,754 ​ ​ 606,673 ​ ​ 598,341 Accumulated depreciation ​ (332,408) ​ (323,240) ​ (318,954) Property and equipment, net ​ $ 286,346 ​ $ 283,433 ​ $ 279,387 ​ In September 2017, Hurricanes Irma and Maria caused damage and disrupted operations at AUC and RUSM. In December 2018, AUC and RUSM received the final insurance settlement proceeds related to the property damage and disruption of operations caused by Hurricanes Irma and Maria. These proceeds produced a gain of $15.6 million, which was recorded in the second quarter of fiscal year 2019. In the first quarter of fiscal year 2019, Adtalem announced its decision to relocate RUSM’s campus operations to Barbados and not return to RUSM’s Dominica campus. We recorded impairment charges of $39.1 million in the nine months ended March 31, 2019 to fully impair the property and equipment in Dominica as management determined the market value less the costs to sell the facilities or move the equipment was zero. The impairment charges are included in restructuring expense in the Consolidated Statements of Income (see Note 6 “Restructuring Charges”). On July 31, 2019, Adtalem sold its Chicago, Illinois, campus facility to DePaul College Prep for $52.0 million. Adtalem received $5.2 million of cash at the time of closing and holds a mortgage, secured by the property, from DePaul College Prep for $46.8 million. The mortgage is due on July 31, 2024 as a balloon payment and bears interest at a rate of 4% per annum, payable monthly. The buyer has an option to make prepayments. Due to Adtalem’s involvement with financing the sale, the transaction did not qualify as a sale for accounting purposes. Adtalem continues to maintain the assets associated with the sale on the Consolidated Balance Sheets. We recorded a note receivable of $40.3 million and a financing payable of $45.5 million at the time of the sale, which were classified as other assets, net and other liabilities, respectively, on the Consolidated Balance Sheet. See Note 9 “Financing Receivables” for a discussion on the discounting of the note receivable. The $5.2 million received during the first quarter of fiscal year 2020 is classified as a financing activity on the Consolidated Statements of Cash Flows. On September 27, 2019, Adtalem closed on the sale of its Columbus, Ohio, campus facility. Net proceeds from the sale of $6.4 million resulted in a gain on the sale of $4.8 million in the first nine months of fiscal year 2020. This gain was recorded at Adtalem’s home office, which is classified as “Home Office and Other” in Note 20 “Segment Information.”

Leases

Leases	9 Months Ended
	Mar. 31, 2020
Leases
Leases	11. Leases We determine if a contract contains a lease at inception. We have entered into operating leases for academic sites, housing facilities, and office space which expire at various dates through February 2030, most of which include options to terminate for a fee or extend the leases for an additional five-year period. The lease term includes options to terminate or extend when it is reasonably certain that the option will be exercised. We elected to account for lease and non-lease components (e.g., common-area maintenance costs) as a single lease component for all operating leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet. We have not entered into any financing leases. Operating lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease assets represent our right to use an underlying asset during the lease term. Operating lease assets and liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. Operating lease assets are adjusted for any prepaid or accrued lease payments, lease incentives, initial direct costs, and impairments. Our incremental borrowing rate is utilized in determining the present value of the lease payments based upon the information available at the commencement date. Our incremental borrowing rate is determined using a secured borrowing rate for the same currency and term as the associated lease. Operating lease expense is recognized on a straight-line basis over the lease term. As of March 31, 2020, we entered into two additional operating leases that have not yet commenced. One asset The components of lease cost were as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ March 31, March 31, ​ ​ 2020 ​ 2020 Operating lease cost ​ $ 14,121 ​ $ 43,129 Sublease income ​ (4,757) ​ (14,943) Total lease cost ​ $ 9,364 ​ $ 28,186 ​ Maturities of lease liabilities by fiscal year as of March 31, 2020 were as follows (in thousands): ​ ​ ​ ​ ​ ​ Operating Fiscal Year ​ Leases 2020 (remaining) ​ $ 16,099 2021 ​ ​ 62,274 2022 ​ ​ 57,881 2023 ​ ​ 47,249 2024 ​ ​ 30,929 Thereafter ​ ​ 51,734 Total lease payments ​ 266,166 Less: imputed interest ​ ​ (35,045) Present value of lease liabilities ​ $ 231,121 ​ Lease term and discount rate were as follows: ​ ​ ​ ​ ​ ​ March 31, ​ ​ 2020 Weighted-average remaining operating lease term (years) ​ ​ 5.1 Weighted-average operating lease discount rate ​ ​ 5.4% ​ Supplemental disclosures of cash flow information related to leases were as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended Nine Months Ended ​ ​ March 31, ​ March 31, ​ ​ 2020 ​ 2020 Cash paid for amounts in the measurement of operating lease liabilities (net of sublease receipts) ​ $ 12,559 ​ $ 36,576 Operating lease assets obtained in exchange for operating lease liabilities ​ $ 12,532 ​ $ 18,187 ​ Adtalem maintains agreements to lease four facilities owned by Adtalem to DeVry University with various expiration dates through December 2023. Adtalem maintains agreements to sublease either a portion or the full leased space at 23 of its operating lease locations. Most of these subleases are a result of Adtalem retaining leases associated with restructured lease activities at DeVry University and Carrington prior to their divestitures during fiscal year 2019. All sublease expirations with DeVry University and Carrington coincide with Adtalem’s original head lease expiration dates. At that time, Adtalem will be relieved of its obligations. In addition, Adtalem has entered into subleases with non-affiliated entities for vacated or partially vacated space from restructuring activities. Adtalem’s sublease agreements expire at various dates through December 2025. We record sublease income as an offset against our lease expense recorded on the head lease. For leases which Adtalem vacated or partially vacated space, we recorded estimated restructuring charges in prior periods. Actual results may differ from these estimates, which could result in additional restructuring charges or reversals. Future minimum lease and sublease rental income under these agreements as of March 31, 2020, were as follows (in thousands): ​ ​ ​ ​ ​ Fiscal Year Amount 2020 (remaining) ​ $ 5,796 2021 ​ ​ 19,852 2022 ​ 16,935 2023 ​ 16,199 2024 ​ 10,438 Thereafter ​ ​ 7,307 Total lease and sublease rental income ​ $ 76,527 ​ As previously disclosed in our 2019 Form 10-K and under the previous lease accounting guidance in ASC 840, future minimum rental commitments for all noncancelable operating leases, adjusted to exclude Adtalem Brazil, having a remaining term in excess of one year at June 30, 2019, were as follows (in thousands): ​ ​ ​ ​ ​ Fiscal Year ​ Amount 2020 ​ $ 67,109 2021 ​ ​ 60,781 2022 ​ ​ 55,982 2023 ​ ​ 44,970 2024 ​ ​ 28,374 Thereafter ​ ​ 36,120 Total minimum lease payments ​ $ 293,336 ​ Rent expense, adjusted to exclude Adtalem Brazil, for the years ended June 30, 2019 and 2018 was $35.8 million and $25.0 million, respectively.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	12. Goodwill and Intangible Assets The table below summarizes goodwill balances by reporting unit (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, June 30, March 31, Reporting Unit ​ 2020 ​ 2019 ​ 2019 Chamberlain ​ $ 4,716 ​ $ 4,716 ​ $ 4,716 AUC ​ 68,321 ​ 68,321 ​ 68,321 RUSM and RUSVM ​ 237,173 ​ 237,173 ​ 237,173 Financial Services ​ 376,025 ​ 377,046 ​ 317,475 Total ​ $ 686,235 ​ $ 687,256 ​ $ 627,685 The table below summarizes goodwill balances by reportable segment (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, June 30, March 31, Reportable Segment ​ 2020 ​ 2019 ​ 2019 Medical and Healthcare ​ $ 310,210 ​ $ 310,210 ​ $ 310,210 Financial Services ​ 376,025 ​ 377,046 ​ 317,475 Total ​ $ 686,235 ​ $ 687,256 ​ $ 627,685 The table below summarizes the changes in goodwill balances by reportable segment (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Medical and Financial ​ ​ ​ ​ Healthcare ​ Services ​ Total June 30, 2018 ​ $ 310,210 ​ $ 317,699 ​ $ 627,909 Foreign exchange rate changes ​ — ​ (224) ​ (224) March 31, 2019 ​ ​ 310,210 ​ ​ 317,475 ​ ​ 627,685 Acquisitions ​ ​ — ​ ​ 59,519 ​ ​ 59,519 Foreign exchange rate changes ​ — ​ 52 ​ 52 June 30, 2019 ​ ​ 310,210 ​ ​ 377,046 ​ ​ 687,256 Purchase accounting adjustments ​ — ​ (92) ​ (92) Foreign exchange rate changes ​ — ​ (929) ​ (929) March 31, 2020 ​ $ 310,210 ​ $ 376,025 ​ $ 686,235 ​ The decrease in the goodwill balance from June 30, 2019 in the Financial Services segment is primarily the result of a change in the value of the Indian Rupee compared to the U.S. dollar. Since EduPristine’s goodwill is recorded in local currency, fluctuations in the values of the Indian Rupee in relation to the U.S. dollar will cause changes in the balance of this asset. Intangible assets consist of the following (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2020 ​ ​ ​ Gross ​ ​ Weighted-Average ​ ​ Carrying ​ Accumulated ​ Amortization ​ ​ Amount ​ Amortization ​ Period Amortizable intangible assets: ​ ​ Customer relationships ​ $ 68,900 ​ $ (19,318) 10 Years Curriculum/software ​ 11,600 ​ (1,611) 6 Years Course delivery technology ​ 7,200 ​ (1,585) 5 Years Total ​ $ 87,700 ​ $ (22,514) Indefinite-lived intangible assets: ​ ​ Trade names ​ $ 95,666 ​ Chamberlain Title IV eligibility and accreditations ​ 1,200 ​ AUC Title IV eligibility and accreditations ​ 100,000 ​ Ross Title IV eligibility and accreditations ​ 14,100 ​ Intellectual property ​ 13,940 ​ Total ​ $ 224,906 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2019 ​ Gross ​ ​ ​ ​ Carrying ​ Accumulated ​ ​ Amount ​ Amortization Amortizable intangible assets: ​ ​ ​ ​ Customer relationships $ 69,300 $ (14,448) Curriculum/software ​ 16,600 ​ (5,193) Course delivery technology ​ 7,200 ​ (487) Total ​ $ 93,100 ​ $ (20,128) Indefinite-lived intangible assets: ​ ​ Trade names ​ $ 95,777 ​ Chamberlain Title IV eligibility and accreditations ​ 1,200 ​ AUC Title IV eligibility and accreditations ​ 100,000 ​ Ross Title IV eligibility and accreditations ​ 14,100 ​ Intellectual property ​ 13,940 ​ Total ​ $ 225,017 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2019 ​ Gross ​ ​ ​ ​ Carrying Accumulated ​ Amount Amortization Amortizable intangible assets: ​ ​ Customer relationships ​ $ 42,900 ​ $ (13,071) Curriculum/software ​ ​ 5,000 ​ ​ (4,583) Course delivery technology ​ ​ 500 ​ ​ (344) Total $ 48,400 $ (17,998) Indefinite-lived intangible assets: ​ ​ ​ ​ ​ ​ Trade names $ 77,371 ​ ​ ​ Chamberlain Title IV eligibility and accreditations ​ ​ 1,200 ​ ​ ​ AUC Title IV eligibility and accreditations ​ ​ 100,000 ​ ​ ​ Ross Title IV eligibility and accreditations ​ ​ 14,100 ​ ​ ​ Intellectual property ​ ​ 13,940 ​ ​ ​ Total $ 206,611 ​ ​ ​ ​ The table below summarizes the indefinite-lived intangible asset balances by reportable segment (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, June 30, March 31, Reportable Segment ​ 2020 ​ 2019 ​ 2019 Medical and Healthcare ​ $ 137,500 ​ $ 137,500 ​ $ 137,500 Financial Services ​ 87,406 ​ 87,517 ​ 69,111 Total ​ $ 224,906 ​ $ 225,017 ​ $ 206,611 ​ Amortization expense for amortized intangible assets was $2.6 million and $7.7 million for the three and nine months ended March 31, 2020, respectively, and $1.6 million and $4.8 million for the three and nine months ended March 31, 2019, respectively. Estimated amortization expense for amortizable intangible assets for the next five fiscal years ending June 30 and in the aggregate, by reporting unit, is as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ Financial Fiscal Year ​ Services ​ 2020 (remaining) ​ $ 2,576 ​ 2021 ​ 10,073 ​ 2022 ​ 9,944 ​ 2023 ​ 9,792 ​ 2024 ​ 9,509 ​ Thereafter ​ 23,292 ​ Total ​ $ 65,186 ​ ​ All amortizable intangible assets except ACAMS customer relationships are amortized on a straight-line basis. The amount amortized for ACAMS customer relationships is based on the estimated retention of the customers, giving consideration to the revenue and cash flow associated with these existing customers. Indefinite-lived intangible assets related to trade names, Title IV eligibility and accreditations, and intellectual property are not amortized, as there are no legal, regulatory, contractual, economic or other factors that limit the useful life of these intangible assets to the reporting entity. In accordance with GAAP, goodwill and indefinite-lived intangibles arising from a business combination are not amortized and charged to expense over time. Instead, these assets must be reviewed annually for impairment or more frequently if circumstances arise indicating potential impairment. Adtalem’s annual impairment review was most recently completed as of May 31, 2019, at which time there was no impairment loss associated with recorded goodwill or indefinite-lived intangible assets for any reporting unit. Adtalem has four reporting units that contained goodwill as of the third quarter of fiscal year 2020. These reporting units constitute components for which discrete financial information is available and regularly reviewed by segment management. If the carrying amount of a reporting unit containing the goodwill exceeds the fair value of that reporting unit, an impairment loss to goodwill is recognized. In analyzing the results of operations and business conditions of all the reporting units, as of March 31, 2020, it was determined that no triggering event had occurred that would indicate the carrying value of a reporting unit had exceeded its fair value. Adtalem has four reporting units that contained indefinite-lived intangible assets as of the third quarter of fiscal year 2020. For indefinite-lived intangible assets, management first analyzes qualitative factors including results of operations and business conditions of the four reporting units that contained indefinite-lived intangible assets, significant changes in cash flows at the individual indefinite-lived intangible asset level, if applicable, as well as how much previously calculated fair values exceed carrying values to determine if it is more likely than not that the intangible assets associated with these reporting units have been impaired. In analyzing the results of operations and business conditions of all the reporting units, as of March 31, 2020, it was determined that no triggering event had occurred that would indicate the carrying value of any indefinite-lived intangible asset had exceeded its fair value. These interim triggering event conclusions were based on the fact that the annual impairment review of Adtalem’s reporting units and indefinite-lived intangible assets resulted in no impairment indicators as of the end of fiscal year 2019, and that no interim events or deviations from planned operating results occurred as of March 31, 2020 that would cause management to reassess these conclusions. Although the COVID-19 pandemic is expected to have a negative effect on the operating results of all four reporting units that contain goodwill and indefinite-lived intangible assets, at this time none of the effects are considered significant enough to create a triggering event. The effects are currently projected to be short-term and would not significantly decrease long-term cash flow projections; however, should economic conditions continue to deteriorate into fiscal year 2021, the revenue and operating results of some reporting units could also deteriorate to the point where a triggering event would exist and require reassessment of the fair values of goodwill and intangible assets and potential impairments. Determining the fair value of a reporting unit or an intangible asset involves the use of significant estimates and assumptions. Management bases its fair value estimates on assumptions it believes to be reasonable at the time, but such assumptions are subject to inherent uncertainty. Actual results may differ from those estimates, which could lead to future impairments of intangible assets or goodwill.

Debt

Debt	9 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Debt	13. Debt Long-term debt consists of the following senior secured credit facility (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, June 30, March 31, ​ ​ 2020 ​ 2019 ​ 2019 Total debt: ​ ​ ​ Term B Loan ​ $ 294,750 ​ $ 297,000 ​ $ 297,750 Revolver ​ 160,000 ​ 110,000 ​ — Total principal payments due ​ 454,750 ​ 407,000 ​ 297,750 Deferred debt issuance costs ​ (5,140) ​ (5,906) ​ (6,161) Total amount outstanding ​ 449,610 ​ 401,094 ​ 291,589 Less current portion: ​ ​ ​ Term B Loan ​ (3,000) ​ (3,000) ​ (3,000) Noncurrent portion ​ $ 446,610 ​ $ 398,094 ​ $ 288,589 ​ Scheduled future maturities of long-term debt for the next five fiscal years ending June 30 and in the aggregate are as follows (in thousands): ​ ​ ​ ​ ​ ​ Maturity Fiscal Year ​ Payments 2020 (remaining) ​ $ 750 2021 ​ 3,000 2022 ​ 3,000 2023 ​ 163,000 2024 ​ 3,000 Thereafter ​ 282,000 Total ​ $ 454,750 ​ On April 13, 2018, Adtalem entered into a credit agreement (the “Credit Agreement”) that provides for (1) a $300 million revolving facility (“Revolver”) with a maturity date of April 13, 2023 and (2) a $300 million senior secured Term B loan (“Term B Loan”) with a maturity date of April 13, 2025. We refer to the Revolver and Term B Loan collectively as the “Credit Facility.” The Revolver has availability for currencies other than U.S. dollars of up to $200 million and $100 million available for letters of credit. Subject to certain conditions set forth in the Credit Agreement, the Credit Facility may be increased by $250 million. Interest on the Term B Loan and the Revolver is set based on LIBOR, which is based on observable market transactions. The U.K. Financial Conduct Authority (“FCA”), which regulates LIBOR, has announced that it has commitments from panel banks to continue to contribute to LIBOR through the end of calendar year 2021, but that it will not use its powers to compel contributions beyond such date. Various parties, including government agencies, are seeking to identify an alternative rate to replace LIBOR. Management is monitoring their efforts, and evaluating the need for an amendment to the Credit Agreement to accommodate a replacement rate. Term B Loan For Eurocurrency rate loans, Term B Loan interest is equal to LIBOR or a LIBOR-equivalent rate plus 3%. For base rate loans, Term B Loan interest is equal to the base rate plus 2%. The Term B Loan amortizes in equal quarterly installments of $750,000, with the balance due at maturity on April 13, 2025. As of March 31, 2020, June 30, 2019, and March 31, 2019, the interest rate for borrowings under the Term B Loan facility was 3.99%, 5.40%, and 5.50%, respectively, which approximated the effective interest rate. On March 24, 2020, we executed a pay-fixed, receive-variable interest rate swap agreement (the “Swap”) with a multinational financial institution to mitigate risks associated with the variable interest rate on our Term B Loan debt. We will pay interest at a fixed rate of 0.946% and receive variable interest of one-month LIBOR (subject to a minimum of 0.00%), on a notional amount equal to the amount outstanding under the Term B Loan. The effective date of the Swap is March 31, 2020 and settlements with the counterparty will occur on a monthly basis. The Swap will terminate on February 28, 2025. During the operating term of the Swap, the annual interest rate on the amount of the Term B Loan will be fixed at 3.946% (including the impact of our current 3% interest rate margin on LIBOR loans) for the applicable interest rate period. The Swap is designated as a cash flow hedge and as such, changes in its fair value are recognized in accumulated other comprehensive loss on the Consolidated Balance Sheet and are reclassified into the Consolidated Statements of Income within interest expense in the periods in which the hedged transactions affect earnings. Revolver Revolver interest is equal to LIBOR or a LIBOR-equivalent rate for Eurocurrency rate loans or a base rate, plus an applicable rate based on Adtalem’s consolidated leverage ratio, as defined in the Credit Agreement. The applicable rate ranges from 1.75% to 2.75% for Eurocurrency rate loans and from 0.75% to 1.75% for base rate loans. As of March 31, 2020 and June 30, 2019, borrowings under the Revolver were $160 million and $110 million with a weighted-average interest rate of 2.86% and 4.66%, respectively. There were no outstanding borrowings under the Revolver as of March 31, 2019. Adtalem had a letter of credit outstanding of $68.4 million as of each of March 31, 2020, June 30, 2019, and March 31, 2019. This letter of credit was posted in the second quarter of fiscal year 2017 in relation to a settlement with the Federal Trade Commission (“FTC”) and requires the letter of credit to be equal to the greater of 10% of DeVry University’s annual Title IV disbursements or $68.4 million for a five-year period. As of March 31, 2020, Adtalem is charged an annual fee equal to 2.25% of the undrawn face amount of the outstanding letters of credit under the Revolver, payable quarterly. Adtalem continues to post the letter of credit in relation to the settlement with the FTC on behalf of DeVry University and is reimbursed by DeVry University for 2.00% of the outstanding amount of this letter of credit. The Credit Agreement also requires payment of a commitment fee equal to 0.40% of the undrawn portion of the Revolver as of March 31, 2020. The amount undrawn under the Revolver, which includes the impact of the outstanding letters of credit, was $71.6 million as of March 31, 2020. The letter of credit fees and commitment fees are adjustable quarterly, based upon Adtalem’s achievement of certain financial ratios. Debt Issuance Costs Adtalem incurred $9.9 million in fees that were capitalized in relation to the Credit Agreement, $7.1 million of which was related to the Term B Loan facility and $2.7 million of which was related to the Revolver facility. The deferred debt issuance costs related to the Term B Loan are presented as a direct deduction from the face amount of the debt, while the deferred debt issuance costs related to the Revolver are classified as other assets, net on the Consolidated Balance Sheets. The deferred debt issuance costs amortization is recorded in interest expense in the Consolidated Statements of Income. The following table summarizes the total deferred debt issuance costs for the Term B Loan and Revolver, which are being amortized over seven years and five years, respectively (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Term B Loan Revolver Total Deferred debt issuance costs as of June 30, 2019 ​ $ 5,906 ​ $ 2,061 ​ $ 7,967 Amortization of deferred debt issuance costs ​ (766) ​ (408) ​ (1,174) Deferred debt issuance costs as of March 31, 2020 ​ $ 5,140 ​ $ 1,653 ​ $ 6,793 ​ Covenants and Guarantees The Credit Agreement contains customary covenants, including restrictions on our restricted subsidiaries’ ability to merge and consolidate with other companies, incur indebtedness, grant liens or security interest on assets, make acquisitions, loans, advances or investments, or sell or otherwise transfer assets. The Credit Agreement contains covenants that, among other things, require maintenance of certain financial ratios. Maintenance of these financial ratios could place restrictions on Adtalem’s ability to pay dividends. Adtalem has not paid a dividend since December 2016. These financial ratios include a consolidated fixed charge coverage ratio, a consolidated leverage ratio, and a U.S. Department of Education financial responsibility ratio based upon a composite score of an equity ratio, a primary reserve ratio, and a net income ratio. Failure to maintain any of these ratios or to comply with other covenants contained in the Credit Agreement would constitute an event of default and could result in termination of the Credit Agreement and require payment of all outstanding borrowings and replacement of outstanding letters of credit. Adtalem was in compliance with the debt covenants as of March 31, 2020. The stock of all U.S. and certain foreign subsidiaries of Adtalem is pledged as collateral for borrowings under the Credit Agreement. The Term B Loan requires mandatory prepayments equal to a percentage of excess cash flow or equal to the net cash proceeds in excess of $50 million from a disposition which is not reinvested in assets within one-year from the date of disposition, among other mandatory prepayment terms (see the Credit Agreement, as filed under Form 8-K dated April 13, 2018, for additional information and term definitions). No mandatory prepayments have been required or made since the execution of the Credit Agreement. Our borrowings under the Credit Facility are guaranteed by us and all of our domestic subsidiaries (subject to certain exceptions) and secured by a first lien on our assets and the assets of our guarantor subsidiaries (excluding real estate), including capital stock of the subsidiaries.

Redeemable Noncontrolling Inter

Redeemable Noncontrolling Interest	9 Months Ended
	Mar. 31, 2020
Noncontrolling Interest [Abstract]
Redeemable Noncontrolling Interest	14. Redeemable Noncontrolling Interest As of June 30, 2019, Adtalem maintained a 97.9% ownership interest in Adtalem Brazil with the remaining 2.1% owned by members of the Adtalem Brazil senior management group. Since July 1, 2015, Adtalem has had the right to exercise a call option and purchase any remaining Adtalem Brazil stock from Adtalem Brazil management. Likewise, Adtalem Brazil management has had the right to exercise a put option and sell its remaining ownership interest in Adtalem Brazil to Adtalem. In addition, Adtalem maintains a 71% ownership interest in EduPristine with the remaining 29% owned by Kaizen Management Advisors (“Kaizen”), an India-based private equity firm, as of March 31, 2020. The adjustment to increase or decrease the Adtalem Brazil and EduPristine noncontrolling interests for their respective proportionate shares of Adtalem Brazil’s and EduPristine’s profit (loss) flows through the Consolidated Statements of Income each reporting period based on Adtalem’s noncontrolling interest accounting policy. Beginning on March 26, 2020, Adtalem has had the right to exercise a call option and purchase any remaining EduPristine stock from Kaizen. Likewise, Kaizen has had the right to exercise a put option and sell up to 33% of its remaining ownership interest in EduPristine to Adtalem. Beginning on March 26, 2022, Kaizen will have the right to exercise a put option and sell its remaining ownership interest in EduPristine to Adtalem. Since the put options are out of the control of Adtalem, authoritative guidance requires the noncontrolling interests, which includes the value of the put options, to be displayed outside of the equity section of the Consolidated Balance Sheets. On July 1, 2019, the Adtalem Brazil management noncontrolling members exercised their put option and sold their remaining ownership interest in Adtalem Brazil to Adtalem resulting in Adtalem owning 100% of Adtalem Brazil. In the first quarter of fiscal year 2020, $6.2 million of redeemable noncontrolling interest was removed from the Consolidated Balance Sheet as a result of the put option exercise. Prior to July 1, 2019, the Adtalem Brazil management put option was being accreted to its fair value in accordance with the terms of the related stock purchase agreement. The adjustments to increase or decrease the put option to its expected redemption value each reporting period was recorded in retained earnings in accordance with GAAP. Adtalem has not adjusted the redemption value related to the Kaizen put option as management believes the redemption value has not materially changed since acquiring a majority stake in EduPristine. The following is a reconciliation of the redeemable noncontrolling interest balance (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ March 31, ​ March 31, ​ 2020 2019 2020 2019 Balance at beginning of period ​ $ 3,082 ​ $ 8,651 ​ $ 9,543 ​ $ 9,110 Net (loss) income attributable to redeemable noncontrolling interest ​ (120) ​ (39) ​ (334) ​ 117 Decrease in redemption value of redeemable noncontrolling interest put option ​ — ​ (130) ​ — ​ (745) Payment for purchase of redeemable noncontrolling interest of subsidiary ​ ​ — ​ ​ — ​ ​ (6,247) ​ ​ — Balance at end of period ​ $ 2,962 ​ $ 8,482 ​ $ 2,962 ​ $ 8,482 ​

Share Repurchases

Share Repurchases	9 Months Ended
	Mar. 31, 2020
Dividends And Share Repurchase Program [Abstract]
Share Repurchase	15. Share Repurchases On November 7, 2018, the Board of Directors (the “Board”) authorized Adtalem’s current share repurchase program, which allows Adtalem to repurchase up to $300 million of its common stock through December 31, 2021. The current share repurchase program commenced in January 2019. Adtalem made share repurchases under the current and former share repurchase programs as follows (in thousands, except shares and per share data): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ Life-to-Date ​ ​ March 31, ​ March 31, ​ Current Share ​ 2020 2019 2020 2019 Repurchase Program Total number of share repurchases ​ ​ 1,164,308 ​ ​ 1,266,160 ​ ​ 3,838,275 ​ ​ 3,631,611 ​ ​ 6,383,431 Total cost of share repurchases ​ $ 36,870 ​ $ 60,970 ​ $ 136,889 ​ $ 176,903 ​ $ 254,769 Average price paid per share ​ $ 31.67 ​ $ 48.15 ​ $ 35.66 ​ $ 48.71 ​ $ 39.91 ​ As of March 31, 2020, $45.2 million of authorized share repurchases were remaining under the current share repurchase program. On January 29, 2020, the Board authorized Adtalem’s twelfth share repurchase program, which allows Adtalem to repurchase up to $300 million of its common stock through December 31, 2021. The new program will commence when the repurchases from the current program are complete. Repurchases under the current program were suspended on March 12, 2020 due to the economic uncertainty caused by the COVID-19 pandemic. The timing and amount of any future repurchases will be determined based on an evaluation of market conditions and other factors. These repurchases may be made through the open market, including block purchases, in privately negotiated transactions, or otherwise. Repurchases will be funded through available cash balances and/or borrowings and may be suspended or discontinued at any time. Shares of stock repurchased under the programs are held as treasury shares. These repurchased shares have reduced the weighted-average number of shares of common stock outstanding for basic and diluted earnings per share calculations.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Mar. 31, 2020
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss	16. Accumulated Other Comprehensive Loss The following table shows the changes in accumulated other comprehensive loss by component (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ ​ March 31, ​ March 31, ​ ​ 2020 2019 2020 2019 ​ Foreign currency translation adjustments ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Beginning balance ​ $ (159,259) ​ $ (143,529) ​ $ (137,389) ​ $ (142,574) ​ Loss on foreign currency translation ​ ​ (117,669) ​ ​ (5,238) ​ ​ (139,539) ​ ​ (6,193) ​ Ending balance ​ $ (276,928) ​ $ (148,767) ​ $ (276,928) ​ $ (148,767) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Marketable securities ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Beginning balance, gross ​ $ 186 ​ $ 15 ​ $ 131 ​ $ 537 ​ Beginning balance, tax effect ​ ​ (45) ​ ​ (4) ​ ​ (32) ​ ​ (131) ​ Beginning balance, net of tax ​ ​ 141 ​ ​ 11 ​ ​ 99 ​ ​ 406 ​ ASU 2016-01 cumulative effect adjustment ​ ​ — ​ ​ — ​ ​ — ​ ​ (381) ​ Unrealized (loss) gain on marketable securities ​ ​ (58) ​ ​ 66 ​ ​ (3) ​ ​ 48 ​ Tax effect ​ ​ 14 ​ ​ (16) ​ ​ 1 ​ ​ (12) ​ Ending balance ​ $ 97 ​ $ 61 ​ $ 97 ​ $ 61 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest rate swap ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Beginning balance, gross ​ $ — ​ $ — ​ $ — ​ $ — ​ Beginning balance, tax effect ​ ​ — ​ ​ — ​ ​ — ​ ​ — ​ Beginning balance, net of tax ​ ​ — ​ ​ — ​ ​ — ​ ​ — ​ Unrealized gain on interest rate swap ​ ​ 598 ​ ​ — ​ ​ 598 ​ ​ — ​ Tax effect ​ ​ (146) ​ ​ — ​ ​ (146) ​ ​ — ​ Ending balance ​ $ 452 ​ $ — ​ $ 452 ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total ending balance at March 31 ​ $ (276,379) ​ $ (148,706) ​ $ (276,379) ​ $ (148,706) ​ ​

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Mar. 31, 2020
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation	17. Stock-Based Compensation Adtalem maintains two stock-based incentive plans: the Amended and Restated Incentive Plan of 2005 and the Fourth Amended and Restated Incentive Plan of 2013. Under these plans, directors, key executives, and managerial employees are eligible to receive incentive stock or nonqualified options to purchase shares of Adtalem’s common stock. The Fourth Amended and Restated Incentive Plan of 2013 and the Amended and Restated Incentive Plan of 2005 also permit the granting of stock appreciation rights, restricted stock units (“RSUs”), performance-based RSUs, and other stock and cash-based compensation. Although options remain outstanding under the 2005 incentive plan, no further stock-based grants will be issued under this plan. The Fourth Amended and Restated Incentive Plan of 2013 and the Amended and Restated Incentive Plan of 2005 are administered by the Compensation Committee of the Board. Options are granted for terms of up to ten years and can vest immediately or over periods of up to five years. The requisite service period is equal to the vesting period. The option price under the plans is the fair market value of the shares on the date of the grant. Stock-based compensation expense is measured at the grant date based on the fair value of the award. Adtalem accounts for stock-based compensation granted to retirement eligible employees that fully vests upon an employee’s retirement under the non-substantive vesting period approach. Under this approach, the entire stock-based compensation expense is recognized at the grant date for stock-based grants issued to retirement eligible employees. For non-retirement eligible employees, stock-based compensation expense is recognized as expense over the employee requisite service period. We account for forfeitures of outstanding but unvested grants in the period they occur. As of March 31, 2020, 6,655,935 authorized but unissued shares of common stock were reserved for issuance under Adtalem’s stock-based incentive plans. The following is a summary of options activity for the nine months ended March 31, 2020: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-Average ​ ​ ​ ​ ​ ​ ​ Remaining ​ Aggregate ​ ​ Number of ​ Weighted-Average ​ Contractual Life ​ Intrinsic Value ​ ​ Options ​ Exercise Price ​ (in years) ​ (in thousands) Outstanding as of July 1, 2019 1,488,478 ​ $ 31.33 ​ Granted 229,125 ​ 43.39 ​ Exercised (85,234) ​ 27.54 ​ Forfeited (65,946) ​ 42.76 ​ Expired (70,604) ​ 51.81 ​ Outstanding as of March 31, 2020 1,495,819 ​ 31.90 6.61 ​ $ 2,937 Exercisable as of March 31, 2020 716,037 ​ $ 28.43 5.32 ​ $ 2,082 ​ The total intrinsic value of options exercised for the nine months ended March 31, 2020 and 2019 was $0.9 million and $4.2 million, respectively. The fair value of Adtalem’s stock option awards was estimated using a binomial model. This model uses historical cancellation and exercise experience of Adtalem to determine the option value. It also takes into account the illiquid nature of employee options during the vesting period. The weighted-average estimated grant date fair value of options granted at market price under Adtalem’s stock-based incentive plans during the first nine months of fiscal years 2020 and 2019 was $16.98 and $20.96, per share, respectively. The fair value of Adtalem’s stock option grants was estimated assuming the following weighted-average assumptions: ​ ​ ​ ​ ​ ​ ​ ​ ​ Fiscal Year ​ ​ 2020 2019 ​ Expected life (in years) 6.51 6.50 Expected volatility 37.66 % 39.60 % Risk-free interest rate 1.40 % 2.73 % Dividend yield 0.00 % 0.00 % ​ The expected life of the options granted is based on the weighted-average exercise life with age and salary adjustment factors from historical exercise behavior. Adtalem’s expected volatility is computed by combining and weighting the implied market volatility, the most recent volatility over the expected life of the option grant, and Adtalem’s long-term historical volatility. If factors change and different assumptions are employed in the valuation of stock-based grants in future periods, the stock-based compensation expense that Adtalem records may differ significantly from what was recorded in previous periods. During the first nine months of fiscal year 2020, Adtalem granted 408,520 RSUs to selected employees and directors. Of these, 135,660 are performance-based RSUs and 272,860 are non-performance-based RSUs. Performance-based RSUs are earned by the recipients over a three-year period based on achievement of return on invested capital and free cash flow per share. Certain awards are subject to achievement of a minimum level of Adtalem’s earnings before interest, taxes, depreciation, and amortization, calculated on a non-GAAP basis. Non-performance-based RSUs are subject to restrictions which lapse ratably over one three ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-Average ​ ​ Number of ​ Grant Date ​ ​ RSUs ​ Fair Value Outstanding as of July 1, 2019 878,030 ​ $ 34.86 Granted 408,520 ​ 42.38 Vested (362,036) ​ 28.75 Forfeited (121,914) ​ 40.17 Outstanding as of March 31, 2020 802,600 ​ $ 39.08 ​ The weighted-average estimated grant date fair values of RSUs granted at market price under Adtalem’s stock-based incentive plans during the first nine months of fiscal years 2020 and 2019 were $42.38 and $49.57, per share, respectively. The following table shows total stock-based compensation expense included in the Consolidated Statements of Income (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ ​ March 31, ​ March 31, ​ ​ 2020 2019 2020 2019 ​ Cost of educational services ​ $ 260 ​ $ 279 ​ $ 1,027 ​ $ 976 ​ Student services and administrative expense ​ 2,521 ​ 2,729 ​ 10,301 ​ 9,393 ​ ​ ​ 2,781 ​ 3,008 ​ 11,328 ​ 10,369 ​ Income tax benefit ​ (642) ​ (692) ​ (3,887) ​ (3,930) ​ Net stock-based compensation expense ​ $ 2,139 ​ $ 2,316 ​ $ 7,441 ​ $ 6,439 ​ ​ As of March 31, 2020, $21.8 million of total pre-tax unrecognized stock-based compensation expense related to unvested grants is expected to be recognized over a weighted-average period of 2.4 years. The total fair value of options and RSUs vested during the nine months ended March 31, 2020 and 2019 was approximately $13.5 million and $13.7 million, respectively. There was no capitalized stock-based compensation cost at each of March 31, 2020, June 30, 2019, and March 31, 2019. Adtalem has an established practice of issuing new shares of common stock to satisfy stock-based grant exercises. However, Adtalem also may issue treasury shares to satisfy stock-based grant exercises under certain of its stock-based incentive plans.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	18. Fair Value Measurements Adtalem has elected not to measure any assets or liabilities at fair value other than those required to be measured at fair value on a recurring basis. Assets measured at fair value on a nonrecurring basis include goodwill, intangible assets, and assets of businesses where the long-term value of the operations have been impaired. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. The guidance specifies a fair value hierarchy based upon the observability of inputs used in valuation techniques. Observable inputs (highest level) reflect market data obtained from independent sources, while unobservable inputs (lowest level) reflect internally developed market assumptions. The guidance establishes fair value measurement classifications under the following hierarchy: Level 1 – Level 2 – Observable inputs other than prices included in Level 1, such as quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs or significant value-drivers are observable in active markets. Level 3 –Model-derived valuations in which one or more significant inputs or significant value-drivers are unobservable. When available, Adtalem uses quoted market prices to determine fair value, and such measurements are classified within Level 1. In cases where market prices are not available, Adtalem makes use of observable market-based inputs to calculate fair value, in which case the measurements are classified within Level 2. If quoted or observable market prices are not available, fair value is based upon internally developed models that use, where possible, current market-based parameters such as interest rates and yield curves. These measurements are classified within Level 3. Fair value measurements are classified according to the lowest level input or value-driver that is significant to the valuation. A measurement may therefore be classified within Level 3 even though there may be significant inputs that are readily observable. The carrying value of our cash and cash equivalents approximates fair value because of their short-term nature. Adtalem maintains a rabbi trust to fund obligations under a non-qualified deferred compensation plan. Amounts in the rabbi trust are invested in stock and bond mutual funds, which are designated as available-for-sale securities carried at fair value, and are included in investments in marketable securities on the Consolidated Balance Sheets. All investments in marketable securities are recorded at fair value based upon quoted market prices using Level 1 inputs. In connection with the sale of Adtalem Brazil completed on April 24, 2020, Adtalem entered into a deal-contingent foreign currency hedge arrangement to economically hedge the Brazilian Real denominated sales price through mitigation of the currency exchange rate risk. The hedge agreement has a total notional amount of R$2,154 million (approximately $415 million as of March 31, 2020). Adtalem recorded a pre-tax unrealized gain on the hedge agreement derivative based on the foreign exchange forward spot rate as of March 31, 2020 of $111.8 million and $83.8 million for the three and nine months ended March 31, 2020, respectively, with a $83.8 million asset included within prepaid expenses and other current assets on the March 31, 2020 Consolidated Balance Sheet. The fair value of this derivative was calculated using observable market-based inputs to a model to calculate fair value, in which case the measurements are classified within Level 2. These model inputs include foreign exchange forward contract spot rates and contract defined point adjustments and settlement prices. On March 24, 2020, we executed a pay-fixed, receive-variable interest rate swap agreement with a multinational financial institution to fully mitigate risks associated with the variable interest rate on our Term B Loan debt with an effective date of March 31, 2020. The fair value of our Swap is based in part on data received from the counterparty, and represents the estimated amount we would receive or pay to settle the Swap, taking into consideration current and projected future interest rates as well as the creditworthiness of the counterparty, all of which can be validated through readily observable data from external sources, in which case the measurements are classified within Level 2. The fair value of the Swap is represented within other assets, net on the Consolidated Balance Sheet with a balance of $0.6 million as of March 31, 2020. See Note 13 “Debt” for additional information on the Swap. As of March 31, 2020, June 30, 2019, and March 31, 2019, there were no assets or liabilities measured at fair value using Level 3 inputs. Assets measured at fair value on a nonrecurring basis include goodwill and indefinite-lived intangibles arising from a business combination. These assets are not amortized and charged to expense over time. Instead, goodwill and indefinite-lived intangibles must be reviewed annually for impairment or more frequently if circumstances arise indicating potential impairment. This impairment review was most recently completed as of May 31, 2019. See Note 12 “Goodwill and Intangible Assets” for additional information on the impairment review, including valuation techniques and assumptions.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure
Commitments and Contingencies	19. Commitments and Contingencies Adtalem is subject to lawsuits, administrative proceedings, regulatory reviews, and investigations associated with financial assistance programs and other matters arising in the normal conduct of its business. As of March 31, 2020, Adtalem believes it has adequately reserved for potential losses. The following is a description of pending legal and regulatory matters that may be considered other than ordinary, routine, and incidental to the business. Descriptions of certain matters from prior SEC filings may not be carried forward in this report to the extent we believe such matters no longer are required to be disclosed or there has not been, to our knowledge, significant activity relating to them. The timing or outcome of the following matters, or their possible impact on Adtalem’s business, financial condition, or results of operations, cannot be predicted at this time. The continued defense, resolution, or settlement of any of the following matters could require us to expend significant resources and could have a material adverse effect on our business, financial condition, results of operations, and cash flows, and result in the imposition of significant restrictions on us and our ability to operate. On October 14, 2016, a putative class action lawsuit was filed by Debbie Petrizzo and five other former DeVry University students, individually and on behalf of others similarly situated, against Adtalem, DeVry University, Inc., and DeVry/New York Inc. (collectively the “Adtalem Parties”) in the United States District Court for the Northern District of Illinois (the “Petrizzo Case”). The complaint was filed on behalf of a putative class of persons consisting of those who enrolled in and/or attended classes at DeVry University during and after 2002 and who were unable to find employment within their chosen field of study within six months of graduation. Citing the civil complaint filed by the FTC on January 26, 2016 against the Adtalem Parties (the “FTC lawsuit”), the plaintiffs claimed that defendants made false or misleading statements regarding DeVry University’s graduate employment rate and asserted claims for unjust enrichment and violations of six different states’ consumer fraud, unlawful trade practices, and consumer protection laws. The plaintiffs seek monetary, declaratory, injunctive, and other unspecified relief. On October 28, 2016, a putative class action lawsuit was filed by Jairo Jara and eleven others, individually and on behalf of others similarly situated, against the Adtalem Parties in the United States District Court for the Northern District of Illinois (the “Jara Case”). The individual plaintiffs claimed to have graduated from DeVry University in 2001 or later and sought to proceed on behalf of a putative class of persons consisting of those who obtained a degree from DeVry University and who were unable to find employment within their chosen field of study within six months of graduation. Citing the FTC lawsuit, the plaintiffs claimed that defendants made false or misleading statements regarding DeVry University’s graduate employment rate and asserted claims for unjust enrichment and violations of ten different states’ consumer fraud, unlawful trade practices, and consumer protection laws. The plaintiffs sought monetary, declaratory, injunctive, and other unspecified relief. By order dated November 28, 2016, the district court ordered the Petrizzo Case and the Jara Case be consolidated under the Petrizzo caption for all further purposes. On December 5, 2016, plaintiffs filed an amended consolidated complaint on behalf of 38 individual plaintiffs and others similarly situated. The amended consolidated complaint sought to bring claims on behalf of the named individuals and a putative nationwide class of individuals for unjust enrichment and alleged violations of the Illinois Consumer Fraud and Deceptive Practices Act and the Illinois Private Businesses and Vocational Schools Act of 2012. In addition, it purported to assert causes of action on behalf of certain of the named individuals and 15 individual state-specific putative classes for alleged violations of 15 different states’ consumer fraud, unlawful trade practices, and consumer protection laws. Finally, it sought to bring individual claims under Georgia state law on behalf of certain named plaintiffs. The plaintiffs sought monetary, declaratory, injunctive, and other unspecified relief. A motion to dismiss the amended complaint was filed by the Adtalem Parties and granted by the court, without prejudice, on February 12, 2018. On April 12, 2018, the Petrizzo plaintiffs refiled their complaint with a new lead plaintiff, Renee Heather Polly. The plaintiffs’ refiled complaint is nearly identical to the complaint previously dismissed by the court on February 12, 2018. The Adtalem Parties moved to dismiss this refiled complaint on May 14, 2018. The court granted defendants’ motion and dismissed the amended complaint with prejudice on February 13, 2019. On March 15, 2019, plaintiffs filed a notice of appeal and this matter is currently pending on appeal before the Seventh Circuit. On April 13, 2018, a putative class action lawsuit was filed by Nicole Versetto, individually and on behalf of others similarly situated, against the Adtalem Parties in the Circuit Court of Cook County, Illinois, Chancery Division. The complaint was filed on behalf of herself and three separate classes of similarly situated individuals who were citizens of the State of Illinois and who purchased or paid for a DeVry University program between January 1, 2008 and April 8, 2016. The plaintiff claims that defendants made false or misleading statements regarding DeVry University’s graduate employment rate and asserts causes of action under the Illinois Uniform Deceptive Trade Practices Act, Illinois Consumer Fraud and Deceptive Trade Practices Act, and Illinois Private Business and Vocational Schools Act, and claims of breach of contract, fraudulent misrepresentation, concealment, negligence, breach of fiduciary duty, conversion, unjust enrichment, and declaratory relief as to violations of state law. The plaintiff seeks compensatory, exemplary, punitive, treble, and statutory penalties and damages, including pre-judgment and post-judgment interest, in addition to restitution, declaratory and injunctive relief, and attorneys’ fees. The Adtalem Parties moved to dismiss this complaint on June 20, 2018. On March 11, 2019, the court granted plaintiff’s motion for leave to file an amended complaint. Plaintiff filed an amended complaint that same day, asserting similar claims, with new lead plaintiff, Dave McCormick. Defendants filed a motion to dismiss plaintiff’s amended complaint on April 15, 2019 and the court granted Defendants’ motion on July 29, 2019, with leave to amend. The plaintiff has filed an amended complaint on August 26, 2019. On October 18, 2019, defendants’ moved to dismiss this complaint as it is substantially similar to the one the court previously dismissed. No hearing on the motion to dismiss is currently scheduled. A status hearing is scheduled for June 8, 2020. This matter is currently stayed. On May 8, 2018, the Carlson Law Firm (“Carlson”) filed a lawsuit against Adtalem and DeVry University, Inc., on behalf of 71 individual former DeVry University students in Rangel v. Adtalem and DeVry University, Inc. Carlson filed this lawsuit in the United States District Court for the Western District of Texas. Plaintiffs contend that DeVry University “made deceptive representations about the benefits of obtaining a degree from DeVry University” in violation of Texas state laws and seek full restitution of all monies paid to DeVry University and any student loan lenders, punitive damages, and attorneys’ fees. The defendants moved to dismiss this complaint on June 5, 2018. On June 27, 2018, Carlson filed a second lawsuit on behalf of 32 former DeVry University students against Adtalem and DeVry University, Inc. in Lindberg v. Adtalem and DeVry University, Inc. Carlson filed this lawsuit in the United States District Court for the Western District of Texas. The allegations are identical to the allegations in the lawsuit Carlson filed on May 8, 2018. Specifically, plaintiffs contend that DeVry University “made deceptive representations about the benefits of obtaining a degree from DeVry University” in violation of Texas state laws and seek full restitution of all monies paid to DeVry University and any student loan lenders, punitive damages, and attorneys’ fees. The defendants moved to dismiss this complaint on August 28, 2018. The court consolidated these two lawsuits on December 10, 2018. The defendants moved to dismiss the consolidated action on December 18, 2018. On January 2, 2019, Carlson filed a motion to intervene on behalf of 13 additional former DeVry University students seeking to join the consolidated lawsuit. The parties re-filed their briefing on the motions to dismiss so that the motion would apply to all three groups of plaintiffs. On April 24, 2019, the Court granted Adtalem’s and DeVry University’s motions to dismiss, with leave to amend. The plaintiffs filed an amended complaint on June 7, 2019. Defendants moved to dismiss the complaint on July 5, 2019. The motion to dismiss was referred to a magistrate judge. On December 13, 2019, the magistrate judge issued a report and recommendation denying defendants’ motion to dismiss. On January 3, 2020, defendants filed their objections to the report and recommendation on the motion to dismiss, and plaintiffs filed a response to the objections on January 8, 2020. The District Court judge adopted the Magistrate Judge’s report and recommendations on March 12, 2020, and the defendants filed an answer to the complaint on April 10, 2020. Discovery is ongoing. On April 4, 2019, the Carlson Law Firm sent notice pursuant to California Legal Remedies Act, Civil Code § 1750, of 105 individuals who purportedly have claims against DeVry University and Adtalem based on allegedly deceptive comments made about the benefits of obtaining a DeVry University degree; specifically, that 90% of graduates obtained a job in their chosen field of study within six months of graduation, and that graduates were paid more than graduates of other universities. On July 16, 2019, the Carlson Law Firm filed a lawsuit in the United States District Court for the Northern District of California – San Jose Division against Adtalem and DeVry University on behalf of 102 individual former DeVry University students in Alvarez v. Adtalem and DeVry University, Inc. The plaintiffs contend that defendants misrepresented the benefits of graduating from DeVry University and falsely and misleadingly advertised the employment rate and income rate of their graduates to induce potential students to purchase educational products and services, and to remain students through graduation. The lawsuit seeks exemplary damages, restitution, economic damages, punitive damages, pre- and post-judgment interest, attorneys’ fees and the cost of suit. The plaintiffs brought claims for fraud by misrepresentation, fraud by concealment, negligent misrepresentation, civil theft, violation of the California Consumer Legal Remedies Act, violation of California’s Unfair Competition Law, and violation of California’s False Advertising Law. Defendants filed a motion to dismiss the complaint on October 1, 2019. On December 16, 2019, the court granted in part and denied in part the motion to dismiss. Defendants filed an answer to the complaint on January 13, 2020. Plaintiffs filed an amended complaint on January 31, 2020, and defendants filed an amended answer on March 2, 2020. The parties court-ordered mediation on May 20, 2020 has been postponed due to COVID-19. Discovery is ongoing. On August 13, 2019, a plaintiff, Magana, filed a putative class action lawsuit against Adtalem and DeVry University, Inc. in the United States District Court for the Eastern District of California, alleging damages based on allegedly deceptive statements made about the benefits of obtaining a DeVry University degree. Plaintiffs assert claims under the California Unfair Competition Law, California False Advertising Law, and claims of fraud/material misrepresentation, fraudulent concealment/intentional omission of material facts, negligent misrepresentation, breach of contract, breach of fiduciary duty, conversion, unjust enrichment, and declaratory relief. This matter is currently stayed. On June 21, 2018, Stoltmann Law Offices filed a lawsuit against Adtalem in Cook County Circuit Court, alleging that Adtalem breached a contract with Stoltmann Law Offices to pay filing fees associated with arbitration claims Stoltmann Law Offices has filed with the Judicial Arbitration and Mediation Services, Inc. (“JAMS”). Stoltmann Law Offices is seeking specific performance from the court. Adtalem moved to dismiss this complaint on August 3, 2018. Prior to the court ruling on Adtalem’s motion to dismiss, Stoltmann Law Offices and 399 individuals filed an amended complaint on August 9, 2018, asserting claims for specific performance, declaratory judgment and a petition to compel arbitration. Adtalem moved to dismiss the amended complaint on August 31, 2018. The court granted Adtalem’s motion to dismiss on November 30, 2018, but granted plaintiffs leave to file a second amended complaint. A single On June 7, 2019, Stoltmann Law Offices filed a complaint in the Northern District of Illinois on behalf of Michael Forsythe seeking to compel arbitration of his consumer claims before JAMS. Adtalem moved to dismiss the complaint on July 1, 2019. The court dismissed the complaint as moot on January 31, 2020. Stoltmann Law Offices is representing hundreds of individuals who have filed claims with JAMS alleging fraud-based claims based on DeVry University’s graduate employment statistics. Stoltmann Law Offices has paid the filing fees for thirty of these arbitrations to move forward. JAMS has sent commencement letters in several waves on June 14, 2019; August 2, 2019; August 5, 2019; November 6, 2019; November 15, 2019; November 25, 2019; February 14, 2020; March 13, 2020; and April 15, 2020. Defendants have filed answers in response to twenty-two arbitration demands. These arbitrations are in various stages of litigation and discovery. On March 29, 2019, a putative class action lawsuit was filed by Robby Brown, individually and on behalf of all others similarly situated, against Adtalem and DeVry University, Inc., in the Western District of Missouri. The complaint was filed on behalf of himself and two separate classes of similarly situated individuals who were citizens of the State of Missouri and who purchased or paid for and received any part of a DeVry University program. The plaintiffs claim that defendants made false or misleading statements regarding DeVry University’s graduate employment rate and assert claims of breach of contract, negligent misrepresentation, fraudulent misrepresentation, fraudulent concealment, breach of fiduciary duty, conversion, unjust enrichment, and declaratory relief. The plaintiffs seek compensatory, exemplary, punitive, treble, and statutory penalties and damages as allowed by law, including pre-judgment and post-judgment interest disgorgement, restitution, injunctive and declaratory relief, and attorneys’ fees. Defendants filed a motion to dismiss the complaint on May 31, 2019. On October 9, 2019, the court granted in part and denied in part the motion to dismiss. The court dismissed plaintiffs’ claims for unjust enrichment and conversion, allowing the remaining claims to proceed. On October 29, 2019, defendants filed an answer to the complaint. This matter is currently stayed. On or about April 1, 2019, Adtalem, Chamberlain and DeVry University received similar Civil Investigative Demands (“CID”) from the U.S. Department of Justice (the “DOJ”). The CIDs were issued pursuant to a False Claims Act inquiry concerning allegations that Adtalem, in particular Chamberlain and Adtalem’s former subsidiary DeVry University, submitted or caused the submission of false claims to the U.S. Department of Defense and U.S. Department of Veteran Affairs for federal funds under the GI Bill Programs and Tuition Assistance Program from 2011 to the date of the CIDs. It is specifically alleged that Chamberlain and DeVry University engaged in unlawful recruitment tactics, and provided incentive payments based directly or indirectly on securing federal financial aid. Adtalem cooperated with this DOJ inquiry and provided documents and other information requested by the DOJ. On February 27, 2020, the DOJ notified the U.S. District Court for the District of Georgia that it would decline to intervene in two qui tam False Claims Act actions filed by former DeVry University employees related to the subject matter of the CIDs and subsequently notified Adtalem that we are no longer needed to produce materials requested in the CID. Those actions were unsealed on March 2, 2020 and it is unknown whether the relators will pursue them. Although we cannot predict the ultimate outcome of these actions, we believe they are without merit and intend to vigorously defend against them. On April 3, 2019, a putative class action lawsuit was filed by T’Lani Robinson, individually and on behalf of all others similarly situated, against Adtalem and DeVry University, Inc., in the Northern District of Georgia. The complaint was filed on behalf of herself and three separate classes of similarly situated individuals who were citizens of the State of Georgia who purchased or paid for and received any part of a DeVry University program. The plaintiffs claim that defendants made false or misleading statements regarding DeVry University’s graduate employment rate and assert claims of breach of contract, negligent misrepresentation, fraudulent misrepresentation, fraudulent concealment, breach of fiduciary duty, conversion, unjust enrichment, and declaratory relief. The plaintiffs seek compensatory, exemplary, punitive, treble, and statutory penalties and damages as allowed by law, including pre-judgment and post-judgment interest disgorgement, restitution, injunctive and declaratory relief, and attorneys’ fees. Defendants filed a motion to dismiss the complaint on May 31, 2019. On November, 25, 2019, the court granted in part and denied in part defendants’ motion to dismiss. The court dismissed the claims for breach of fiduciary duty and conversion with prejudice. The court dismissed the claims for negligent misrepresentation, fraudulent misrepresentation, fraudulent concealment, and unjust enrichment without prejudice, ordering plaintiffs’ to file an amended class-action complaint within fourteen days of the order. The court allowed the claims for breach of contract and declaratory relief to proceed. On December 9, 2019, plaintiff filed an amended class-action complaint. On December 23, 2019, defendants filed their answer to the amended class action complaint. The matter is currently stayed.

Segment Information

Segment Information	9 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Segment Information	20. Segment Information During the fourth quarter of fiscal year 2019, Adtalem renamed two of its segments: Professional Education was renamed Financial Services, and Technology and Business was renamed Business and Law. Beginning in the first quarter of fiscal year 2020, Adtalem Brazil operations were classified as discontinued operations. See Note 4 “Discontinued Operations and Assets Held for Sale” for additional information. Segment information presented excludes the results of Adtalem Brazil. Adtalem eliminated its Business and Law reportable segment during the first quarter of fiscal year 2020 when Adtalem Brazil was classified as discontinued operations. In addition, DeVry University and Carrington are presented as discontinued operations, see Note 4 “Discontinued Operations and Assets Held for Sale” for additional information. Discontinued operations assets are included in the table below to reconcile to total consolidated assets presented on the Consolidated Balance Sheets. In addition, certain expenses previously allocated to Adtalem Brazil within our former Business and Law segment during fiscal year 2019 were reclassified to the Home Office and Other segment based on discontinued operations reporting guidance regarding allocation of corporate overhead. For fiscal year 2020, home office costs to support the remaining businesses are being allocated to the Medical and Healthcare and Financial Services segments. We present two reportable segments as follows: Medical and Healthcare Financial Services These segments are consistent with the method by which the Chief Operating Decision Maker (Adtalem’s Chairman, President and Chief Executive Officer) evaluates performance and allocates resources. Performance evaluations are based on each segment’s operating income excluding special items. Operating income excludes special items that consists of restructuring expense, gain on sale of assets, and settlement gain. Adtalem’s management excludes these items from its review of the results of the operating segments for purposes of measuring segment profitability and allocating resources. Intersegment sales are accounted for at amounts comparable to sales to nonaffiliated customers and are eliminated in consolidation. “Home Office and Other” includes activity not allocated to a reportable segment and is included to reconcile segment results to the Consolidated Financial Statements. Segments may have allocated depreciation expense related to depreciable assets reported as an asset in a different segment. The accounting policies of the segments are the same as those described in Note 2 “Summary of Significant Accounting Policies.” Summary financial information by reportable segment is as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ ​ March 31, ​ March 31, ​ ​ 2020 2019 2020 2019 ​ Revenue: ​ ​ ​ ​ Medical and Healthcare ​ $ 227,344 ​ $ 223,575 ​ $ 655,011 ​ $ 638,302 ​ Financial Services ​ 44,143 ​ 35,935 ​ 137,261 ​ 113,723 ​ Home Office and Other ​ — ​ (807) ​ — ​ (2,422) ​ Total consolidated revenue ​ $ 271,487 ​ $ 258,703 ​ $ 792,272 ​ $ 749,603 ​ Operating income from continuing operations excluding special items: ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 57,559 ​ $ 52,960 ​ $ 127,786 ​ $ 141,152 ​ Financial Services ​ 4,190 ​ 5,086 ​ 13,976 ​ 19,469 ​ Home Office and Other ​ (5,408) ​ (10,281) ​ (15,663) ​ (29,982) ​ Total consolidated operating income from continuing operations excluding special items ​ ​ 56,341 ​ ​ 47,765 ​ ​ 126,099 ​ ​ 130,639 ​ Reconciliation to Consolidated Financial Statements: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Restructuring expense ​ (1,854) ​ (2,186) ​ (10,339) ​ (45,194) ​ Gain on sale of assets ​ ​ — ​ ​ — ​ ​ 4,779 ​ ​ — ​ Settlement gain ​ ​ — ​ ​ — ​ ​ — ​ ​ 15,571 ​ Total consolidated operating income from continuing operations ​ ​ 54,487 ​ ​ 45,579 ​ ​ 120,539 ​ ​ 101,016 ​ Net other income (expense) ​ 105,881 ​ (3,009) ​ 69,816 ​ (11,913) ​ Total consolidated income from continuing operations before income taxes ​ $ 160,368 ​ $ 42,570 ​ $ 190,355 ​ $ 89,103 ​ Segment assets: ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 917,657 ​ $ 827,452 ​ $ 917,657 ​ $ 827,452 ​ Financial Services ​ 577,699 ​ 446,752 ​ 577,699 ​ 446,752 ​ Home Office and Other ​ 457,686 ​ 317,000 ​ 457,686 ​ 317,000 ​ Discontinued Operations ​ 490,978 ​ 557,499 ​ 490,978 ​ 557,499 ​ Total consolidated assets ​ $ 2,444,020 ​ $ 2,148,703 ​ $ 2,444,020 ​ $ 2,148,703 ​ Capital expenditures: ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 7,274 ​ $ 10,978 ​ $ 20,108 ​ $ 37,696 ​ Financial Services ​ 568 ​ 84 ​ 1,980 ​ 1,487 ​ Home Office and Other ​ 3,781 ​ 2,149 ​ 9,846 ​ 6,086 ​ Total consolidated capital expenditures ​ $ 11,623 ​ $ 13,211 ​ $ 31,934 ​ $ 45,269 ​ Depreciation expense: ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 7,127 ​ $ 7,680 ​ $ 21,898 ​ $ 20,449 ​ Financial Services ​ 556 ​ 480 ​ 1,438 ​ 1,212 ​ Home Office and Other ​ 866 ​ 653 ​ 2,437 ​ 3,065 ​ Total consolidated depreciation expense ​ $ 8,549 ​ $ 8,813 ​ $ 25,773 ​ $ 24,726 ​ Intangible asset amortization expense: ​ ​ ​ ​ ​ Financial Services ​ $ 2,576 ​ $ 1,605 ​ $ 7,686 ​ $ 4,816 ​ Total consolidated intangible asset amortization expense ​ $ 2,576 ​ $ 1,605 ​ $ 7,686 ​ $ 4,816 ​ Adtalem conducts its educational and financial services operations in the U.S., Barbados, St. Kitts, St. Maarten, India, Europe, China, Canada, and the Middle East. Other international revenue was less than 5% of total revenue for each of the three and nine months ended March 31, 2020 and 2019. Revenue and long-lived assets by geographic area are as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ ​ March 31, ​ March 31, ​ ​ 2020 2019 2020 2019 ​ Revenue from unaffiliated customers: ​ ​ ​ ​ Domestic operations ​ $ 176,946 ​ $ 160,949 ​ $ 507,482 ​ $ 468,788 ​ International operations: ​ ​ ​ ​ ​ ​ Barbados, Dominica, St. Kitts, and St. Maarten ​ 92,259 ​ 95,366 ​ 277,934 ​ 274,207 ​ Other ​ 2,282 ​ 2,388 ​ 6,856 ​ 6,608 ​ Total international ​ 94,541 ​ 97,754 ​ 284,790 ​ 280,815 ​ Total consolidated revenue ​ $ 271,487 ​ $ 258,703 ​ $ 792,272 ​ $ 749,603 ​ Long-lived assets: ​ ​ ​ ​ ​ Domestic operations ​ $ 208,812 ​ $ 156,881 ​ $ 208,812 ​ $ 156,881 ​ International operations: ​ ​ ​ ​ ​ ​ Barbados, Dominica, St. Kitts, and St. Maarten ​ 160,552 ​ 174,827 ​ 160,552 ​ 174,827 ​ Other ​ 1,807 ​ 2,065 ​ 1,807 ​ 2,065 ​ Total international ​ 162,359 ​ 176,892 ​ 162,359 ​ 176,892 ​ Total consolidated long-lived assets ​ $ 371,171 ​ $ 333,773 ​ $ 371,171 ​ $ 333,773 ​ ​ No one customer accounted for more than 10% of Adtalem’s consolidated revenue.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation A full listing of our significant accounting policies is described in Note 4 “Summary of Significant Accounting Policies” of our Annual Report on Form 10-K for the fiscal year ended June 30, 2019 (“2019 Form 10-K”). We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial statements and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (which are normal and recurring in nature) considered necessary for a fair presentation have been included. These consolidated financial statements and accompanying notes should be read in conjunction with our annual consolidated financial statements and the notes thereto included in our 2019 Form 10-K. We use the same accounting policies in preparing quarterly and annual financial statements. Unless otherwise noted, amounts presented within the Notes to Consolidated Financial Statements refer to our continuing operations. The World Health Organization declared the novel coronavirus (“COVID-19” or “virus”) to be a public health emergency on January 30, 2020. The virus has had tragic consequences across the globe, and its full impact is not yet known as of the May 5, 2020 filing date of this Form 10-Q. While the virus did not have significant impacts to the third quarter of fiscal year 2020 results of operations, depending on the length and severity of social distancing and other measures established to combat the virus, there could be significant impacts on future results of operations. Due to the effects of COVID-19 on operations and the seasonal nature of our business, quarterly revenue, expenses, earnings, and cash flows are not necessarily indicative of the results that may be achieved for the full fiscal year. Certain prior period amounts have been reclassified for consistency with the current period presentation.
Recent Accounting Standards	Recent Accounting Standards Recently adopted accounting standards In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02: “Leases (Topic 842).” This guidance was issued to increase transparency and comparability among organizations by recognizing right-of-use assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. We adopted this guidance, along with the related clarifications and improvements, effective July 1, 2019 using the modified retrospective approach without adjusting prior comparative periods. The adoption of this standard significantly impacts our Consolidated Balance Sheets, but did not impact our Consolidated Statements of Income. We elected the practical expedients package which allows us to forego reassessing (i) whether any expired or existing contracts are or contain leases; (ii) the lease classification for any expired or expiring leases; and (iii) initial direct costs for any existing leases. We did not elect the hindsight practical expedient, which permits the use of hindsight when determining the lease term and impairment of operating lease assets. See Note 11 “Leases” for the disclosures related to this new accounting standard. The impact on the Consolidated Balance Sheet upon adoption of Accounting Standards Codification (“ASC”) 842 is as follows (in thousands, except par value): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, ​ Adjustments due to ​ July 1, ​ 2019 adoption of ASC 842 2019 Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ Current assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ Cash and cash equivalents ​ $ 299,445 ​ $ — ​ $ 299,445 Investments in marketable securities ​ 8,680 ​ — ​ 8,680 Restricted cash ​ 1,022 ​ — ​ 1,022 Accounts receivable, net ​ 157,829 ​ — ​ 157,829 Prepaid expenses and other current assets ​ 37,724 ​ (3,483) ​ 34,241 Total current assets ​ 504,700 ​ (3,483) ​ 501,217 Noncurrent assets: ​ ​ ​ ​ ​ ​ Property and equipment, net ​ ​ 364,683 ​ ​ — ​ ​ 364,683 Operating lease assets ​ — ​ 282,978 ​ 282,978 Deferred income taxes ​ 18,314 ​ — ​ 18,314 Intangible assets, net ​ 418,097 ​ — ​ 418,097 Goodwill ​ 874,451 ​ — ​ 874,451 Other assets, net ​ 62,451 ​ — ​ 62,451 Total noncurrent assets ​ 1,737,996 ​ 282,978 ​ 2,020,974 Total assets ​ $ 2,242,696 ​ $ 279,495 ​ $ 2,522,191 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities and shareholders' equity: ​ ​ ​ Current liabilities: ​ ​ ​ Accounts payable ​ $ 57,627 ​ $ — ​ $ 57,627 Accrued salaries, wages, and benefits ​ 64,492 ​ — ​ 64,492 Accrued liabilities ​ 86,722 ​ (16,946) ​ 69,776 Deferred revenue ​ 99,790 ​ — ​ 99,790 Current operating lease liabilities ​ — ​ 66,707 ​ 66,707 Current portion of long-term debt ​ 3,000 ​ — ​ 3,000 Total current liabilities ​ 311,631 ​ 49,761 ​ 361,392 Noncurrent liabilities: ​ ​ ​ ​ ​ ​ Long-term debt ​ 398,094 ​ — ​ 398,094 Long-term operating lease liabilities ​ — ​ 269,387 ​ 269,387 Deferred income taxes ​ 29,426 ​ — ​ 29,426 Other liabilities ​ 102,472 ​ (39,653) ​ 62,819 Total noncurrent liabilities ​ 529,992 ​ 229,734 ​ 759,726 Total liabilities ​ 841,623 ​ 279,495 ​ 1,121,118 Redeemable noncontrolling interest ​ 9,543 ​ — ​ 9,543 Shareholders' equity: ​ ​ ​ ​ ​ ​ Common stock, $0.01 par value ​ 801 ​ — ​ 801 Additional paid-in capital ​ 486,061 ​ — ​ 486,061 Retained earnings ​ 2,012,902 ​ — ​ 2,012,902 Accumulated other comprehensive loss ​ (137,290) ​ — ​ (137,290) Treasury stock, at cost ​ (970,944) ​ — ​ (970,944) Total shareholders' equity ​ 1,391,530 ​ — ​ 1,391,530 Total liabilities and shareholders' equity ​ $ 2,242,696 ​ $ 279,495 ​ $ 2,522,191 ​ Upon the adoption of ASC 842, the following balances were removed from the Consolidated Balance Sheet as of July 1, 2019: (i) $3.5 million of prepaid rent balances within prepaid expenses and other current assets; (ii) $6.8 million of current deferred rent liability balances within accrued liabilities; (iii) $10.1 million of current restructure liability balances within accrued liabilities; (iv) $24.8 million of noncurrent deferred rent liability balances within other liabilities; and (v) $14.9 million of noncurrent restructure liability balances within other liabilities. In March 2020, FASB issued ASU No. 2020-04: “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance was issued to provide for temporary optional expedients and exceptions to the current guidance on certain contract modifications and hedge relationships to ease the burdens related to the expected market transition from the London Inter-bank Offered Rate (“LIBOR”) or other reference rates to alternative reference rates. The guidance is effective as of March 12, 2020 through December 31, 2022. We adopted this guidance in the third quarter of fiscal year 2020 and is not expected to have a significant effect on Adtalem’s Consolidated Financial Statements. Recently issued accounting standards not yet adopted In June 2016, FASB issued ASU No. 2016-13: “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” The guidance was issued to provide financial statement users with more decision-useful information about the expected losses on financial instruments by replacing the incurred loss impairment methodology with a methodology that reflects expected credit losses by requiring a broader range of reasonable and supportable information to inform credit loss estimates. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Management is evaluating the impact the guidance will have on Adtalem’s Consolidated Financial Statements and believes the guidance will be applied to our allowance for bad debts on trade receivables and institutional loans and will not have a significant impact on Adtalem’s Consolidated Financial Statements.
Reclassifications	Reclassifications Beginning in the first quarter of fiscal year 2020, Adtalem Brazil operations were classified as discontinued operations. See Note 4 “Discontinued Operations and Assets Held for Sale” for additional information. Prior period amounts have been revised to conform to the current classification. Certain expenses in prior periods previously allocated to Adtalem Brazil within our former Business and Law segment have been reclassified to the Home Office and Other segment based on discontinued operation reporting guidance regarding allocation of corporate overhead. For fiscal year 2020, home office costs to support the remaining businesses are being allocated to the Medical and Healthcare and Financial Services segments. See Note 20 “Segment Information” for additional information.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Summary of impact on the Consolidated Balance Sheet upon adoption of ASC 842	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, ​ Adjustments due to ​ July 1, ​ 2019 adoption of ASC 842 2019 Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ Current assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ Cash and cash equivalents ​ $ 299,445 ​ $ — ​ $ 299,445 Investments in marketable securities ​ 8,680 ​ — ​ 8,680 Restricted cash ​ 1,022 ​ — ​ 1,022 Accounts receivable, net ​ 157,829 ​ — ​ 157,829 Prepaid expenses and other current assets ​ 37,724 ​ (3,483) ​ 34,241 Total current assets ​ 504,700 ​ (3,483) ​ 501,217 Noncurrent assets: ​ ​ ​ ​ ​ ​ Property and equipment, net ​ ​ 364,683 ​ ​ — ​ ​ 364,683 Operating lease assets ​ — ​ 282,978 ​ 282,978 Deferred income taxes ​ 18,314 ​ — ​ 18,314 Intangible assets, net ​ 418,097 ​ — ​ 418,097 Goodwill ​ 874,451 ​ — ​ 874,451 Other assets, net ​ 62,451 ​ — ​ 62,451 Total noncurrent assets ​ 1,737,996 ​ 282,978 ​ 2,020,974 Total assets ​ $ 2,242,696 ​ $ 279,495 ​ $ 2,522,191 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities and shareholders' equity: ​ ​ ​ Current liabilities: ​ ​ ​ Accounts payable ​ $ 57,627 ​ $ — ​ $ 57,627 Accrued salaries, wages, and benefits ​ 64,492 ​ — ​ 64,492 Accrued liabilities ​ 86,722 ​ (16,946) ​ 69,776 Deferred revenue ​ 99,790 ​ — ​ 99,790 Current operating lease liabilities ​ — ​ 66,707 ​ 66,707 Current portion of long-term debt ​ 3,000 ​ — ​ 3,000 Total current liabilities ​ 311,631 ​ 49,761 ​ 361,392 Noncurrent liabilities: ​ ​ ​ ​ ​ ​ Long-term debt ​ 398,094 ​ — ​ 398,094 Long-term operating lease liabilities ​ — ​ 269,387 ​ 269,387 Deferred income taxes ​ 29,426 ​ — ​ 29,426 Other liabilities ​ 102,472 ​ (39,653) ​ 62,819 Total noncurrent liabilities ​ 529,992 ​ 229,734 ​ 759,726 Total liabilities ​ 841,623 ​ 279,495 ​ 1,121,118 Redeemable noncontrolling interest ​ 9,543 ​ — ​ 9,543 Shareholders' equity: ​ ​ ​ ​ ​ ​ Common stock, $0.01 par value ​ 801 ​ — ​ 801 Additional paid-in capital ​ 486,061 ​ — ​ 486,061 Retained earnings ​ 2,012,902 ​ — ​ 2,012,902 Accumulated other comprehensive loss ​ (137,290) ​ — ​ (137,290) Treasury stock, at cost ​ (970,944) ​ — ​ (970,944) Total shareholders' equity ​ 1,391,530 ​ — ​ 1,391,530 Total liabilities and shareholders' equity ​ $ 2,242,696 ​ $ 279,495 ​ $ 2,522,191

Acquisitions (Tables)

Acquisitions (Tables) - OnCourse Learning [Member]	9 Months Ended
	Mar. 31, 2020
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed at the date of acquisition (in thousands): ​ ​ ​ ​ ​ May 31, ​ ​ 2019 Current assets ​ $ 5,260 Property and equipment ​ 1,197 Intangible assets ​ 63,100 Goodwill ​ 59,427 Total assets acquired ​ 128,984 Liabilities assumed ​ 9,445 Net assets acquired ​ $ 119,539
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	​ ​ ​ ​ ​ ​ ​ May 31, 2019 ​ ​ Value ​ Estimated ​ Assigned Useful Life Customer relationships ​ $ 26,400 ​ 11 years Curriculum ​ 11,600 6 years Course delivery technology ​ 6,700 5 years

Discontinued Operations and A_2

Discontinued Operations and Assets Held for Sale (Tables)	9 Months Ended
	Mar. 31, 2020
Discontinued Operations and Assets Held for Sale
Balance Sheet Information of Assets and Liabilities Reported as Discontinued Operations	The following is a summary of balance sheet information of assets and liabilities reported as held for sale, which includes only Adtalem Brazil balances as Carrington and DeVry University were sold as of each period presented below (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, ​ June 30, ​ March 31, ​ 2020 2019 2019 Assets: ​ ​ ​ Current assets: ​ ​ ​ Cash and cash equivalents ​ $ 83,961 ​ $ 95,243 ​ $ 90,511 Accounts receivable, net ​ 52,507 ​ 74,269 ​ 65,794 Prepaid expenses and other current assets ​ 5,949 ​ 8,411 ​ 10,252 Total current assets held for sale ​ 142,417 ​ 177,923 ​ 166,557 Noncurrent assets: ​ ​ ​ ​ Property and equipment, net ​ ​ 57,610 ​ ​ 81,250 ​ ​ 80,234 Operating lease assets ​ 54,092 ​ — ​ — Intangible assets, net ​ 88,403 ​ 120,108 ​ 118,134 Goodwill ​ 138,914 ​ 187,195 ​ 183,575 Other assets, net ​ 9,542 ​ 10,338 ​ 8,999 Total noncurrent assets held for sale ​ 348,561 ​ 398,891 ​ 390,942 Total assets held for sale ​ $ 490,978 ​ $ 576,814 ​ $ 557,499 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ ​ ​ Current liabilities: ​ ​ ​ ​ Accounts payable ​ $ 2,378 ​ $ 4,242 ​ $ 3,230 Accrued payroll and benefits ​ 10,671 ​ 17,828 ​ 15,462 Accrued liabilities ​ 4,891 ​ 10,193 ​ 12,008 Deferred revenue ​ 8,688 ​ 3,846 ​ 13,990 Current operating lease liabilities ​ 8,322 ​ — ​ — Total current liabilities held for sale ​ 34,950 ​ 36,109 ​ 44,690 Noncurrent liabilities: ​ ​ ​ ​ ​ Long-term operating lease liabilities ​ 46,747 ​ — ​ — Other liabilities ​ 10,103 ​ 16,146 ​ 16,372 Total noncurrent liabilities held for sale ​ 56,850 ​ 16,146 ​ 16,372 Total liabilities held for sale ​ $ 91,800 ​ $ 52,255 ​ $ 61,062 The following is a summary of income statement information of operations reported as discontinued operations, which includes Adtalem Brazil operations and includes Carrington’s and DeVry University’s operations through the date of each respective sale (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ ​ March 31, ​ March 31, ​ ​ 2020 2019 2020 2019 ​ Revenue ​ $ 41,355 ​ $ 49,906 ​ $ 142,160 ​ $ 355,506 ​ Operating cost and expense: ​ ​ ​ ​ ​ ​ Cost of educational services ​ 28,940 ​ 36,147 ​ 98,605 ​ 222,837 ​ Student services and administrative expense ​ 17,781 ​ 11,252 ​ 47,860 ​ 130,615 ​ Restructuring expense (gain) ​ 199 ​ (257) ​ 625 ​ (570) ​ Asset impairment charge - building and equipment ​ — ​ — ​ — ​ 1,953 ​ Total operating cost and expense ​ 46,920 ​ 47,142 ​ 147,090 ​ 354,835 ​ Operating (loss) income from discontinued operations ​ (5,565) ​ 2,764 ​ (4,930) ​ 671 ​ Other income (expense): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest and dividend income ​ ​ 425 ​ ​ 941 ​ ​ 2,164 ​ ​ 2,917 ​ Interest expense ​ ​ (807) ​ ​ (483) ​ ​ (2,770) ​ ​ (2,317) ​ Net other (expense) income ​ (382) ​ 458 ​ (606) ​ 600 ​ (Loss) income from discontinued operations before income taxes ​ ​ (5,947) ​ ​ 3,222 ​ ​ (5,536) ​ ​ 1,271 ​ Loss on disposal of discontinued operations before income taxes ​ ​ — ​ ​ (265) ​ ​ — ​ ​ (32,979) ​ Benefit from income taxes ​ 3,228 ​ 182 ​ 3,778 ​ 5,762 ​ (Loss) income from discontinued operations ​ ​ (2,719) ​ ​ 3,139 ​ ​ (1,758) ​ ​ (25,946) ​ Net income attributable to redeemable noncontrolling interest ​ ​ — ​ ​ (74) ​ ​ — ​ ​ (382) ​ Net (loss) income from discontinued operations attributable to Adtalem ​ $ (2,719) ​ $ 3,065 ​ $ (1,758) ​ $ (26,328) ​

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Disaggregate revenue	The following tables disaggregate revenue by source (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended March 31, 2020 ​ Medical and Financial Home Office ​ Consolidated Higher education $ 222,019 $ — $ — $ 222,019 Test preparation/certifications ​ ​ — ​ ​ 26,236 ​ ​ — ​ ​ 26,236 Conferences/seminars ​ ​ — ​ ​ 11,925 ​ ​ — ​ ​ 11,925 Memberships/subscriptions ​ ​ — ​ ​ 5,590 ​ ​ — ​ ​ 5,590 Other ​ ​ 5,325 ​ ​ 392 ​ ​ — ​ ​ 5,717 Total $ 227,344 $ 44,143 $ — $ 271,487 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Nine Months Ended March 31, 2020 ​ Medical and Financial Home Office ​ Consolidated Higher education $ 637,625 $ — $ — $ 637,625 Test preparation/certifications ​ ​ — ​ ​ 78,145 ​ ​ — ​ ​ 78,145 Conferences/seminars ​ ​ — ​ ​ 42,738 ​ ​ — ​ ​ 42,738 Memberships/subscriptions ​ ​ — ​ ​ 15,512 ​ ​ — ​ ​ 15,512 Other ​ ​ 17,386 ​ ​ 866 ​ ​ — ​ ​ 18,252 Total $ 655,011 $ 137,261 $ — $ 792,272 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended March 31, 2019 ​ Medical and Financial Home Office ​ Consolidated Higher education $ 217,423 $ — $ — $ 217,423 Test preparation/certifications ​ ​ — ​ ​ 27,562 ​ ​ (807) ​ ​ 26,755 Conferences/seminars ​ ​ — ​ ​ 3,860 ​ ​ — ​ ​ 3,860 Memberships/subscriptions ​ ​ — ​ ​ 4,299 ​ ​ — ​ ​ 4,299 Other ​ ​ 6,152 ​ ​ 214 ​ ​ — ​ ​ 6,366 Total $ 223,575 $ 35,935 $ (807) $ 258,703 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Nine Months Ended March 31, 2019 ​ ​ Medical and Financial Home Office ​ Consolidated Higher education ​ $ 630,083 $ — $ — $ 630,083 Test preparation/certifications ​ ​ — ​ ​ 83,576 ​ ​ (2,422) ​ ​ 81,154 Conferences/seminars ​ ​ — ​ ​ 17,405 ​ ​ — ​ ​ 17,405 Memberships/subscriptions ​ ​ — ​ ​ 12,135 ​ ​ — ​ ​ 12,135 Other ​ ​ 8,219 ​ ​ 607 ​ ​ — ​ ​ 8,826 Total $ 638,302 $ 113,723 $ (2,422) $ 749,603

Restructuring Charges (Tables)

Restructuring Charges (Tables)	9 Months Ended
	Mar. 31, 2020
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs	Pre-tax restructuring charges by segment were as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended March 31, 2020 ​ Nine Months Ended March 31, 2020 ​ Real Estate Termination ​ ​ Real Estate Termination ​ ​ ​ ​ and Other ​ Benefits ​ Total ​ and Other ​ Benefits ​ Total Medical and Healthcare ​ $ 810 ​ $ — ​ $ 810 ​ $ 1,129 ​ $ 225 ​ $ 1,354 Financial Services ​ — ​ — ​ — ​ 2,862 ​ 254 ​ 3,116 Home Office and Other ​ 255 ​ 789 ​ 1,044 ​ 4,779 ​ 1,090 ​ 5,869 Total ​ $ 1,065 ​ $ 789 ​ $ 1,854 ​ $ 8,770 ​ $ 1,569 ​ $ 10,339 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended March 31, 2019 ​ Nine Months Ended March 31, 2019 ​ Real Estate Termination ​ ​ Real Estate Termination ​ ​ ​ ​ and Other ​ Benefits ​ Total ​ and Other ​ Benefits ​ Total Medical and Healthcare ​ $ (110) ​ $ (23) ​ $ (133) ​ $ 40,033 ​ $ 1,294 ​ $ 41,327 Home Office and Other ​ 2,271 ​ 48 ​ 2,319 ​ 3,748 ​ 119 ​ 3,867 Total ​ $ 2,161 ​ $ 25 ​ $ 2,186 ​ $ 43,781 ​ $ 1,413 ​ $ 45,194
Separation and Restructuring Plan Activity	The following table summarizes the separation and restructuring plan activity for the fiscal years 2020 and 2019, for which cash payments are required (in thousands): ​ ​ ​ ​ Liability balance as of June 30, 2018 $ 38,927 Increase in liability (separation and other charges) ​ 8,870 Reduction in liability (payments and adjustments) ​ (22,714) Liability balance as of June 30, 2019 ​ 25,083 ASC 842 (leases) adjustment (1) ​ ​ (25,030) Liability balance as of July 1, 2019 ​ 53 Increase in liability (separation and other charges) ​ 3,551 Reduction in liability (payments and adjustments) ​ (3,331) Liability balance as of March 31, 2020 ​ $ 273 (1)

Earnings per Share (Tables)

Earnings per Share (Tables)	9 Months Ended
	Mar. 31, 2020
Earnings per Share
Earnings per Share	The following table sets forth the computations of basic and diluted earnings per share and stock awards not included in the computation of diluted earnings per share when their effect is anti-dilutive (in thousands, except per share data): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ March 31, ​ March 31, ​ 2020 2019 2020 2019 Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income (loss) attributable to Adtalem: ​ ​ ​ ​ ​ ​ ​ ​ Continuing operations ​ $ 153,551 ​ $ 34,840 ​ $ 172,476 ​ $ 71,998 Discontinued operations ​ ​ (2,719) ​ ​ 3,065 ​ ​ (1,758) ​ ​ (26,328) Net ​ $ 150,832 ​ $ 37,905 ​ $ 170,718 ​ $ 45,670 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-average shares outstanding ​ 52,498 ​ 57,583 ​ 53,647 ​ 58,656 Unvested participating RSUs ​ 457 ​ 478 ​ 470 ​ 543 Weighted-average basic shares outstanding ​ 52,955 ​ 58,061 ​ 54,117 ​ 59,199 Effect of dilutive stock awards ​ 364 ​ 741 ​ 459 ​ 805 Weighted-average diluted shares outstanding ​ 53,319 ​ 58,802 ​ 54,576 ​ 60,004 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Earnings (loss) per share attributable to Adtalem: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Continuing operations ​ $ 2.90 ​ $ 0.60 ​ $ 3.19 ​ $ 1.22 Discontinued operations ​ $ (0.05) ​ $ 0.05 ​ $ (0.03) ​ $ (0.44) Net ​ $ 2.85 ​ $ 0.65 ​ $ 3.15 ​ $ 0.77 Diluted: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Continuing operations ​ $ 2.88 ​ $ 0.59 ​ $ 3.16 ​ $ 1.20 Discontinued operations ​ $ (0.05) ​ $ 0.05 ​ $ (0.03) ​ $ (0.44) Net ​ $ 2.83 ​ $ 0.64 ​ $ 3.13 ​ $ 0.76 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-average anti-dilutive stock awards ​ ​ 992 ​ ​ 194 ​ ​ 942 ​ ​ 223

Financing Receivables (Tables)

Financing Receivables (Tables)	9 Months Ended
	Mar. 31, 2020
Receivables [Abstract]
Institutional Loan Balances and Related Allowances for Credit Losses	The following table details the institutional loan balances along with the related allowances for credit losses (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Nine Months Ended ​ Year Ended ​ Nine Months Ended ​ ​ March 31, 2020 ​ June 30, 2019 ​ March 31, 2019 Gross institutional loans ​ ​ $ 50,296 ​ ​ $ 47,937 ​ ​ $ 47,259 Allowance for credit losses: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Balance as of July 1 $ (6,289) ​ ​ ​ $ (10,003) ​ ​ ​ $ (10,003) ​ ​ ​ Charge-offs and adjustments ​ ​ 664 ​ ​ ​ ​ ​ 10,777 ​ ​ ​ ​ ​ 9,965 ​ ​ ​ Recoveries ​ ​ (40) ​ ​ ​ ​ ​ (83) ​ ​ ​ ​ ​ (73) ​ ​ ​ Additional provision ​ ​ (9,026) ​ ​ ​ ​ ​ (6,980) ​ ​ ​ ​ ​ (4,571) ​ ​ ​ Balance as of end of period ​ ​ ​ ​ ​ (14,691) ​ ​ ​ ​ ​ (6,289) ​ ​ ​ ​ ​ (4,682) Net institutional loans ​ ​ ​ $ 35,605 ​ ​ ​ $ 41,648 ​ ​ ​ $ 42,577
Institutional Student Loans Past Due	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Over ​ ​ ​ ​ ​ ​ ​ Total ​ ​ 1-29 Days ​ 30-59 Days ​ 60-89 Days ​ 90 Days ​ Total ​ ​ ​ Institutional ​ ​ Past Due ​ Past Due ​ Past Due ​ Past Due ​ Past Due ​ Current ​ Loans Institutional loans: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2020 ​ $ 3,484 ​ $ 1,145 ​ $ 1,673 ​ $ 13,382 ​ $ 19,684 ​ $ 30,612 ​ $ 50,296 June 30, 2019 ​ $ 3,578 ​ $ 2,458 ​ $ 687 ​ $ 9,888 ​ $ 16,611 ​ $ 31,326 ​ $ 47,937 March 31, 2019 ​ $ 4,092 ​ $ 4,412 ​ $ 4,125 ​ $ 4,543 ​ $ 17,172 ​ $ 30,087 ​ $ 47,259

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Mar. 31, 2020
Property and Equipment, Net
Schedule of Property and equipment, net	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, ​ June 30, ​ March 31, ​ 2020 2019 2019 Land $ 41,480 ​ $ 41,938 $ 41,182 Building ​ ​ 319,006 ​ ​ 322,657 ​ ​ 314,927 Equipment ​ ​ 244,369 ​ ​ 228,533 ​ ​ 227,692 Construction in progress ​ ​ 13,899 ​ ​ 13,545 ​ ​ 14,540 Property and equipment, gross ​ ​ 618,754 ​ ​ 606,673 ​ ​ 598,341 Accumulated depreciation ​ (332,408) ​ (323,240) ​ (318,954) Property and equipment, net ​ $ 286,346 ​ $ 283,433 ​ $ 279,387

Leases (Tables)

Leases (Tables)	9 Months Ended
	Mar. 31, 2020
Leases
Summary of components of lease cost	The components of lease cost were as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ March 31, March 31, ​ ​ 2020 ​ 2020 Operating lease cost ​ $ 14,121 ​ $ 43,129 Sublease income ​ (4,757) ​ (14,943) Total lease cost ​ $ 9,364 ​ $ 28,186
Summary of maturities of lease liabilities	​ ​ ​ ​ ​ ​ Operating Fiscal Year ​ Leases 2020 (remaining) ​ $ 16,099 2021 ​ ​ 62,274 2022 ​ ​ 57,881 2023 ​ ​ 47,249 2024 ​ ​ 30,929 Thereafter ​ ​ 51,734 Total lease payments ​ 266,166 Less: imputed interest ​ ​ (35,045) Present value of lease liabilities ​ $ 231,121
Summary of lease term and discount rate	​ ​ ​ ​ ​ ​ March 31, ​ ​ 2020 Weighted-average remaining operating lease term (years) ​ ​ 5.1 Weighted-average operating lease discount rate ​ ​ 5.4%
Summary of supplemental disclosures of cash flow information related to leases	​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended Nine Months Ended ​ ​ March 31, ​ March 31, ​ ​ 2020 ​ 2020 Cash paid for amounts in the measurement of operating lease liabilities (net of sublease receipts) ​ $ 12,559 ​ $ 36,576 Operating lease assets obtained in exchange for operating lease liabilities ​ $ 12,532 ​ $ 18,187
Schedule of Future minimum lease and sublease rental income	​ ​ ​ ​ ​ Fiscal Year Amount 2020 (remaining) ​ $ 5,796 2021 ​ ​ 19,852 2022 ​ 16,935 2023 ​ 16,199 2024 ​ 10,438 Thereafter ​ ​ 7,307 Total lease and sublease rental income ​ $ 76,527
Summary of future minimum rental commitments for all noncancelable operating leases	​ ​ ​ ​ ​ Fiscal Year ​ Amount 2020 ​ $ 67,109 2021 ​ ​ 60,781 2022 ​ ​ 55,982 2023 ​ ​ 44,970 2024 ​ ​ 28,374 Thereafter ​ ​ 36,120 Total minimum lease payments ​ $ 293,336

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in Carrying Amount of Goodwill	The table below summarizes goodwill balances by reporting unit (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, June 30, March 31, Reporting Unit ​ 2020 ​ 2019 ​ 2019 Chamberlain ​ $ 4,716 ​ $ 4,716 ​ $ 4,716 AUC ​ 68,321 ​ 68,321 ​ 68,321 RUSM and RUSVM ​ 237,173 ​ 237,173 ​ 237,173 Financial Services ​ 376,025 ​ 377,046 ​ 317,475 Total ​ $ 686,235 ​ $ 687,256 ​ $ 627,685 The table below summarizes goodwill balances by reportable segment (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, June 30, March 31, Reportable Segment ​ 2020 ​ 2019 ​ 2019 Medical and Healthcare ​ $ 310,210 ​ $ 310,210 ​ $ 310,210 Financial Services ​ 376,025 ​ 377,046 ​ 317,475 Total ​ $ 686,235 ​ $ 687,256 ​ $ 627,685 The table below summarizes the changes in goodwill balances by reportable segment (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Medical and Financial ​ ​ ​ ​ Healthcare ​ Services ​ Total June 30, 2018 ​ $ 310,210 ​ $ 317,699 ​ $ 627,909 Foreign exchange rate changes ​ — ​ (224) ​ (224) March 31, 2019 ​ ​ 310,210 ​ ​ 317,475 ​ ​ 627,685 Acquisitions ​ ​ — ​ ​ 59,519 ​ ​ 59,519 Foreign exchange rate changes ​ — ​ 52 ​ 52 June 30, 2019 ​ ​ 310,210 ​ ​ 377,046 ​ ​ 687,256 Purchase accounting adjustments ​ — ​ (92) ​ (92) Foreign exchange rate changes ​ — ​ (929) ​ (929) March 31, 2020 ​ $ 310,210 ​ $ 376,025 ​ $ 686,235
Schedule of Intangible Assets	Intangible assets consist of the following (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2020 ​ ​ ​ Gross ​ ​ Weighted-Average ​ ​ Carrying ​ Accumulated ​ Amortization ​ ​ Amount ​ Amortization ​ Period Amortizable intangible assets: ​ ​ Customer relationships ​ $ 68,900 ​ $ (19,318) 10 Years Curriculum/software ​ 11,600 ​ (1,611) 6 Years Course delivery technology ​ 7,200 ​ (1,585) 5 Years Total ​ $ 87,700 ​ $ (22,514) Indefinite-lived intangible assets: ​ ​ Trade names ​ $ 95,666 ​ Chamberlain Title IV eligibility and accreditations ​ 1,200 ​ AUC Title IV eligibility and accreditations ​ 100,000 ​ Ross Title IV eligibility and accreditations ​ 14,100 ​ Intellectual property ​ 13,940 ​ Total ​ $ 224,906 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2019 ​ Gross ​ ​ ​ ​ Carrying ​ Accumulated ​ ​ Amount ​ Amortization Amortizable intangible assets: ​ ​ ​ ​ Customer relationships $ 69,300 $ (14,448) Curriculum/software ​ 16,600 ​ (5,193) Course delivery technology ​ 7,200 ​ (487) Total ​ $ 93,100 ​ $ (20,128) Indefinite-lived intangible assets: ​ ​ Trade names ​ $ 95,777 ​ Chamberlain Title IV eligibility and accreditations ​ 1,200 ​ AUC Title IV eligibility and accreditations ​ 100,000 ​ Ross Title IV eligibility and accreditations ​ 14,100 ​ Intellectual property ​ 13,940 ​ Total ​ $ 225,017 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2019 ​ Gross ​ ​ ​ ​ Carrying Accumulated ​ Amount Amortization Amortizable intangible assets: ​ ​ Customer relationships ​ $ 42,900 ​ $ (13,071) Curriculum/software ​ ​ 5,000 ​ ​ (4,583) Course delivery technology ​ ​ 500 ​ ​ (344) Total $ 48,400 $ (17,998) Indefinite-lived intangible assets: ​ ​ ​ ​ ​ ​ Trade names $ 77,371 ​ ​ ​ Chamberlain Title IV eligibility and accreditations ​ ​ 1,200 ​ ​ ​ AUC Title IV eligibility and accreditations ​ ​ 100,000 ​ ​ ​ Ross Title IV eligibility and accreditations ​ ​ 14,100 ​ ​ ​ Intellectual property ​ ​ 13,940 ​ ​ ​ Total $ 206,611 ​ ​ ​
Summary of Indefinite-Lived Intangible Assets Balances by Reporting Segment	The table below summarizes the indefinite-lived intangible asset balances by reportable segment (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, June 30, March 31, Reportable Segment ​ 2020 ​ 2019 ​ 2019 Medical and Healthcare ​ $ 137,500 ​ $ 137,500 ​ $ 137,500 Financial Services ​ 87,406 ​ 87,517 ​ 69,111 Total ​ $ 224,906 ​ $ 225,017 ​ $ 206,611
Estimated Amortization Expense for Amortized Intangible Assets	Estimated amortization expense for amortizable intangible assets for the next five fiscal years ending June 30 and in the aggregate, by reporting unit, is as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ Financial Fiscal Year ​ Services ​ 2020 (remaining) ​ $ 2,576 ​ 2021 ​ 10,073 ​ 2022 ​ 9,944 ​ 2023 ​ 9,792 ​ 2024 ​ 9,509 ​ Thereafter ​ 23,292 ​ Total ​ $ 65,186 ​

Debt (Tables)

Debt (Tables)	9 Months Ended
	Mar. 31, 2020
Debt Instruments [Abstract]
Schedule of Long-term Debt Instruments	Long-term debt consists of the following senior secured credit facility (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, June 30, March 31, ​ ​ 2020 ​ 2019 ​ 2019 Total debt: ​ ​ ​ Term B Loan ​ $ 294,750 ​ $ 297,000 ​ $ 297,750 Revolver ​ 160,000 ​ 110,000 ​ — Total principal payments due ​ 454,750 ​ 407,000 ​ 297,750 Deferred debt issuance costs ​ (5,140) ​ (5,906) ​ (6,161) Total amount outstanding ​ 449,610 ​ 401,094 ​ 291,589 Less current portion: ​ ​ ​ Term B Loan ​ (3,000) ​ (3,000) ​ (3,000) Noncurrent portion ​ $ 446,610 ​ $ 398,094 ​ $ 288,589
Schedule of Maturities of Long-term Debt	​ ​ ​ ​ ​ ​ Maturity Fiscal Year ​ Payments 2020 (remaining) ​ $ 750 2021 ​ 3,000 2022 ​ 3,000 2023 ​ 163,000 2024 ​ 3,000 Thereafter ​ 282,000 Total ​ $ 454,750
Schedule Of Debt Issuance Costs	The following table summarizes the total deferred debt issuance costs for the Term B Loan and Revolver, which are being amortized over seven years and five years, respectively (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Term B Loan Revolver Total Deferred debt issuance costs as of June 30, 2019 ​ $ 5,906 ​ $ 2,061 ​ $ 7,967 Amortization of deferred debt issuance costs ​ (766) ​ (408) ​ (1,174) Deferred debt issuance costs as of March 31, 2020 ​ $ 5,140 ​ $ 1,653 ​ $ 6,793

Redeemable Noncontrolling Int_2

Redeemable Noncontrolling Interest (Tables)	9 Months Ended
	Mar. 31, 2020
Noncontrolling Interest [Abstract]
Reconciliation of Non-Controlling Interest Balance	The following is a reconciliation of the redeemable noncontrolling interest balance (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ March 31, ​ March 31, ​ 2020 2019 2020 2019 Balance at beginning of period ​ $ 3,082 ​ $ 8,651 ​ $ 9,543 ​ $ 9,110 Net (loss) income attributable to redeemable noncontrolling interest ​ (120) ​ (39) ​ (334) ​ 117 Decrease in redemption value of redeemable noncontrolling interest put option ​ — ​ (130) ​ — ​ (745) Payment for purchase of redeemable noncontrolling interest of subsidiary ​ ​ — ​ ​ — ​ ​ (6,247) ​ ​ — Balance at end of period ​ $ 2,962 ​ $ 8,482 ​ $ 2,962 ​ $ 8,482

Share Repurchase (Tables)

Share Repurchase (Tables)	9 Months Ended
	Mar. 31, 2020
Treasury Stock, Number of Shares and Restriction Disclosures [Abstract]
Shares Repurchased Under Programs	Adtalem made share repurchases under the current and former share repurchase programs as follows (in thousands, except shares and per share data): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ Life-to-Date ​ ​ March 31, ​ March 31, ​ Current Share ​ 2020 2019 2020 2019 Repurchase Program Total number of share repurchases ​ ​ 1,164,308 ​ ​ 1,266,160 ​ ​ 3,838,275 ​ ​ 3,631,611 ​ ​ 6,383,431 Total cost of share repurchases ​ $ 36,870 ​ $ 60,970 ​ $ 136,889 ​ $ 176,903 ​ $ 254,769 Average price paid per share ​ $ 31.67 ​ $ 48.15 ​ $ 35.66 ​ $ 48.71 ​ $ 39.91

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Mar. 31, 2020
Accumulated Other Comprehensive Loss
Schedule of accumulated other comprehensive income loss	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ ​ March 31, ​ March 31, ​ ​ 2020 2019 2020 2019 ​ Foreign currency translation adjustments ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Beginning balance ​ $ (159,259) ​ $ (143,529) ​ $ (137,389) ​ $ (142,574) ​ Loss on foreign currency translation ​ ​ (117,669) ​ ​ (5,238) ​ ​ (139,539) ​ ​ (6,193) ​ Ending balance ​ $ (276,928) ​ $ (148,767) ​ $ (276,928) ​ $ (148,767) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Marketable securities ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Beginning balance, gross ​ $ 186 ​ $ 15 ​ $ 131 ​ $ 537 ​ Beginning balance, tax effect ​ ​ (45) ​ ​ (4) ​ ​ (32) ​ ​ (131) ​ Beginning balance, net of tax ​ ​ 141 ​ ​ 11 ​ ​ 99 ​ ​ 406 ​ ASU 2016-01 cumulative effect adjustment ​ ​ — ​ ​ — ​ ​ — ​ ​ (381) ​ Unrealized (loss) gain on marketable securities ​ ​ (58) ​ ​ 66 ​ ​ (3) ​ ​ 48 ​ Tax effect ​ ​ 14 ​ ​ (16) ​ ​ 1 ​ ​ (12) ​ Ending balance ​ $ 97 ​ $ 61 ​ $ 97 ​ $ 61 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest rate swap ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Beginning balance, gross ​ $ — ​ $ — ​ $ — ​ $ — ​ Beginning balance, tax effect ​ ​ — ​ ​ — ​ ​ — ​ ​ — ​ Beginning balance, net of tax ​ ​ — ​ ​ — ​ ​ — ​ ​ — ​ Unrealized gain on interest rate swap ​ ​ 598 ​ ​ — ​ ​ 598 ​ ​ — ​ Tax effect ​ ​ (146) ​ ​ — ​ ​ (146) ​ ​ — ​ Ending balance ​ $ 452 ​ $ — ​ $ 452 ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total ending balance at March 31 ​ $ (276,379) ​ $ (148,706) ​ $ (276,379) ​ $ (148,706) ​

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Mar. 31, 2020
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of options Activity	The following is a summary of options activity for the nine months ended March 31, 2020: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-Average ​ ​ ​ ​ ​ ​ ​ Remaining ​ Aggregate ​ ​ Number of ​ Weighted-Average ​ Contractual Life ​ Intrinsic Value ​ ​ Options ​ Exercise Price ​ (in years) ​ (in thousands) Outstanding as of July 1, 2019 1,488,478 ​ $ 31.33 ​ Granted 229,125 ​ 43.39 ​ Exercised (85,234) ​ 27.54 ​ Forfeited (65,946) ​ 42.76 ​ Expired (70,604) ​ 51.81 ​ Outstanding as of March 31, 2020 1,495,819 ​ 31.90 6.61 ​ $ 2,937 Exercisable as of March 31, 2020 716,037 ​ $ 28.43 5.32 ​ $ 2,082
Fair Values of Stock Option Awards Estimated Weighted Average Assumptions	The fair value of Adtalem’s stock option grants was estimated assuming the following weighted-average assumptions: ​ ​ ​ ​ ​ ​ ​ ​ ​ Fiscal Year ​ ​ 2020 2019 ​ Expected life (in years) 6.51 6.50 Expected volatility 37.66 % 39.60 % Risk-free interest rate 1.40 % 2.73 % Dividend yield 0.00 % 0.00 %
Summary of Restricted Stock Units Activity	The following is a summary of RSU activity for the nine months ended March 31, 2020: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-Average ​ ​ Number of ​ Grant Date ​ ​ RSUs ​ Fair Value Outstanding as of July 1, 2019 878,030 ​ $ 34.86 Granted 408,520 ​ 42.38 Vested (362,036) ​ 28.75 Forfeited (121,914) ​ 40.17 Outstanding as of March 31, 2020 802,600 ​ $ 39.08
Total Stock-Based Compensation Expense Included in Consolidated Statement of Earnings	The following table shows total stock-based compensation expense included in the Consolidated Statements of Income (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ ​ March 31, ​ March 31, ​ ​ 2020 2019 2020 2019 ​ Cost of educational services ​ $ 260 ​ $ 279 ​ $ 1,027 ​ $ 976 ​ Student services and administrative expense ​ 2,521 ​ 2,729 ​ 10,301 ​ 9,393 ​ ​ ​ 2,781 ​ 3,008 ​ 11,328 ​ 10,369 ​ Income tax benefit ​ (642) ​ (692) ​ (3,887) ​ (3,930) ​ Net stock-based compensation expense ​ $ 2,139 ​ $ 2,316 ​ $ 7,441 ​ $ 6,439 ​

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Tabulation of Business Segment Information Based on Current Segmentation	Summary financial information by reportable segment is as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ ​ March 31, ​ March 31, ​ ​ 2020 2019 2020 2019 ​ Revenue: ​ ​ ​ ​ Medical and Healthcare ​ $ 227,344 ​ $ 223,575 ​ $ 655,011 ​ $ 638,302 ​ Financial Services ​ 44,143 ​ 35,935 ​ 137,261 ​ 113,723 ​ Home Office and Other ​ — ​ (807) ​ — ​ (2,422) ​ Total consolidated revenue ​ $ 271,487 ​ $ 258,703 ​ $ 792,272 ​ $ 749,603 ​ Operating income from continuing operations excluding special items: ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 57,559 ​ $ 52,960 ​ $ 127,786 ​ $ 141,152 ​ Financial Services ​ 4,190 ​ 5,086 ​ 13,976 ​ 19,469 ​ Home Office and Other ​ (5,408) ​ (10,281) ​ (15,663) ​ (29,982) ​ Total consolidated operating income from continuing operations excluding special items ​ ​ 56,341 ​ ​ 47,765 ​ ​ 126,099 ​ ​ 130,639 ​ Reconciliation to Consolidated Financial Statements: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Restructuring expense ​ (1,854) ​ (2,186) ​ (10,339) ​ (45,194) ​ Gain on sale of assets ​ ​ — ​ ​ — ​ ​ 4,779 ​ ​ — ​ Settlement gain ​ ​ — ​ ​ — ​ ​ — ​ ​ 15,571 ​ Total consolidated operating income from continuing operations ​ ​ 54,487 ​ ​ 45,579 ​ ​ 120,539 ​ ​ 101,016 ​ Net other income (expense) ​ 105,881 ​ (3,009) ​ 69,816 ​ (11,913) ​ Total consolidated income from continuing operations before income taxes ​ $ 160,368 ​ $ 42,570 ​ $ 190,355 ​ $ 89,103 ​ Segment assets: ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 917,657 ​ $ 827,452 ​ $ 917,657 ​ $ 827,452 ​ Financial Services ​ 577,699 ​ 446,752 ​ 577,699 ​ 446,752 ​ Home Office and Other ​ 457,686 ​ 317,000 ​ 457,686 ​ 317,000 ​ Discontinued Operations ​ 490,978 ​ 557,499 ​ 490,978 ​ 557,499 ​ Total consolidated assets ​ $ 2,444,020 ​ $ 2,148,703 ​ $ 2,444,020 ​ $ 2,148,703 ​ Capital expenditures: ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 7,274 ​ $ 10,978 ​ $ 20,108 ​ $ 37,696 ​ Financial Services ​ 568 ​ 84 ​ 1,980 ​ 1,487 ​ Home Office and Other ​ 3,781 ​ 2,149 ​ 9,846 ​ 6,086 ​ Total consolidated capital expenditures ​ $ 11,623 ​ $ 13,211 ​ $ 31,934 ​ $ 45,269 ​ Depreciation expense: ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 7,127 ​ $ 7,680 ​ $ 21,898 ​ $ 20,449 ​ Financial Services ​ 556 ​ 480 ​ 1,438 ​ 1,212 ​ Home Office and Other ​ 866 ​ 653 ​ 2,437 ​ 3,065 ​ Total consolidated depreciation expense ​ $ 8,549 ​ $ 8,813 ​ $ 25,773 ​ $ 24,726 ​ Intangible asset amortization expense: ​ ​ ​ ​ ​ Financial Services ​ $ 2,576 ​ $ 1,605 ​ $ 7,686 ​ $ 4,816 ​ Total consolidated intangible asset amortization expense ​ $ 2,576 ​ $ 1,605 ​ $ 7,686 ​ $ 4,816 ​
Revenues and Long-Lived Assets by Geographic Area	Revenue and long-lived assets by geographic area are as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ ​ March 31, ​ March 31, ​ ​ 2020 2019 2020 2019 ​ Revenue from unaffiliated customers: ​ ​ ​ ​ Domestic operations ​ $ 176,946 ​ $ 160,949 ​ $ 507,482 ​ $ 468,788 ​ International operations: ​ ​ ​ ​ ​ ​ Barbados, Dominica, St. Kitts, and St. Maarten ​ 92,259 ​ 95,366 ​ 277,934 ​ 274,207 ​ Other ​ 2,282 ​ 2,388 ​ 6,856 ​ 6,608 ​ Total international ​ 94,541 ​ 97,754 ​ 284,790 ​ 280,815 ​ Total consolidated revenue ​ $ 271,487 ​ $ 258,703 ​ $ 792,272 ​ $ 749,603 ​ Long-lived assets: ​ ​ ​ ​ ​ Domestic operations ​ $ 208,812 ​ $ 156,881 ​ $ 208,812 ​ $ 156,881 ​ International operations: ​ ​ ​ ​ ​ ​ Barbados, Dominica, St. Kitts, and St. Maarten ​ 160,552 ​ 174,827 ​ 160,552 ​ 174,827 ​ Other ​ 1,807 ​ 2,065 ​ 1,807 ​ 2,065 ​ Total international ​ 162,359 ​ 176,892 ​ 162,359 ​ 176,892 ​ Total consolidated long-lived assets ​ $ 371,171 ​ $ 333,773 ​ $ 371,171 ​ $ 333,773 ​

Nature of Operations (Details)

Nature of Operations (Details) - 9 months ended Mar. 31, 2020	segment	item
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reporting segments	2	2

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Impact on Consolidated Balance Sheet Upon Adoption of ASC 842) (Detail) - USD ($) $ / shares in Units, $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Jul. 01, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Jun. 30, 2018
Current assets:
Cash and cash equivalents	$ 167,771			$ 204,202	$ 230,700
Investments in marketable securities	7,754			8,680	8,341
Restricted cash	807			1,022	391
Accounts receivable, net	98,732			83,560	89,578
Prepaid expenses and other current assets	126,785			29,313	44,524
Total current assets	544,266			504,700	540,091
Noncurrent assets:
Property and equipment, net	286,346			283,433	279,387
Operating lease assets	188,629			0	0
Deferred income taxes	15,066			18,314	19,199
Intangible assets, net	290,092			297,989	237,013
Goodwill	686,235			687,256	627,685
Other assets, net	84,825			52,113	54,386
Total noncurrent assets	1,899,754			1,737,996	1,608,612
Total assets	2,444,020			2,242,696	2,148,703
Current liabilities:
Accounts payable	33,932			53,385	39,092
Accrued salaries, wages and benefits	40,373			46,664	39,439
Accrued liabilities	60,458			76,529	74,614
Deferred revenue	120,047			95,944	108,370
Current operating lease liabilities	51,926			0	0
Current portion of long-term debt	3,000			3,000	3,000
Total current liabilities	344,686			311,631	309,205
Noncurrent liabilities:
Long-term debt	446,610			398,094	288,589
Long-term operating lease liabilities	179,195			0	0
Deferred income taxes	28,147			29,426	33,278
Other liabilities	91,011			86,326	88,190
Total noncurrent liabilities	801,813			529,992	426,429
Total liabilities	1,146,499			841,623	735,634
Redeemable noncontrolling interest	2,962	$ 3,082		9,543	8,482	$ 8,651	$ 9,110
Shareholders' equity:
Common Stock, $0.01 Par Value	806			801	801
Additional paid-in capital	499,703			486,061	483,043
Retained earnings	2,183,620			2,012,902	1,964,169
Accumulated other comprehensive loss	(276,379)			(137,290)	(148,706)
Treasury Stock, at cost	(1,113,191)			(970,944)	(894,720)
Total shareholders' equity	1,294,559	$ 1,294,912		1,391,530	1,404,587	$ 1,429,647	$ 1,519,286
Total liabilities and shareholders' equity	$ 2,444,020			$ 2,242,696	$ 2,148,703
Common Stock, Par Value	$ 0.01		$ 0.01	$ 0.01	$ 0.01
ASC 842
Current assets:
Cash and cash equivalents			$ 299,445
Investments in marketable securities			8,680
Restricted cash			1,022
Accounts receivable, net			157,829
Prepaid expenses and other current assets			34,241
Total current assets			501,217
Noncurrent assets:
Property and equipment, net			364,683
Operating lease assets			282,978
Deferred income taxes			18,314
Intangible assets, net			418,097
Goodwill			874,451
Other assets, net			62,451
Total noncurrent assets			2,020,974
Total assets			2,522,191
Current liabilities:
Accounts payable			57,627
Accrued salaries, wages and benefits			64,492
Accrued liabilities			69,776
Deferred revenue			99,790
Current operating lease liabilities			66,707
Current portion of long-term debt			3,000
Total current liabilities			361,392
Noncurrent liabilities:
Long-term debt			398,094
Long-term operating lease liabilities			269,387
Deferred income taxes			29,426
Other liabilities			62,819
Total noncurrent liabilities			759,726
Total liabilities			1,121,118
Redeemable noncontrolling interest			9,543
Shareholders' equity:
Common Stock, $0.01 Par Value			801
Additional paid-in capital			486,061
Retained earnings			2,012,902
Accumulated other comprehensive loss			(137,290)
Treasury Stock, at cost			(970,944)
Total shareholders' equity			1,391,530
Total liabilities and shareholders' equity			2,522,191
ASC 842 | June 30, 2019
Current assets:
Cash and cash equivalents				$ 299,445
Investments in marketable securities				8,680
Restricted cash				1,022
Accounts receivable, net				157,829
Prepaid expenses and other current assets				37,724
Total current assets				504,700
Noncurrent assets:
Property and equipment, net				364,683
Deferred income taxes				18,314
Intangible assets, net				418,097
Goodwill				874,451
Other assets, net				62,451
Total noncurrent assets				1,737,996
Total assets				2,242,696
Current liabilities:
Accounts payable				57,627
Accrued salaries, wages and benefits				64,492
Accrued liabilities				86,722
Deferred revenue				99,790
Current portion of long-term debt				3,000
Total current liabilities				311,631
Noncurrent liabilities:
Long-term debt				398,094
Deferred income taxes				29,426
Other liabilities				102,472
Total noncurrent liabilities				529,992
Total liabilities				841,623
Redeemable noncontrolling interest				9,543
Shareholders' equity:
Common Stock, $0.01 Par Value				801
Additional paid-in capital				486,061
Retained earnings				2,012,902
Accumulated other comprehensive loss				(137,290)
Treasury Stock, at cost				(970,944)
Total shareholders' equity				1,391,530
Total liabilities and shareholders' equity				$ 2,242,696
ASC 842 | Adjustments due to adoption of ASC 842
Current assets:
Prepaid expenses and other current assets			(3,483)
Total current assets			(3,483)
Noncurrent assets:
Operating lease assets			282,978
Total noncurrent assets			282,978
Total assets			279,495
Current liabilities:
Accrued liabilities			(16,946)
Current operating lease liabilities			66,707
Total current liabilities			49,761
Noncurrent liabilities:
Long-term operating lease liabilities			269,387
Other liabilities			(39,653)
Total noncurrent liabilities			229,734
Total liabilities			279,495
Shareholders' equity:
Total liabilities and shareholders' equity			279,495
ASC 842 | Adjustments due to adoption of ASC 842 | Accrued Liabilities [Member]
Shareholders' equity:
Deferred rent liability, current			6,800
Restructuring liability, current			10,100
ASC 842 | Adjustments due to adoption of ASC 842 | Prepaid Expenses and Other Current Assets
Shareholders' equity:
Prepaid Rent			3,500
ASC 842 | Adjustments due to adoption of ASC 842 | Other Noncurrent Liabilities [Member]
Shareholders' equity:
Deferred rent liability, Noncurrent			24,800
Restructuring liability, Noncurrent			$ 14,900

Acquisitions (Estimated Fair Va

Acquisitions (Estimated Fair Values of Assets Acquired and Liabilities Assumed) (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Jun. 30, 2019	May 31, 2019	Mar. 31, 2019
Business Acquisition [Line Items]
Goodwill	$ 686,235	$ 687,256		$ 627,685
OnCourse Learning [Member]
Business Acquisition [Line Items]
Current Assets			$ 5,260
Property and Equipment			1,197
Intangible Assets			63,100
Goodwill			59,427
Total Assets Acquired			128,984
Liabilities Assumed			9,445
Net Assets Acquired			$ 119,539

Acquisitions (Acquired Intangib

Acquisitions (Acquired Intangible Assets Subject to Amortization and Values and Estimated Useful Lives) (Detail) - OnCourse Learning [Member] $ in Thousands	May 31, 2019USD ($)	May 31, 2019USD ($)
Business Acquisition [Line Items]
Amortizable intangible assets, estimated useful lives	9 years
Customer Relationships [Member]
Business Acquisition [Line Items]
Intangible assets, finite lived	$ 26,400	$ 26,400
Amortizable intangible assets, estimated useful lives		11 years
Curriculum/Software [Member]
Business Acquisition [Line Items]
Intangible assets, finite lived	11,600	$ 11,600
Amortizable intangible assets, estimated useful lives		6 years
Course Delivery Technology
Business Acquisition [Line Items]
Intangible assets, finite lived	$ 6,700	$ 6,700
Amortizable intangible assets, estimated useful lives		5 years

Acquisitions (Additional Inform

Acquisitions (Additional Information) (Detail) - USD ($)	May 31, 2019	Dec. 31, 2019	Jun. 30, 2019	Mar. 31, 2019
Business Acquisition [Line Items]
Cash paid for acquisition			$ 118,400,000
Long-term line of credit				$ 0
Proceeds from net working capital		$ 100,000
OnCourse Learning [Member]
Business Acquisition [Line Items]
Percentage of voting interests acquired	100.00%
Payments to acquire business	$ 118,300,000
Cash acquired from acquisition	1,200,000
Long-term line of credit	100,000,000
Intangible Assets	$ 63,100,000
Amortizable intangible assets, estimated useful lives	9 years
OnCourse Learning [Member] | Trade Name [Member]
Business Acquisition [Line Items]
Intangible Assets	$ 18,400,000

Discontinued Operations and A_3

Discontinued Operations and Assets Held for Sale (Summary of Balance Sheet Information of Assets and Liabilities) (Detail) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2019
Current Assets:
Cash and cash equivalents	$ 83,961	$ 90,511	$ 95,243
Accounts receivable, net	52,507	65,794	74,269
Prepaid expenses and other current assets	5,949	10,252	8,411
Total current assets held for sale	142,417	166,557	177,923
Noncurrent assets:
Property and equipment, net	57,610	80,234	81,250
Operating lease assets	54,092	0	0
Intangible assets, net	88,403	118,134	120,108
Goodwill	138,914	183,575	187,195
Other assets, net	9,542	8,999	10,338
Total noncurrent assets held for sale	348,561	390,942	398,891
Total assets held for sale	490,978	557,499	576,814
Current liabilities:
Accounts payable	2,378	3,230	4,242
Accrued payroll and benefits	10,671	15,462	17,828
Accrued liabilities	4,891	12,008	10,193
Deferred revenue	8,688	13,990	3,846
Current operating lease liabilities	8,322	0	0
Total current liabilities held for sale	34,950	44,690	36,109
Noncurrent liabilities:
Long-term operating lease liabilities	46,747	0	0
Other liabilities	10,103	16,372	16,146
Total noncurrent liabilities held for sale	56,850	16,372	16,146
Total liabilities held for sale	$ 91,800	$ 61,062	$ 52,255

Discontinued Operations and A_4

Discontinued Operations and Assets Held for Sale (Summary of Income Statement Information of Operations) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Discontinued Operations and Assets Held for Sale
Revenue	$ 41,355	$ 49,906	$ 142,160	$ 355,506
Operating cost and expense:
Cost of educational services	28,940	36,147	98,605	222,837
Student services and administrative expense	17,781	11,252	47,860	130,615
Restructuring expense (gain)	199	(257)	625	(570)
Asset impairment charge - building and equipment				1,953
Total operating cost and expense	46,920	47,142	147,090	354,835
Operating (loss) income from discontinued operations	(5,565)	2,764	(4,930)	671
Interest and dividend income	425	941	2,164	2,917
Interest expense	(807)	(483)	(2,770)	(2,317)
Net other (expense) income	(382)	458	(606)	600
(Loss) income from discontinued operations before income taxes	(5,947)	3,222	(5,536)	1,271
Loss on disposal of discontinued operations before income taxes		(265)	0	(32,979)
Benefit from income taxes	3,228	182	3,778	5,762
(Loss) income from discontinued operations	(2,719)	3,139	(1,758)	(25,946)
Net income attributable to redeemable noncontrolling interest from discontinued operations		(74)	0	(382)
Net (loss) income from discontinued operations	$ (2,719)	$ 3,065	$ (1,758)	$ (26,328)

Discontinued Operations and A_5

Discontinued Operations and Assets Held for Sale (Additional Information) (Detail) $ in Thousands, R$ in Millions

Apr. 24, 2020USD ($)

Dec. 11, 2018USD ($)

Mar. 31, 2020USD ($)

Mar. 31, 2019USD ($)

Dec. 31, 2018USD ($)

Mar. 31, 2020USD ($)

Mar. 31, 2019USD ($)

Jun. 30, 2020USD ($)

Mar. 31, 2020BRL (R$)

Mar. 31, 2020USD ($)

Oct. 18, 2019BRL (R$)

Jun. 30, 2019USD ($)

Property and equipment, net

$ 80,234

$ 80,234

$ 57,610

$ 81,250

Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax

$ 265

$ 0

32,979

Payments to Acquire Loans Held-for-investment

$ 0

$ 10,000

Sublease term

1 year

Gain on cash flow hedge

$ 111,800

$ 83,800

Carrington College [Member] | Discontinued Operations, Disposed of by Sale

Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax

$ 11,100

Cash and restricted cash

(9,900)

DeVry University [Member]

Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax

21,700

Payments to Acquire Loans Held-for-investment

$ 10,000

Earn Out Term

10 years

Earn Out Maximum

$ 20,000

Receivable with Imputed Interest, Face Amount

$ 10,000

Receivable with Imputed Interest, Effective Yield (Interest Rate)

4.00%

4.00%

Receivable with Imputed Interest, Due Date

Jan. 1, 2022

Jan. 1, 2022

Cash and restricted cash

$ (39,000)

Adtalem Educacional Do Brasil [Member] | Discontinued Operations, Disposed of by Sale

Consideration from disposal | R$

R$ 1920.0

Derivative notional amount

R$ 2154.0

415,000

Gain on cash flow hedge

$ 111,800

$ 83,800

Adtalem Educacional Do Brasil [Member] | Discontinued Operations, Disposed of by Sale | Scenario, Plan [Member]

Gain on cash flow hedge

$ 110,700

Adtalem Educacional Do Brasil [Member] | Discontinued Operations, Disposed of by Sale | Subsequent Event [Member]

Net proceeds after settlement of debt ,transaction fees ,taxes and hedge proceeds

$ 424,000

Disposal Group Including Discontinued Operation Cash Proceeds Net Of Debt

$ 73,000

Adtalem Educacional Do Brasil [Member] | Discontinued Operations, Disposed of by Sale | Prepaid Expenses and Other Current Assets

Derivative Asset

$ 83,800

Revenues (Disaggregate revenue)

Revenues (Disaggregate revenue) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Disaggregation of Revenue [Line Items]
Revenues	$ 271,487	$ 258,703	$ 792,272	$ 749,603
Higher Education [Member]
Disaggregation of Revenue [Line Items]
Revenues	222,019	217,423	637,625	630,083
Test Preparation/Certifications
Disaggregation of Revenue [Line Items]
Revenues	26,236	26,755	78,145	81,154
Conferences Seminars [Member]
Disaggregation of Revenue [Line Items]
Revenues	11,925	3,860	42,738	17,405
Memberships Subscriptions [Member]
Disaggregation of Revenue [Line Items]
Revenues	5,590	4,299	15,512	12,135
Other [Member]
Disaggregation of Revenue [Line Items]
Revenues	5,717	6,366	18,252	8,826
Medical and Healthcare [Member]
Disaggregation of Revenue [Line Items]
Revenues	227,344	223,575	655,011	638,302
Medical and Healthcare [Member] | Higher Education [Member]
Disaggregation of Revenue [Line Items]
Revenues	222,019	217,423	637,625	630,083
Medical and Healthcare [Member] | Test Preparation/Certifications
Disaggregation of Revenue [Line Items]
Revenues		0		0
Medical and Healthcare [Member] | Conferences Seminars [Member]
Disaggregation of Revenue [Line Items]
Revenues		0		0
Medical and Healthcare [Member] | Memberships Subscriptions [Member]
Disaggregation of Revenue [Line Items]
Revenues		0		0
Medical and Healthcare [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Revenues	5,325	6,152	17,386	8,219
Financial Services [Member]
Disaggregation of Revenue [Line Items]
Revenues	44,143	35,935	137,261	113,723
Financial Services [Member] | Higher Education [Member]
Disaggregation of Revenue [Line Items]
Revenues		0		0
Financial Services [Member] | Test Preparation/Certifications
Disaggregation of Revenue [Line Items]
Revenues	26,236	27,562	78,145	83,576
Financial Services [Member] | Conferences Seminars [Member]
Disaggregation of Revenue [Line Items]
Revenues	11,925	3,860	42,738	17,405
Financial Services [Member] | Memberships Subscriptions [Member]
Disaggregation of Revenue [Line Items]
Revenues	5,590	4,299	15,512	12,135
Financial Services [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 392	214	866	607
Home Office And Other [Member]
Disaggregation of Revenue [Line Items]
Revenues		(807)	$ 0	(2,422)
Home Office And Other [Member] | Higher Education [Member]
Disaggregation of Revenue [Line Items]
Revenues		0		0
Home Office And Other [Member] | Test Preparation/Certifications
Disaggregation of Revenue [Line Items]
Revenues		(807)		(2,422)
Home Office And Other [Member] | Conferences Seminars [Member]
Disaggregation of Revenue [Line Items]
Revenues		0		0
Home Office And Other [Member] | Memberships Subscriptions [Member]
Disaggregation of Revenue [Line Items]
Revenues		0		0
Home Office And Other [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Revenues		$ 0		$ 0

Revenues (Additional Informatio

Revenues (Additional Information) (Detail) - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019
Disaggregation of Revenue [Line Items]
Revenue recognized included in the deferred revenue	$ 91
Allowance for bad debts	$ 24.2	$ 14.5	$ 11
Maximum
Disaggregation of Revenue [Line Items]
Revenue practical expedient remaining performance obligation	1 year

Restructuring Charges (Restruct

Restructuring Charges (Restructuring and Related Costs) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	$ 1,854	$ 2,186	$ 10,339	$ 45,194
Medical and Healthcare [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	810	(133)	1,354	41,327
Financial Services [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges			3,116
Home Office And Other [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	1,044	2,319	5,869	3,867
Real Estate and Other
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	1,065	2,161	8,770	43,781
Real Estate and Other | Medical and Healthcare [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	810	(110)	1,129	40,033
Real Estate and Other | Financial Services [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges			2,862
Real Estate and Other | Home Office And Other [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	255	2,271	4,779	3,748
Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	789	25	1,569	1,413
Termination Benefits | Medical and Healthcare [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		(23)	225	1,294
Termination Benefits | Financial Services [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges			254
Termination Benefits | Home Office And Other [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	$ 789	$ 48	$ 1,090	$ 119

Restructuring Charges (Separati

Restructuring Charges (Separation and Restructuring Plan Activity) (Detail) - USD ($) $ in Thousands	Jul. 01, 2019	Mar. 31, 2020	Jun. 30, 2019
Restructuring Cost and Reserve [Line Items]
Liability beginning balance	$ 25,083	$ 25,083	$ 38,927
Increase in liability (separation and other charges)		3,551	8,870
Reduction in liability (payments and adjustments)		(3,331)	(22,714)
Liability ending balance	53	$ 273	$ 25,083
ASC 842
Restructuring Cost and Reserve [Line Items]
Reduction in liability from ASU implementation	$ (25,030)

Restructuring Charges (Addition

Restructuring Charges (Additional Information) (Detail) $ in Thousands	9 Months Ended
	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Jun. 30, 2019USD ($)	Jan. 31, 2019USD ($)
Restructuring Cost and Reserve [Line Items]
Property and equipment, gross	$ 618,754	$ 598,341	$ 606,673
Restructuring and Related Cost, Number of Positions Eliminated	34	203
Adtalem Global Education Inc. [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve current	$ 300
Ross University School of Medicine [Member] | Dominica Campus [Member]
Restructuring Cost and Reserve [Line Items]
Property and equipment, gross				$ 0

Income Taxes (Detail)

Income Taxes (Detail) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2020USD ($)	Mar. 31, 2019	Mar. 31, 2020USD ($)item	Mar. 31, 2019	Jun. 30, 2019USD ($)
Income Tax Contingency [Line Items]
Effective Income Tax Rate Reconciliation, Percent	4.30%	18.40%	9.60%	19.50%
Gain on cash flow hedge	$ 111.8		$ 83.8
Number of operating units benefit from local tax incentives | item			3
U.S. federal corporate tax rate			21.00%		21.00%
Minimum | Scenario, Plan [Member]
Income Tax Contingency [Line Items]
Decrease in Unrecognized Tax Benefits is Reasonably Possible					$ 25
Maximum | Scenario, Plan [Member]
Income Tax Contingency [Line Items]
Decrease in Unrecognized Tax Benefits is Reasonably Possible					$ 27

Earnings per Share (Details)

Earnings per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Numerator:
Continuing operations	$ 153,551	$ 34,840	$ 172,476	$ 71,998
Discontinued operations	(2,719)	3,065	(1,758)	(26,328)
Net income attributable to Adtalem Global Education	$ 150,832	$ 37,905	$ 170,718	$ 45,670
Denominator:
Weighted-average shares outstanding	52,498	57,583	53,647	58,656
Unvested participating RSUs	457	478	470	543
Weighted-average basic shares outstanding	52,955	58,061	54,117	59,199
Effect of dilutive stock awards	364	741	459	805
Weighted-average diluted shares outstanding	53,319	58,802	54,576	60,004
Basic:
Continuing operations	$ 2.90	$ 0.60	$ 3.19	$ 1.22
Discontinued operations	(0.05)	0.05	(0.03)	(0.44)
Net	2.85	0.65	3.15	0.77
Diluted:
Continuing operations	2.88	0.59	3.16	1.20
Discontinued operations	(0.05)	0.05	(0.03)	(0.44)
Net	$ 2.83	$ 0.64	$ 3.13	$ 0.76
Weighted Average
Diluted:
Weighted-average anti-dilutive stock awards	992	194	942	223

Financing Receivables (Institut

Financing Receivables (Institutional Loan Balances and Related Allowances for Credit Losses) (Detail) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2019
Receivables [Abstract]
Gross Institutional Loans	$ 50,296	$ 47,259	$ 47,937
Allowance for Credit Losses:
Balance at July 1	(6,289)	(10,003)	(10,003)
Charge-offs and Adjustments	664	9,965	10,777
Recoveries	(40)	(73)	(83)
Additional Provision	(9,026)	(4,571)	(6,980)
Balance at End of Period	(14,691)	(4,682)	(6,289)
Net Institutional Loans	$ 35,605	$ 42,577	$ 41,648

Financing Receivables (Instit_2

Financing Receivables (Institutional Loans Past Due) (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019
Financing Receivable, Recorded Investment, Past Due [Line Items]
Institutional Loans, Past Due	$ 19,684	$ 16,611	$ 17,172
Institutional Loans, Current	30,612	31,326	30,087
Total Institutional Loans	50,296	47,937	47,259
Financing Receivables, 1 to 29 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Institutional Loans, Past Due	3,484	3,578	4,092
Financing Receivables, 30 to 59 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Institutional Loans, Past Due	1,145	2,458	4,412
Financing Receivables, 60 to 89 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Institutional Loans, Past Due	1,673	687	4,125
Financing Receivables Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Institutional Loans, Past Due	$ 13,382	$ 9,888	$ 4,543

Financing Receivables (Addition

Financing Receivables (Additional Information) (Detail) - USD ($) $ in Thousands	Jul. 31, 2019	Dec. 11, 2018	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2018
Financing Receivables [Line Items]
Financing Receivable Allowance For Credit Losses			$ 14,691	$ 6,289	$ 4,682	$ 10,003
Minimum
Financing Receivables [Line Items]
Receivable with Imputed Interest, Effective Yield (Interest Rate)			3.00%
Maximum
Financing Receivables [Line Items]
Receivable with Imputed Interest, Effective Yield (Interest Rate)			12.00%
Accounts Receivable
Financing Receivables [Line Items]
Net Institutional Student Loans, Current			$ 16,900	16,600	15,700
Other Assets
Financing Receivables [Line Items]
Net Institutional Student Loans, Noncurrent			$ 18,700	$ 25,100	$ 26,900
DeVry University [Member]
Financing Receivables [Line Items]
Receivable with Imputed Interest, Face Amount		$ 10,000
Receivable with Imputed Interest, Effective Yield (Interest Rate)		4.00%	4.00%
Receivable with Imputed Interest, Due Date		Jan. 1, 2022	Jan. 1, 2022
Future Cash Flows Discounting Rate			4.00%
DePaul College Prep | Discontinued Operations, Disposed of by Sale
Financing Receivables [Line Items]
Receivable with Imputed Interest, Face Amount	$ 46,800
Receivable with Imputed Interest, Effective Yield (Interest Rate)	4.00%		4.00%
Loan Receivable			$ 41,100
Future Cash Flows Discounting Rate			7.00%

Property and Equipment, Net (Sc

Property and Equipment, Net (Schedule of Property and equipment, net) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019
Property and Equipment, Net
Property and equipment, gross	$ 618,754	$ 606,673	$ 598,341
Accumulated depreciation	(332,408)	(323,240)	(318,954)
Property and equipment, net	286,346	283,433	279,387
Land [Member]
Property and Equipment, Net
Property and equipment, gross	41,480	41,938	41,182
Building [Member]
Property and Equipment, Net
Property and equipment, gross	319,006	322,657	314,927
Equipment [Member]
Property and Equipment, Net
Property and equipment, gross	244,369	228,533	227,692
Construction in progress [Member]
Property and Equipment, Net
Property and equipment, gross	$ 13,899	$ 13,545	$ 14,540

Property and Equipment, Net (Ad

Property and Equipment, Net (Additional Information) (Details) - USD ($) $ in Thousands	Sep. 27, 2019	Jul. 31, 2019	Mar. 31, 2020	Sep. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2019
Real Estate [Line Items]
Gain on Business Interruption Insurance Recovery							$ 0	$ 15,571
Property and equipment, net			$ 286,346		$ 279,387		286,346	279,387	$ 283,433
Proceeds From Down Payment On Seller Loan							5,200	0
Notes receivable			52,507		65,794		52,507	65,794	74,269
Financing payables			10,103		16,372		10,103	16,372	$ 16,146
Proceeds from Sales of Assets, Investing Activities							6,421	0
Realized Gain on Sale of Assets			$ 0		0		$ 4,779	0
Discontinued Operations, Disposed of by Sale | DePaul College Prep
Real Estate [Line Items]
Proceeds from disposal		$ 52,000
Proceeds From Down Payment On Seller Loan		5,200		$ 5,200
Receivable with Imputed Interest, Face Amount		$ 46,800
Receivable with Imputed Interest, Effective Yield (Interest Rate)		4.00%					4.00%
Discontinued Operations, Disposed of by Sale | DePaul College Prep | Other Assets
Real Estate [Line Items]
Notes receivable		$ 40,300
Discontinued Operations, Disposed of by Sale | DePaul College Prep | Other Liabilities
Real Estate [Line Items]
Financing payables		$ 45,500
Discontinued Operations, Disposed of by Sale | Columbus, Ohio Campus
Real Estate [Line Items]
Proceeds from Sales of Assets, Investing Activities	$ 6,400
American University Of The Caribbean And Ross University [Member]
Real Estate [Line Items]
Gain on Business Interruption Insurance Recovery						$ 15,600
Dominica Campus [Member] | Ross University School of Medicine [Member]
Real Estate [Line Items]
Impairment of Long-Lived Assets Held-for-use								39,100
Property and equipment, net					$ 0			$ 0

Leases (Components of Lease Cos

Leases (Components of Lease Cost) (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2020
Lease, Cost [Abstract]
Operating Lease Cost	$ 14,121	$ 43,129
Sublease Income	(4,757)	(14,943)
Total Lease Cost	$ 9,364	$ 28,186

Leases (Maturities of Lease Lia

Leases (Maturities of Lease Liabilities) (Detail) $ in Thousands	Mar. 31, 2020USD ($)
Maturities of lease liabilities
2020 (Remaining)	$ 16,099
2021	62,274
2022	57,881
2023	47,249
2024	30,929
Thereafter	51,734
Total lease payments	266,166
Less: imputed interest	(35,045)
Present value of lease liabilities	$ 231,121

Leases (Lease Term, Discount Ra

Leases (Lease Term, Discount Rate and Cash Flow Information ) (Detail) $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 31, 2020USD ($)	Mar. 31, 2020USD ($)
Leases
Weighted-average remaining operating lease term (years)	5 years 1 month 6 days	5 years 1 month 6 days
Weighted-average operating lease discount rate	5.40%	5.40%
Cash paid for amounts in the measurement of operating lease liabilities (net of sublease receipts)	$ 12,559	$ 36,576
Operating lease assets obtained in exchange for operating lease liabilities	$ 12,532	$ 18,187

Leases (Future Minimum Rental C

Leases (Future Minimum Rental Commitments for Noncancelable Operating Leases ) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Mar. 31, 2020
Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract]
2020 (Remaining)			$ 5,796
2021			19,852
2022			16,935
2023			16,199
2024			10,438
Thereafter			7,307
Total			$ 76,527
Future minimum rental commitments for all noncancelable operating leases
2020	$ 67,109
2021	60,781
2022	55,982
2023	44,970
2024	28,374
Thereafter	36,120
Total minimum lease payments	293,336
Rent expense	$ 35,800	$ 25,000

Leases (Additional Information)

Leases (Additional Information) (Detail) $ in Thousands	9 Months Ended
	Mar. 31, 2020USD ($)facilitylocation	Sep. 30, 2020USD ($)	Jun. 30, 2020USD ($)	Jun. 30, 2019USD ($)	Mar. 31, 2019USD ($)
Lessee, Lease, Description [Line Items]
Option to terminate lease	true
Option to extend lease	true
Extension term	5 years
Number of facilities owned by lessor | facility	4
Number of operating lease locations the entity has agreements to sublease either a portion or the full leased space | location	23
Operating Lease, Right-of-Use Asset	$ 188,629			$ 0	$ 0
Operating Lease, Liability	$ 231,121
Operating Lease, Lease Not yet Commenced, Contract One [Member] | Forecast [Member]
Lessee, Lease, Description [Line Items]
Lease term on property lease that has not yet commenced			11 years
Operating Lease, Right-of-Use Asset			$ 9,700
Operating Lease, Liability			$ 9,700
Operating Lease, Lease Not yet Commenced, Contract Two [Member] | Forecast [Member]
Lessee, Lease, Description [Line Items]
Lease term on property lease that has not yet commenced		10 years
Operating Lease, Right-of-Use Asset		$ 10,100
Operating Lease, Liability		$ 10,100

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Summary of Goodwill Balances by Reporting Unit) (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019
Goodwill [Line Items]
Goodwill	$ 686,235	$ 687,256	$ 627,685
Chamberlain University [Member]
Goodwill [Line Items]
Goodwill	4,716	4,716	4,716
AUC [Member]
Goodwill [Line Items]
Goodwill	68,321	68,321	68,321
RUSM and RUSVM [Member]
Goodwill [Line Items]
Goodwill	237,173	237,173	237,173
Financial Services [Member]
Goodwill [Line Items]
Goodwill	$ 376,025	$ 377,046	$ 317,475

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Summary of Goodwill Balances by Reporting Segment) (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019
Goodwill [Line Items]
Goodwill	$ 686,235	$ 687,256	$ 627,685
Medical and Healthcare [Member]
Goodwill [Line Items]
Goodwill	310,210	310,210	310,210
Financial Services [Member]
Goodwill [Line Items]
Goodwill	$ 376,025	$ 377,046	$ 317,475

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill, by Segment) (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jun. 30, 2019	Mar. 31, 2020	Mar. 31, 2019
Goodwill [Line Items]
Goodwill beginning balance	$ 627,685	$ 687,256	$ 627,909
Purchase Accounting Adjustments		(92)
Acquisitions	59,519
Foreign exchange rate changes	52	(929)	(224)
Goodwill ending balance	687,256	686,235	627,685
Medical and Healthcare [Member]
Goodwill [Line Items]
Goodwill beginning balance	310,210	310,210	310,210
Purchase Accounting Adjustments		0
Acquisitions	0
Foreign exchange rate changes	0	0	0
Goodwill ending balance	310,210	310,210	310,210
Financial Services [Member]
Goodwill [Line Items]
Goodwill beginning balance	317,475	377,046	317,699
Purchase Accounting Adjustments		(92)
Acquisitions	59,519
Foreign exchange rate changes	52	(929)	(224)
Goodwill ending balance	$ 377,046	$ 376,025	$ 317,475

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets (Schedule of Intangible Assets) (Detail) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019
Intangible Assets [Line Items]
Amortizable Intangible Assets, Gross Carrying Amount	$ 87,700	$ 93,100	$ 48,400
Amortizable Intangible Assets, Accumulated Amortization	(22,514)	(20,128)	(17,998)
Indefinite-lived Intangible Assets, Gross Carrying Amount	224,906	225,017	206,611
Customer Relationships [Member]
Intangible Assets [Line Items]
Amortizable Intangible Assets, Gross Carrying Amount	68,900	69,300	42,900
Amortizable Intangible Assets, Accumulated Amortization	$ (19,318)	(14,448)	(13,071)
Amortizable Intangible Assets, Weighted Average Amortization Period	10 years
Curriculum/Software [Member]
Intangible Assets [Line Items]
Amortizable Intangible Assets, Gross Carrying Amount	$ 11,600	16,600	5,000
Amortizable Intangible Assets, Accumulated Amortization	$ (1,611)	(5,193)	(4,583)
Amortizable Intangible Assets, Weighted Average Amortization Period	6 years
Course Delivery Technology
Intangible Assets [Line Items]
Amortizable Intangible Assets, Gross Carrying Amount	$ 7,200	7,200
Amortizable Intangible Assets, Accumulated Amortization	$ (1,585)	(487)
Amortizable Intangible Assets, Weighted Average Amortization Period	5 years
Patented Technology [Member]
Intangible Assets [Line Items]
Amortizable Intangible Assets, Gross Carrying Amount			500
Amortizable Intangible Assets, Accumulated Amortization			(344)
Trade Names [Member]
Intangible Assets [Line Items]
Indefinite-lived Intangible Assets, Gross Carrying Amount	$ 95,666	95,777	77,371
Chamberlain Title IV Eligibility And Accreditations [Member]
Intangible Assets [Line Items]
Indefinite-lived Intangible Assets, Gross Carrying Amount	1,200	1,200	1,200
AUC Title IV Eligibility And Accreditations [Member]
Intangible Assets [Line Items]
Indefinite-lived Intangible Assets, Gross Carrying Amount	100,000	100,000	100,000
Ross Title IV Eligibility And Accreditations [Member]
Intangible Assets [Line Items]
Indefinite-lived Intangible Assets, Gross Carrying Amount	14,100	14,100	14,100
Intellectual Property [Member]
Intangible Assets [Line Items]
Indefinite-lived Intangible Assets, Gross Carrying Amount	$ 13,940	$ 13,940	$ 13,940

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets (Summary of Indefinite-Lived Intangible Assets Balances by Reporting Segment) (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets balances	$ 224,906	$ 225,017	$ 206,611
Medical and Healthcare [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets balances	137,500	137,500	137,500
Financial Services [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets balances	$ 87,406	$ 87,517	$ 69,111

Goodwill and Intangible Asset_7

Goodwill and Intangible Assets (Estimated Amortization Expense for Amortized Intangible Assets) (Detail) - Financial Services [Member] $ in Thousands	Mar. 31, 2020USD ($)
Intangible Assets [Line Items]
2020 (Remaining)	$ 2,576
2021	10,073
2022	9,944
2023	9,792
2024	9,509
Thereafter	23,292
Total	$ 65,186

Goodwill and Intangible Asset_8

Goodwill and Intangible Assets (Additional Information) (Detail) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	May 31, 2019USD ($)	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Mar. 31, 2020USD ($)segment	Mar. 31, 2019USD ($)	Jun. 30, 2019USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Number of reporting units | segment				4
Amortization of Intangible Assets		$ 2,576	$ 1,605	$ 7,686	$ 4,816
Goodwill write-off	$ 0					$ 0

Debt (Long-term debt) (Detail)

Debt (Long-term debt) (Detail) - USD ($)	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019
Total Debt:
Long-term Debt, Gross	$ 454,750,000	$ 407,000,000	$ 297,750,000
Line of credit			0
Deferred Debt Issuance Costs	(6,793,000)	(7,967,000)
Total Amount Outstanding	449,610,000	401,094,000	291,589,000
Less Current Portion:
Term B Loan	(3,000,000)	(3,000,000)	(3,000,000)
Noncurrent Portion	446,610,000	398,094,000	288,589,000
Revolver [Member]
Total Debt:
Long-term Debt, Gross	160,000,000	110,000,000
Term Loan [Member]
Total Debt:
Long-term Debt, Gross	294,750,000	297,000,000	297,750,000
Deferred Debt Issuance Costs	$ (5,140,000)	$ (5,906,000)	$ (6,161,000)

Debt (Scheduled maturities of l

Debt (Scheduled maturities of long-term debt) (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019
Debt Disclosure [Abstract]
2020 (remaining)	$ 750
2021	3,000
2022	3,000
2023	163,000
2024	3,000
Thereafter	282,000
Long-term Debt	$ 454,750	$ 407,000	$ 297,750

Debt (Debt Issuance Costs) (Det

Debt (Debt Issuance Costs) (Detail) $ in Thousands	Mar. 31, 2020USD ($)
Deferred Debt Issuance Costs at June 30, 2019	$ 7,967
Amortization of Deferred Debt Issuance Costs	(1,174)
Deferred debt issuance costs as of December 31, 2019	6,793
Term B Loan [Member]
Deferred Debt Issuance Costs at June 30, 2019	5,906
Amortization of Deferred Debt Issuance Costs	(766)
Deferred debt issuance costs as of December 31, 2019	5,140
Revolver [Member]
Deferred Debt Issuance Costs at June 30, 2019	2,061
Amortization of Deferred Debt Issuance Costs	(408)
Deferred debt issuance costs as of December 31, 2019	$ 1,653

Debt (Additional Information) (

Debt (Additional Information) (Detail) - USD ($)	Mar. 24, 2020	Apr. 13, 2018	Dec. 31, 2016	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019
Line of Credit Facility [Line Items]
Letters of credit outstanding			$ 68,400,000	$ 68,400,000	$ 68,400,000	$ 68,400,000
Letter Of Credit Title Iv Disbursement Percentage			10.00%
Commitment fee percentage				0.40%
Credit annual fee percentage reimbursement				2.00%
Annual fee percentage				2.25%
Line of Credit facility, initiation date		Apr. 13, 2018
Outstanding letters of credit				$ 71,600,000
Long-term debt				449,610,000	401,094,000	291,589,000
Increase in line of credit facility		$ 250,000,000
Long-term Line of Credit						0
Debt issuance costs, gross		$ 9,900,000
Long-term debt, gross				$ 454,750,000	$ 407,000,000	$ 297,750,000
Term Loan [Member]
Line of Credit Facility [Line Items]
Interest rate for borrowings under the Term B Loan facility				3.99%	5.40%	5.50%
Debt instrument, maturity date		Apr. 13, 2025
Debt instrument, face amount		$ 300,000,000
Principal payment		750,000
Debt issuance costs, gross		$ 7,100,000
Amortization period		7 years
Weighted Average
Line of Credit Facility [Line Items]
Application rate, percentage				2.86%
Eurocurrency Rate [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Debt instrument, description of variable rate basis				LIBOR-equivalent rate plus 3%
Basic spread rate	3.00%			3.00%
Base Rate [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Debt instrument, description of variable rate basis				base rate plus 2%
Basic spread rate				2.00%
Revolver [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity		$ 300,000,000
Line of credit facility, expiration date		Apr. 13, 2023
Foreign currency borrowing capacity		$ 200,000,000
Long-term Line of Credit				$ 160,000,000	$ 110,000,000
Debt issuance costs, gross		$ 2,700,000
Amortization period		5 years
Revolver [Member] | Minimum
Line of Credit Facility [Line Items]
Application rate, percentage				1.75%
Revolver [Member] | Maximum
Line of Credit Facility [Line Items]
Application rate, percentage				2.75%
Revolver [Member] | Weighted Average
Line of Credit Facility [Line Items]
Application rate, percentage					4.66%
Revolver [Member] | Prime Rate [Member] | Minimum
Line of Credit Facility [Line Items]
Application rate, percentage				0.75%
Revolver [Member] | Prime Rate [Member] | Maximum
Line of Credit Facility [Line Items]
Application rate, percentage				1.75%
Letter of Credit [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity		$ 100,000,000
Term B Loan [Member]
Line of Credit Facility [Line Items]
Debt Covenant, Mandatory Cash Payment In Excess Of Amount Minimum				$ 50,000,000
Interest Rate Swap | Term Loan [Member]
Line of Credit Facility [Line Items]
Derivative, Fixed Interest Rate	0.946%
Derivative, Swaption Interest Rate				3.946%
Interest Rate Swap | LIBOR | Minimum | Term Loan [Member]
Line of Credit Facility [Line Items]
Derivative, Floor Interest Rate	0.00%

Redeemable Noncontrolling Int_3

Redeemable Noncontrolling Interest (Reconciliation of Non-Controlling Interest Balance) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Noncontrolling Interest [Abstract]
Balance at Beginning of Period	$ 3,082	$ 8,651	$ 9,543	$ 9,110
Net (loss) income attributable to redeemable noncontrolling interest	(120)	(39)	(334)	117
Decrease in redemption value of redeemable noncontrolling interest put option		(130)		(745)
Payment for purchase of redeemable noncontrolling interest of subsidiary			(6,247)
Balance at End of Period	$ 2,962	$ 8,482	$ 2,962	$ 8,482

Redeemable Noncontrolling Int_4

Redeemable Noncontrolling Interest (Additional Information) (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Mar. 31, 2020	Mar. 26, 2020	Jul. 01, 2019	Jun. 30, 2019
Noncontrolling Interest [Line Items]
Decrease in noncontrolling interest		$ 6,247
Adtalem Brazil [Member]
Noncontrolling Interest [Line Items]
Ownership interest of parent in subsidiary				100.00%	97.90%
Decrease in noncontrolling interest	$ 6,200
Edupristine [Member]
Noncontrolling Interest [Line Items]
Ownership interest of parent in subsidiary		71.00%
Ownership percentage held by minority available for purchase			33.00%
Adtalem Brazil Senior Management Group [Member] | Adtalem Brazil [Member]
Noncontrolling Interest [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners					2.10%
Kaizen [Member] | Edupristine [Member]
Noncontrolling Interest [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners		29.00%

Share Repurchase (Detail)

Share Repurchase (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended		21 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Jan. 29, 2020	Nov. 07, 2018
Equity, Class of Treasury Stock [Line Items]
Total number of share repurchases	1,164,308	1,266,160	3,838,275	3,631,611	6,383,431
Total cost of share repurchases	$ 36,870	$ 60,970	$ 136,889	$ 176,903	$ 254,769
Average price paid per share	$ 31.67	$ 48.15	$ 35.66	$ 48.71	$ 39.91
Authorized On January Thirty-One Two-Thousand Twenty [Member]
Equity, Class of Treasury Stock [Line Items]
Authorized amount for repurchase						$ 300,000
Maximum | Authorized on November 7, 2018
Equity, Class of Treasury Stock [Line Items]
Authorized amount for repurchase							$ 300,000
Remaining authorized amount for repurchase	$ 45,200		$ 45,200		$ 45,200

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at the beginning of period - Net of Tax	$ 1,294,912	$ 1,429,647	$ 1,391,530	$ 1,519,286
Balance at the end of period - Net of Tax	1,294,559	1,404,587	1,294,559	1,404,587
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at the beginning of period - Net of Tax	(159,118)	(143,518)	(137,290)	(142,168)
ASU 2016-01 cumulative effect adjustment - Net of Tax				(381)
Balance at the end of period - Net of Tax	(276,379)	(148,706)	(276,379)	(148,706)
Foreign currency translation adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at the beginning of period - Net of Tax	(159,259)	(143,529)	(137,389)	(142,574)
Other comprehensive income (loss) - Gross	(117,669)	(5,238)	(139,539)	(6,193)
Balance at the end of period - Net of Tax	(276,928)	(148,767)	(276,928)	(148,767)
Marketable Securities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at the beginning of period - Gross	186	15	131	537
Balance at the beginning of period - Tax	(45)	(4)	(32)	(131)
Balance at the beginning of period - Net of Tax	141	11	99	406
ASU 2016-01 cumulative effect adjustment - Gross				(381)
Other comprehensive income (loss) - Gross	(58)	66	(3)	48
Other comprehensive income (loss) - Tax	(14)	16	(1)	12
Balance at the end of period - Net of Tax	97	$ 61	97	$ 61
Interest Rate Swap
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) - Gross	598		598
Other comprehensive income (loss) - Tax	(146)		(146)
Balance at the end of period - Net of Tax	$ 452		$ 452

Stock-Based Compensation (Summa

Stock-Based Compensation (Summary of Options Activity) (Detail) - Stock Option $ / shares in Units, $ in Thousands	9 Months Ended
	Mar. 31, 2020USD ($)$ / sharesshares
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Number of Options, Outstanding at beginning of period | shares	1,488,478
Number of Options, Granted | shares	229,125
Number of Options, Exercised | shares	(85,234)
Number of Options Forfeited | shares	(65,946)
Number of Options Expired | shares	(70,604)
Number of Options, Outstanding at end of period | shares	1,495,819
Number of Options, Exercisable at end of period | shares	716,037
Weighted Average Exercise Price at beginning of period | $ / shares	$ 31.33
Weighted Average Exercise Price, Options Granted | $ / shares	43.39
Weighted Average Exercise Price, Options Exercised | $ / shares	27.54
Weighted Average Exercise Price, Options Forfeited | $ / shares	42.76
Weighted Average Exercise Price, Options Expired | $ / shares	51.81
Weighted Average Exercise Price, Outstanding at end of period | $ / shares	31.90
Weighted Average Exercise Price, Exercisable at end of period | $ / shares	$ 28.43
Weighted Average Remaining Contractual Life, Outstanding at end of period	6 years 7 months 9 days
Weighted Average Remaining Contractual Life, Exercisable at end of period	5 years 3 months 25 days
Aggregate Intrinsic Value, Outstanding at End of period | $	$ 2,937
Aggregate Intrinsic Value, Exercisable at end of period | $	$ 2,082

Stock-Based Compensation (Fair

Stock-Based Compensation (Fair Values of Stock Option Awards Weighted Average Assumptions) (Detail)	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Expected Life (in Years)	6 years 6 months 3 days	6 years 6 months
Expected Volatility	37.66%	39.60%
Risk-free Interest Rate	1.40%	2.73%
Dividend Yield	0.00%	0.00%

Stock-Based Compensation (Sum_2

Stock-Based Compensation (Summary of Restricted Stock Units Activity) (Detail) - Restricted Stock Units - $ / shares	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Units Outstanding at beginning of period	878,030
Restricted Stock Units Outstanding, Shares Granted	408,520
Restricted Stock Units Outstanding, Shares Vested	(362,036)
Restricted Stock Units Outstanding, Shares Forfeited	(121,914)
Restricted Stock Units Outstanding at end of period	802,600
Weighted Average Grant Date Fair Value, Nonvested beginning balance	$ 34.86
Weighted Average Grant Date Fair Value, Shares Granted	42.38	$ 49.57
Weighted Average Grant Date Fair Value, Shares Vested	28.75
Weighted Average Grant Date Fair Value, Shares Forfeited	40.17
Weighted Average Grant Date Fair Value, Nonvested ending balance	$ 39.08

Stock-Based Compensation (Total

Stock-Based Compensation (Total Stock-Based Compensation Expense Included in Consolidated Statement of Income) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation Expense	$ 2,781	$ 3,008	$ 11,328	$ 10,369
Income Tax Benefit	(642)	(692)	(3,887)	(3,930)
Net Stock-Based Compensation Expense	2,139	2,316	7,441	6,439
Cost of Educational Services
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation Expense	260	279	1,027	976
Student Services And Administrative Expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation Expense	$ 2,521	$ 2,729	$ 10,301	$ 9,393

Stock-Based Compensation (Addit

Stock-Based Compensation (Additional Information) (Detail)	9 Months Ended		12 Months Ended
	Mar. 31, 2020USD ($)item$ / sharesshares	Mar. 31, 2019USD ($)$ / shares	Jun. 30, 2019USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total intrinsic value of options exercised | $	$ 900,000	$ 4,200,000
Total pre-tax unrecognized compensation costs related to non-vested awards | $	$ 21,800,000
Total pre-tax unrecognized compensation costs related to non-vested awards expected to be recognized, years	2 years 4 months 24 days
Total fair value of options and Restricted Stock Units vested | $	$ 13,500,000	13,700,000
Share-based Payment Arrangement, Amount Capitalized | $	$ 0	$ 0	$ 0
Stock Incentive Plans
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangements plans | item	2
Weighted average estimated grant date fair values, for options granted at market price, per share | $ / shares	$ 16.98	$ 20.96
Common Stock, Capital Shares Reserved for Future Issuance | shares	6,655,935
Stock Incentive Plans | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of options (in years)	10 years
Vesting Period (in years)	5 years
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares	$ 42.38	$ 49.57
Restricted Stock Units Outstanding, Shares Granted | shares	408,520
Performance Based Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of options (in years)	3 years
Restricted Stock Units Outstanding, Shares Granted | shares	135,660
Non-Performance Based Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of options (in years)	3 years
Restricted Stock Units Outstanding, Shares Granted | shares	272,860
Non-Performance Based Shares | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of options (in years)	1 year
Non-Performance Based Shares | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of options (in years)	4 years

Fair Value Measurements (Detail

Fair Value Measurements (Details) R$ in Millions, $ in Millions	3 Months Ended	9 Months Ended
	Mar. 31, 2020USD ($)	Mar. 31, 2020USD ($)	Mar. 31, 2020BRL (R$)
Derivatives, Fair Value [Line Items]
Gain on cash flow hedge	$ 111.8	$ 83.8
Adtalem Educacional Do Brasil [Member] | Discontinued Operations, Disposed of by Sale
Derivatives, Fair Value [Line Items]
Derivative notional amount	415	415	R$ 2154
Gain on cash flow hedge	111.8	83.8
Adtalem Educacional Do Brasil [Member] | Discontinued Operations, Disposed of by Sale | Prepaid Expenses and Other Current Assets
Derivatives, Fair Value [Line Items]
Derivative Asset	83.8	83.8
Term Loan [Member] | Other Assets | Interest Rate Swap
Derivatives, Fair Value [Line Items]
Derivative Asset	$ 0.6	$ 0.6

Commitments and Contingencies (

Commitments and Contingencies (Detail)

Nov. 25, 2019

Jul. 16, 2019individual

Apr. 04, 2019individual

Apr. 03, 2019class

Mar. 29, 2019class

Jan. 03, 2019individual

Jan. 02, 2019individualitem

Aug. 09, 2018individual

Jun. 27, 2018individual

May 08, 2018individual

Apr. 13, 2018class

Nov. 28, 2016individualstate

Oct. 28, 2016individualstate

Oct. 14, 2016stateindividual

Mar. 31, 2020lawsuit

Jun. 14, 2019lawsuit

Dec. 10, 2018lawsuit

Loss Contingencies [Line Items]

Number of lawsuits | lawsuit

2

Number of arbitrations | lawsuit

30

Number Of Arbitrations Answered | lawsuit

22

Petrizzo and Jara Case [Member]

Loss Contingencies [Line Items]

Number of other individuals filed lawsuit

38

Number of different states involved in lawsuit | state

15

Number of individual state specific putative class | state

15

Petrizzo Case [Member]

Loss Contingencies [Line Items]

Number of other individuals filed lawsuit

5

Number of different states involved in lawsuit | state

6

Jara Case [Member]

Loss Contingencies [Line Items]

Number of other individuals filed lawsuit

11

Number of different states involved in lawsuit | state

10

Nicole Versetto [Member]

Loss Contingencies [Line Items]

Number of other individuals filed lawsuit | class

3

Carlson Case [Member]

Loss Contingencies [Line Items]

Number of other individuals filed lawsuit

102

13

32

71

Number of groups plaintiffs motions to dismiss | item

3

Number of other individuals to whom notice has been sent

105

Percentage of graduates obtained job in field of study

90.00%

Stoltmann Case [Member]

Loss Contingencies [Line Items]

Number of other individuals filed lawsuit

399

Number Of Individuals to File Second Amended Claim

1

Robby Brown Case [Member]

Loss Contingencies [Line Items]

Number of other individuals filed lawsuit | class

2

T Lani Robinson Case [Member]

Loss Contingencies [Line Items]

Number of other individuals filed lawsuit | class

3

T Lani Robinson Case [Member] | Maximum

Loss Contingencies [Line Items]

Period of filling of class action complaint from date of order

14 days

Segment Information (Tabulation

Segment Information (Tabulation of Business Segment Information Based on Current Segmentation) (Detail) - USD ($) $ in Thousands	Sep. 27, 2019	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2019
Segment Reporting Information [Line Items]
Total Consolidated Revenue		$ 271,487	$ 258,703	$ 792,272	$ 749,603
Total Consolidated Assets		2,444,020	2,148,703	2,444,020	2,148,703	$ 2,242,696
Capital Expenditures				31,934	45,269
Restructuring expense		(1,854)	(2,186)	(10,339)	(45,194)
Gain on sale of assets		0	0	4,779	0
Insurance Settlement Gain				0	15,571
Total consolidated operating income from continuing operations		54,487	45,579	120,539	101,016
Net other income (expense)		105,881	(3,009)	69,816	(11,913)
Total consolidated income from continuing operations before income taxes		160,368	42,570	190,355	89,103
Total Consolidated Additions to Long-Lived Assets		11,623	13,211	31,934	45,269
Total Consolidated Depreciation Expense		8,549	8,813	25,773	24,726
Total Consolidated Intangible Asset Amortization Expense		2,576	1,605	7,686	4,816
Discontinued Operations, Held-for-sale [Member]
Segment Reporting Information [Line Items]
Total Consolidated Assets		490,978	557,499	490,978	557,499
Discontinued Operations, Held-for-sale [Member] | Columbus, Ohio Campus
Segment Reporting Information [Line Items]
Gain on sale of assets	$ 4,800
Medical and Healthcare [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue		227,344	223,575	655,011	638,302
Total Consolidated Assets		917,657	827,452	917,657	827,452
Restructuring expense		(810)	133	(1,354)	(41,327)
Total Consolidated Additions to Long-Lived Assets		7,274	10,978	20,108	37,696
Total Consolidated Depreciation Expense		7,127	7,680	21,898	20,449
Financial Services [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue		44,143	35,935	137,261	113,723
Total Consolidated Assets		577,699	446,752	577,699	446,752
Restructuring expense				(3,116)
Total Consolidated Additions to Long-Lived Assets		568	84	1,980	1,487
Total Consolidated Depreciation Expense		556	480	1,438	1,212
Total Consolidated Intangible Asset Amortization Expense		2,576	1,605	7,686	4,816
Home Office And Other [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue		0	(807)		(2,422)
Total Consolidated Assets		457,686	317,000	457,686	317,000
Restructuring expense		(1,044)	(2,319)	(5,869)	(3,867)
Total Consolidated Additions to Long-Lived Assets		3,781	2,149	9,846	6,086
Total Consolidated Depreciation Expense		866	653	2,437	3,065
Operating Segments [Member]
Segment Reporting Information [Line Items]
Total consolidated operating income from continuing operations		56,341	47,765	126,099	130,639
Operating Segments [Member] | Medical and Healthcare [Member]
Segment Reporting Information [Line Items]
Total consolidated operating income from continuing operations		57,559	52,960	127,786	141,152
Operating Segments [Member] | Financial Services [Member]
Segment Reporting Information [Line Items]
Total consolidated operating income from continuing operations		4,190	5,086	13,976	19,469
Operating Segments [Member] | Home Office And Other [Member]
Segment Reporting Information [Line Items]
Total consolidated operating income from continuing operations		(5,408)	(10,281)	(15,663)	(29,982)
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Restructuring expense		(1,854)	(2,186)	(10,339)	(45,194)
Gain on sale of assets		0	0	4,779	0
Insurance Settlement Gain		$ 0	$ 0	$ 0	$ 15,571

Segment Information (Revenues a

Segment Information (Revenues and Long-Lived Assets by Geographic Area) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Total Consolidated Revenue	$ 271,487	$ 258,703	$ 792,272	$ 749,603
Total Consolidated Long-lived Assets	371,171	333,773	371,171	333,773
Domestic Operations [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue	176,946	160,949	507,482	468,788
Total Consolidated Long-lived Assets	208,812	156,881	208,812	156,881
Barbados, Dominica, St. Kitts and St. Maarten [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue	92,259	95,366	277,934	274,207
Total Consolidated Long-lived Assets	160,552	174,827	160,552	174,827
Other International Operations [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue	2,282	2,388	6,856	6,608
Total Consolidated Long-lived Assets	1,807	2,065	1,807	2,065
International Operations [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue	94,541	97,754	284,790	280,815
Total Consolidated Long-lived Assets	$ 162,359	$ 176,892	$ 162,359	$ 176,892

Segment Information (Additional

Segment Information (Additional Information) (Detail)	3 Months Ended			9 Months Ended
	Mar. 31, 2020	Jun. 30, 2019segment	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2020segment	Mar. 31, 2020item	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Number of segments renamed		2
Number of reporting segments					2	2
Sales Revenue, Net [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage	10.00%		10.00%				10.00%	10.00%
Other International Operations [Member]
Segment Reporting Information [Line Items]
Concentration risk	less than 5%		less than 5%	less than 5%				less than 5%